Clinical Practice Guideline for Cardiac Rehabilitation in Korea by 源��슜�슧
Annals of Rehabilitation Medicine
Clinical Practice Guideline
Ann Rehabil Med 2019;43(3):355-443
pISSN: 2234-0645 • eISSN: 2234-0653
https://doi.org/10.5535/arm.2019.43.3.355
Clinical Practice Guideline for Cardiac 
Rehabilitation in Korea
Chul Kim, MD, PhD1, Jidong Sung, MD, PhD2, Jong Hwa Lee, MD, PhD3, Won-Seok Kim, MD, PhD4,5,  
Goo Joo Lee, MD6, Sungju Jee, MD, PhD7, Il-Young Jung, MD7, Ueon Woo Rah, MD, PhD8,  
Byung Ok Kim, MD, PhD9, Kyoung Hyo Choi, MD, PhD10, Bum Sun Kwon, MD, PhD11,  
Seung Don Yoo, MD, PhD12, Heui Je Bang, MD6, Hyung-Ik Shin, MD, PhD13, Yong Wook Kim, MD, PhD14, 
Heeyoune Jung, MD15, Eung Ju Kim, MD, PhD16, Jung Hwan Lee, MD, PhD17, In Hyun Jung, MD, PhD9,  
Jae-Seung Jung, MD, PhD18, Jong-Young Lee, MD, PhD19, Jae-Young Han, MD, PhD20,  
Eun Young Han, MD, PhD21, Yu Hui Won, MD, PhD22, Woosik Han, MD23, Sora Baek, MD, PhD24,  
Kyung-Lim Joa, MD, PhD25, Sook Joung Lee, MD, PhD26, Ae Ryoung Kim, MD27, So Young Lee, MD21,  
Jihee Kim, MD28, Hee Eun Choi, MD29, Byeong-Ju Lee, MD30, Soon Kim, PhD31
1Department of Rehabilitation Medicine, Inje University School of Medicine, Sanggye Paik Hospital, Seoul; 2Division of 
Cardiology, Department of Medicine, Sungkyunkwan University School of Medicine–Heart Vascular Stroke Institute, Samsung 
Medical Center, Seoul; 3Department of Physical Medicine and Rehabilitation, Dong-A University College of Medicine–Regional 
Cardiocerebrovascular Center, Dong-A Medical Center, Busan; 4Department of Rehabilitation Medicine,  Seoul National University 
Bundang Hospital, Seoul National University College of Medicine, Seongnam; 5Gyeonggi Regional Cardiocerebrovascular 
Center, Seongnam; 6Department of Rehabilitation Medicine, Chungbuk National University College of Medicine, Chungbuk 
National University Hospital, Chungbuk Regional Cardiocerebrovascular Center, Cheongju; 7Department of Rehabilitation 
Medicine, Chungnam National University College of Medicine–Daejeon Chungcheong Regional Cardiocerebrovascular Center, 
Chugnam National University Hospital, Daejeon; 8Department of Physical Medicine and Rehabilitation, Ajou University School 
of Medicine, Suwon; 9Department of Internal Medicine, Inje University School of Medicine, Sanggye Paik Hospital, Seoul; 
10Department of Rehabilitation Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul; 11Department of 
Rehabilitation Medicine, Dongguk University School of Medicine, Goyang; 12Department of Rehabilitation Medicine, Kyung Hee 
University College of Medicine, Seoul; 13Department of Rehabilitation Medicine, Seoul National University College of Medicine, 
Seoul National University Children's Hospital, Seoul; 14Department and Institute of Rehabilitation Medicine, Yonsei University 
College of Medicine, Seoul; 15National Traffic Injury Rehabilitation Hospital, Yangpyeong; 16Division of Cardiology, Department 
of Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul; 17Namdarun Rehabilitation Clinic, 
Received February 12, 2019; Accepted May 31, 2019
Corresponding author: Goo Joo Lee
Department of Rehabilitation Medicine, Chungbuk National University Hospital, 776 1(il)sunhwan-ro, Heungdeok-gu, Cheongju 28644, Korea. Tel: 
+82-43-269-7845, Fax: +82-43-269-6228, E-mail: rmdr29@cbnuh.or.kr
ORCID: Chul Kim (http://orcid.org/0000-0001-8223-2945); Jidong Sung (http://orcid.org/0000-0002-1006-5727); Jong Hwa Lee (http://orcid.org/0000-
0003-2489-358X); Won-Seok Kim (http://orcid.org/0000-0002-1199-5707); Goo Joo Lee (http://orcid.org/0000-0002-8436-4463); Sungju Jee (http://
orcid.org/0000-0002-9400-9609); Il-Young Jung (http://orcid.org/0000-0001-8204-8195); Ueon Woo Rah (http://orcid.org/0000-0002-5667-160X); 
Byung Ok Kim (http://orcid.org/0000-0002-7920-2750); Kyoung Hyo Choi (http://orcid.org/0000-0001-9137-3889); Bum Sun Kwon (http://orcid.
org/0000-0001-7755-435X); Seung Don Yoo (http://orcid.org/0000-0003-4513-2560); Heui Je Bang (http://orcid.org/0000-0001-5280-122X); Hyung-
Ik Shin (http://orcid.org/0000-0001-8805-3104); Yong Wook Kim (http://orcid.org/0000-0002-5234-2454); Heeyoune Jung (http://orcid.org/0000-
0002-4649-3053); Eung Ju Kim (http://orcid.org/0000-0003-2322-6267); Jung Hwan Lee (http://orcid.org/0000-0003-2680-6953); In Hyun Jung (http://
orcid.org/0000-0002-1793-215X); Jae-Seung Jung (http://orcid.org/0000-0002-8848-4112); Jong-Young Lee (http://orcid.org/0000-0001-5737-4968); 
Jae-Young Han (http://orcid.org/0000-0003-1672-8875); Eun Young Han (http://orcid.org/0000-0002-4780-8862); Yu Hui Won (http://orcid.org/0000-
0003-2007-9652); Woosik Han (http://orcid.org/0000-0003-4002-3154); Sora Baek (http://orcid.org/0000-0003-3404-6202); Kyung-Lim Joa (http://
orcid.org/0000-0002-3747-9831); Sook Joung Lee (http://orcid.org/0000-0002-6894-445X); Ae Ryoung Kim (http://orcid.org/0000-0003-3765-3024); 
So Young Lee (http://orcid.org/0000-0002-0433-4548); Jihee Kim (http://orcid.org/0000-0003-2758-124X); Hee Eun Choi (http://orcid.org/0000-0002-
8753-929X); Byeong-Ju Lee (http://orcid.org/0000-0002-7250-8909); Soon Kim (http://orcid.org/0000-0001-7154-2809).
 This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright © 2019 by Korean Academy of Rehabilitation Medicine
Chul Kim, et al.
356 www.e-arm.org
INTRODUCTION
Cardiovascular mortality rose by 42.8% over a 10-year 
period in South Korea, to become the second leading 
cause of death in 2014. According to a 2016 report by Sta-
tistics Korea, of 100,000 people, 58.2 died from cardiovas-
cular disease (CVD), and of these 52% died from ischemic 
heart disease, namely acute myocardial infarction (AMI) 
[1-3]. The high mortality rate is influenced by deaths at 
the time of onset as well as deaths from recurrence and 
complications in the short-term and long-term after on-
set. The disease is accompanied by multiple problems, 
such as reduced exercise capacity and poorer quality of 
life (QOL).
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Objective  Though clinical practice guidelines (CPGs) for cardiac rehabilitation (CR) are an effective and widely 
used treatment method worldwide, they are as yet not widely accepted in Korea. Given that cardiovascular disease 
is the second leading cause of death in Korea, it is urgent that CR programs be developed. In 2008, the Government 
of Korea implemented CR programs at 11 university hospitals as part of its Regional Cardio-Cerebrovascular 
Center Project, and three additional medical facilities will be added in 2019. In addition, owing to the promotion 
of CR nationwide and the introduction of CR insurance benefits, 40 medical institutions nationwide have begun 
CR programs even as a growing number of medical institutions are preparing to offer CR. The purpose of this 
research was to develop evidence-based CPGs to support CR implementation in Korea.
Methods  This study is based on an analysis of CPGs elsewhere in the world, an extensive literature search, a 
systematic analysis of multiple randomized control trials, and a CPG management, development, and assessment 
committee comprised of 33 authors—primarily rehabilitation specialists, cardiologists, and thoracic surgeons in 
21 university hospitals and two general hospitals. Twelve consultants, primarily rehabilitation, sports medicine, 
and preventive medicine specialists, CPG experts, nurses, physical therapists, clinical nutritionists, and library 
and information experts participated in the research and development of these CPGs. After the draft guidelines 
were developed, three rounds of public hearings were held with staff members from relevant academic societies 
and stakeholders, after which the guidelines were further reviewed and modified.
Principal Conclusions  CR involves a more cost-effective use of healthcare resources relative to that of general 
treatments, and the exercise component of CR lowers cardiovascular mortality and readmission rates, regardless 
of the type of coronary heart disease and type and setting of CR. Individualized CR programs should be considered 
together with various factors, including differences in heart function and lifestyle, and doing so will boost 
participation and adherence with the CR program, ultimately meeting the final goals of the program, namely 
reducing the recurrence of myocardial infarction and mortality rates.
Keywords  Acute coronary syndrome, Cardiac rehabilitation, Mortality, Clinical practice guidelines, Secondary 
prevention
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Acute coronary syndrome (ACS) clinically manifests 
as an acute condition, but is actually an acute onset of 
chronic systemic vascular disease (atherosclerosis) that 
has been progressing slowly over a long period. Further, 
despite receiving appropriate treatment in the acute 
phase, patients are left with a chronic vascular condition, 
so lifelong treatment and management is essential fol-
lowing discharge [4]. Moreover, even after being treated 
for acute CVD, patients with tachycardia, frequent ar-
rhythmia, reduced cardiac output, orthostatic hypoten-
sion, and exercise-induced hypertension have difficulty 
exercising, and older patients and those with complica-
tions face a permanent and marked reduction in their 
capacity to exercise at an appropriate fitness level. When 
this state persists, atherosclerosis progresses further, 
thereby causing adverse outcomes in the long-term—5 
to 10 years after onset (e.g., QOL, recurrence, readmis-
sion, death). Therefore, patients should be put on a 
cardiac rehabilitation (CR) program as soon as they are 
stabilized following acute phase treatment. This program 
includes individualized exercise training, optimal medi-
cal treatment, and education for self-care of risk factors 
(e.g., smoking cessation, diet therapy, physical activities, 
diabetes and hypertension management, stress manage-
ment).
CR is actively performed in many Western countries, 
where its effectiveness and safety have already been es-
tablished, and clinical practice guidelines (CPGs) for CR 
have been developed in consideration of each country’s 
circumstances, and medical and scientific evidence 
documenting CR has been systematically organized to 
inform medical professionals’ decision-making [4-9]. 
In Korea, on the other hand, CVD treatment is still 
focused on acute phase treatment and lacks a sound 
understanding of CR. As a result, only a handful of hos-
pitals nationwide offer CR. The purpose of this research 
is to develop CPGs that will promote CR in Korea. The 
CPGs proposed here are based on medical and scientific 
evidence, and are intended to inform medical decision-
making. These guidelines should not be uniformly ap-
plied to all patients, and medical professionals must 
make final decisions in consideration of a patient’s medi-
cal state and other circumstances. These CPGs do not 
limit a physician’s practice, and neither can they be used 
to assess or review a physician’s practice.
These CPGs address CR and secondary prevention pro-
grams for male and female adult patients who have been 
admitted and treated for ACS and survived the acute 
phase treatment. They do not deal with primary preven-
tion of CVD or CR among pediatric patients. Moreover, 
due to limited time and resources, this first edition does 
not cover heart failure, valvular heart diseases, congeni-
tal heart diseases, arrhythmia, or other heart and periph-
eral vascular deformities, as such contents will be devel-
oped in future revisions and updates. ACS includes AMI 
and unstable angina, and acute phase treatment includes 
intensive treatment at the coronary care unit (CCU), 
medical drug therapy, percutaneous coronary interven-
tions (PCIs), and coronary artery bypass grafting (CABG) 
surgery.
More specifically, the purpose of these CPGs is to pro-
vide best practice guidelines for CR after ACS based on 
objective, scientific evidence, for physicians and other 
medical professionals (e.g., nurses, physical therapists, 
clinical nutritionists) responsible for CR of patients with 
ACS. Furthermore, these guidelines were developed in 
an attempt to minimize gaps between medical and sci-
entific evidence and actual clinical practice, as well as 
gaps in CR treatments across hospitals and physicians, 
thereby ultimately contributing to the development of 
a universal, evidence-based CR program. These CPGs 
discuss the health benefits and risks of each individual 
patient requiring CR. Their ultimate objective is to im-
prove patients’ QOL by restoring their cardiopulmonary 
functions, reducing recurrence and readmission, and 
lowering mortality rates.
These are the first CPGs for CR to be developed in Ko-
rea. Some contents of the Scottish [5] guidelines for CR 
were adapted with additional references to other foreign 
CPGs for CR [4-9], and based on studies published be-
tween January 1, 2009 and April 30, 2018. However, these 
CPGs only deal with patients experiencing ACS, so in 
future they will have to be supplemented by including 
content for other heart diseases. We aim to revise these 
guidelines every 3–4 years, when a consensus is reached 
on the need for revisions in light of new knowledge.
METHODS
Research framework
The group that developed these CPGs was comprised 
of writers and consultants. Thirty-three authors, primar-
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ily rehabilitation specialists, cardiologists, and thoracic 
surgeons in 21 university hospitals and two general hos-
pitals, were involved in the CPG management, develop-
ment, and assessment committees. During the research 
and development process, opinions were garnered from 
12 consultants including rehabilitation, sports, and pre-
ventive medicine specialists, CPG experts, nurses, physi-
cal therapists, clinical nutritionists, and library and infor-
mation experts.
This research was based on an extensive literature 
review of CR, the assessment of CR outcomes, exercise 
therapies appropriate for CR, and educational compo-
nents for secondary prevention. The key questions relat-
ed to each of these aspects were selected during a process 
that involved all members of the CPG management and 
development committees, and finalized with reference 
to the latest foreign CPGs [4-9], in consultation with the 
CPG consultation committee. Individual guidelines were 
then developed in relation to circumstances in Korea. 
Key questions that had not been adequately analyzed in 
existing guidelines were developed de novo, and finalized 
in consultation with the CPG consultation committee in 
consideration of the circumstances in Korea.
To select foreign CPGs for adaptation, the Scottish 
(2017) [5], British (2013) [6], American (2011) [7], Cana-
dian (2009) [4], and Japanese (2012) [8] CPGs for CR pub-
lished within the past ten years were evaluated using ac-
cepted Appraisal Guidelines for Research and Evaluation 
II (AGREE II) [10]. Two investigators appraised one set 
of CPGs, and guidelines assigned an average ‘total score 
for each domain’ of 80 or greater (out of a score of 161) by 
two investigators, and a ‘rigor of development’ score of 
70% or greater for each domain (out of a score of 56).
As summarized in Table 1, the Scottish (2017) [5] and 
British (2013) [6] CPGs were selected after being reviewed 
by the CPG management committees, and the Scottish 
Intercollegiate Guidelines Network (SIGN) CPGs [5], 
which had been published more recently, were chosen as 
the major guidelines for adaptation in this study. Refer-
ences regarding specific key questions and topics were 
taken from all five foreign CPGs [4-9].
Percentage score for each domain (%) = 
Total score for each domain - minimum score for each domain
Maximum score for each domain - minimum score for each domain
×100
The key questions were used to inform the CPGs were 
primarily selected during a process that involved all 
members of the CPG management and development 
committees. The Scottish CPGs (SIGN 2017) [5] were used 
as the primary reference, but the English (NICE 2013) [6], 
American (AHA 2011) [7], Canadian (CACR 2009) [4], and 
Japanese (JCS 2012) [8] CPGs were also used for reference 
in relation to key questions not adequately addressed in 
the SIGN 2017 guidelines. Those developed de novo due 
to the lack of available references were as follows: “Is a 
submaximal exercise test, such as a 6-minute walk test 
Table 1. Appraisal of foreign clinical practice guidelines for cardiac rehabilitation with AGREE II
Guideline (country)
Reviewer 
no#
Rigor of 
development
Rigor 
percentage
Total score for 
each domain
Overall 
appraisal
Result
SIGN 2017 (Scotland) 1 50 83 130 6 Selected
2 46 125 6
NICE 2013 (England) 3 50 89 121 6 Partial selection
4 56 135 6
AHA 2011 (USA) 5 37 67 90 5 Partial selection
6 30 89 4
CACR 2009 (Canada) 7 20 44 71 3 Partial reference
8 38 99 4
JCS 2012 (Japan) 7 26 34 70 3 Partial reference
8 23 75 4
AGREE, Appraisal Guidelines for Research and Evaluation; SIGN, Scottish Intercollegiate Guidelines Network; NICE, 
National Institute for Health and Care Excellence; AHA, American Heart Association; CACR, Canadian Association of 
Cardiac Rehabilitation; JCS, Japanese Circulation Society.
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useful for cardiac rehabilitation?”, “Is high-intensity in-
terval training more effective than continuous moderate-
intensity training as an aerobic exercise?”, and “Should 
policosanol be recommended as a food supplement?” 
(Table 2).
Data sources
To gather evidence to inform the development of the 
CPGs, PubMed was searched using the following key 
terms and search strategies: Search (‘cardiac rehabilita-
tion’ [TIAB] OR ‘cardiac rehabilitation’ [MeSH]), Filters 
(Consensus Development Conference; Guideline; NIH; 
Practice Guidelines). In addition, PubMed was searched 
for guidelines using key words such as myocardial infarc-
tion (MI) as follows: Search ((rehabilitation or ‘second-
ary prevention’) and (‘myocardial infarction’ or ‘acute 
coronary syndrome’)), Filters (Consensus Development 
Conference; NIH; Guidelines; Practice Guidelines).
Studies published after publication of the latest foreign 
CPGs were primarily found in the following three data-
bases: Cochrane Library (www.cochranelibrary.com), 
PubMed (www.ncbi.nlm.nih.gov/pubmed), and EMBASE 
(www.embase.com).
MeSH terms were used ‘cardiac rehabilitation’ in the 
Cochrane Library and PubMed, and Emtree terms ‘heart 
rehabilitation’ were used when searching EMBASE. Based 
Table 2. Key questions for clinical practice guidelines for cardiac rehabilitation
Question Description
KQ1 Must cardiac rehabilitation be included in the treatment of acute coronary syndrome? 
KQ2 Does cardiac rehabilitation influence the outcome of patients with cardiovascular disease?
KQ3 Does cardiac rehabilitation improve the quality of life of patients with cardiovascular disease? 
KQ4 When should cardiac rehabilitation be begun? (Timing of cardiac rehabilitation)
KQ5 How should cardiac rehabilitation programs be structured? 
KQ6 Can cardiac rehabilitation programs lower health management costs for patients with acute coronary 
syndrome? 
KQ7 Are individualized cardiac rehabilitation programs more effective than the existing fixed cardiac 
rehabilitation program?
KQ8 Should psychological interventions concerning anxiety, depression, and stress be included in the 
cardiac rehabilitation program? 
KQ9 Is a cardiopulmonary exercise test necessary for cardiac rehabilitation? 
KQ10 Is a submaximal exercise test, such as a 6-minute walk test, useful for cardiac rehabilitation? 
KQ11 What are the effective measures for promoting participation in cardiac rehabilitation? 
KQ12 What are the effective measures for increasing physical activity compliance rates? 
KQ13 When should patients begin cardiac rehabilitation following coronary artery bypass grafting? 
KQ14 Should aerobic exercises be included in the cardiac rehabilitation program? 
KQ15 Should resistance (muscle training) exercises be included in the cardiac rehabilitation program? 
KQ16 How can the safety of cardiac rehabilitation exercises be enhanced? 
KQ17 Can a home-based cardiac rehabilitation program replace a hospital-based cardiac rehabilitation 
program? 
KQ18 Should cardiac rehabilitation programs be recommended to elderly patients?
KQ19 Is patient education a necessary part of cardiac rehabilitation? 
KQ20 What contents should be included in patient education? 
KQ21 What interventions are needed to improve patients’ adherence to taking their medications?
KQ22 What is an effective intervention for patients who need to stop smoking?
KQ23 What diet therapies are recommended for patients undergoing cardiac rehabilitation? 
KQ24 Should a specific food supplement be recommended? 
KQ25 Would an ICT-based modality be helpful in maintaining the effects of education in the long-term? 
ICT, information & communication technology.
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on the search strategies used in SIGN 2017, CR-related 
search strategies for each study question were developed, 
and the specific search terms for each were entered us-
ing AND or OR operators. Operators and synonyms were 
taken from the search strategies published in Cochrane 
Review articles found in the Cochrane Library using the 
MESH term ‘cardiac rehabilitation’. After conducting a 
search in the Cochrane Library, the search strategy was 
saved, and the same search strategy used in the EMBASE. 
The Cochrane Library and EMBASE use the same search 
strategies, such as proximity operators, and the search 
strategy for PubMed was also nearly identical, with the 
exception of different proximity operators. Therefore, 
due to space limitations, we present only the search strat-
egy used for the Cochrane Library in this report (refer 
to Appendix). When making revisions with reference to 
existing guidelines, we limited the searches to systematic 
review articles, and the year of publication was set to the 
year following the publication of the existing guidelines. 
Korean articles were searched in RISS, KMbase, and Ko-
reaMed using terms ‘cardiac rehabilitation’ and ‘심장재
활’ (cardiac rehabilitation). After the duplicate removal, 
the two researchers selected the first, second, and third 
document selection for the same documents. In case of 
disagreement during the article selection process, the 
consensus was reached after the discussion or the final 
decision was made by the third researcher’s arbitration.
For assessing the methodological quality of article, 
AMSTAR 2.0, GRADE system used for systematic re-
view, Cochrane risk-of-bias (RoB) used for randomized 
controlled trials, and the RoB assessment tool for non-
randomized studies (RoBANS) used for non-randomized 
controlled trials. Two researchers evaluated the quality 
of one article. In case of disagreement during the assess-
ing the methodological quality of article, the consensus 
was reached after the discussion or the final decision was 
made by the third researcher’s arbitration. Data obtained 
in the search were accepted as evidence of the studies’ 
populations (human cases of ACS), designs, and methods 
(sample size, blinding, data analysis), results (objectivity 
of results and consistency throughout studies), language 
(Korean and English), and applicability to Korea. Both 
adaptation and de novo methods were used. For the for-
mer, all available evidence cited in foreign guidelines was 
reviewed, as the level of evidence and recommendations 
presented by each country used different evidence ap-
praisal methods, and an evidence chart was developed 
based on all the subsequent evidence published after 
the publication of the latest foreign CPGs. After drafting 
the CPGs, the levels of evidence (LOE) and strength of 
recommendations (SOR) were determined based on the 
evidence chart and with reference to the method used in 
the SIGN 2017 [5]. 
LOE ranged from 1++ (highest quality) to 4 (lowest 
quality) [5] (Table 3). The SOR was determined in consid-
eration of the LOE, reliability and consistency of the LOE, 
impact on patients, applicability in Korea, and balance 
between harm and benefits, but instead of following the 
GRADE classification of ABCD, recommendations were 
classified as either strong or conditional and Good-Prac-
tice Points (GPPs) were given according to the method 
used in the SIGN 2017 (Table 4). The SIGN stopped using 
Table 3. Levels of evidence [5]
Level Evidence statement
1++ High-quality meta-analyses, systematic reviews of randomized control trials, or randomized control 
trials with a very low risk of bias
1+ Well-conducted meta-analyses, systematic reviews, or randomized control trials with a low risk of bias
1- Meta-analyses, systematic reviews, or randomized control trials with a high risk of bias
2++ High-quality systematic reviews of case-control or cohort studies
High-quality case-control or cohort studies with a very low risk of confounding or bias and a high 
probability that the relationship is causal
2+ Well-conducted case-control or cohort studies with a low risk of confounding or bias and a moderate 
probability that the relationship is causal
2- Case-control or cohort studies with a high risk of confounding or bias and a significant risk that the 
relationship is not causal
3 Non-analytic studies (e.g., case reports, case series)
4 Expert opinion
Recommendations for Cardiac Rehabilitation and Secondary Prevention After Acute Coronary Syndrome
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the ABCD classification in 2013 due difficulties associ-
ated with its practical application, and has been classify-
ing recommendations into strong, conditional, and GPPs 
since then [5].
Process followed to develop cPGs
Expert panels consisting of 11 rehabilitation special-
ists, cardiologists, and thoracic surgeons achieved formal 
consensus using the nominal group technique. Authors 
of the draft guidelines first reviewed the evidence collect-
ed with these panels, and then conducted a question and 
answer session, after which the final recommendations 
and the LOEs and SORs were determined through a vote. 
Participants gave their opinions using a 9-point scale (1, 
2, 3 ‘inappropriate’; 4, 5, 6 ‘uncertain’; 7, 8, 9 ‘appropri-
ate’). If the ratings given by more than 70% of the panel 
(8 out of 11) were within a single 3-point band, and there 
were no objections with the phrasing of the recommen-
dation, a consensus was deemed to have been reached.
The SORs were indicated as strong, conditional, or 
GPPs, in consideration of the LOE, likely impacts on pa-
tients, their applicability in Korea, and the balance that 
would be achieved between benefits and harm. ‘Strong’ 
recommendations were used when it was deemed that 
the benefits of the recommendation would outweigh 
the harm for a vast majority of people. If recommended, 
it was phrased as ‘must be performed’, ‘should be per-
formed’, or ‘should be strongly recommended’. If it was 
not recommended, the possible phrases used were ‘must 
not be performed’, ‘should not be performed’, and ‘should 
not be recommended’. The word ‘conditional’ was used 
when the benefits of the recommendation would out-
weigh its harms on most people. If recommended, it was 
phrased as ‘recommend’ or ‘is recommended’, and if it 
was not recommended, it was phrased as ‘should not be 
performed’ and ‘is not recommended’. Therefore, for in-
terventions that were conditionally recommended, per-
formance should be determined on the basis of an indi-
vidual’s values and preferences, and after discussing the 
intervention with the patient and ensuring the decision is 
based on a thorough understanding of the intervention’s 
importance. Finally, GPPs were used when the SORs 
could not be determined due to a low LOE in the litera-
ture but the practice was deemed to be a recommended 
Table 4. Recommendations and Good-Practice Points [5]
Recommendation Some recommendations can be made with more certainty than others. The wording 
used in the recommendations in this guideline denotes the certainty with which the 
recommendation is made (the ‘strength’ of the recommendation).
The ‘strength’ of a recommendation takes into account the quality (level) of the 
evidence. Although higher-quality evidence is more likely to be associated with 
strong recommendations than lower-quality evidence, a particular level of quality 
does not automatically lead to a particular strength of recommendation.
Other factors that are taken into account when forming recommendations include: 
relevance to the NHS in Scotland; applicability of published evidence to the target 
population; consistency of the body of evidence, and the balance of benefits and 
harms of the options.
R For ‘strong’ recommendations on interventions that ‘should’ be used, the 
guideline development group is confident that, for the vast majority of people, 
the intervention (or interventions) will do more good than harm. For ‘strong’ 
recommendations on interventions that ‘should not’ be used, the guideline 
development group is confident that, for the vast majority of people, the 
intervention (or interventions) will do more harm than good.
For ‘conditional’ recommendations on interventions that should be ‘considered’, 
the guideline development group is confident that the intervention will do 
more good than harm for most patients. The choice of intervention is therefore 
more likely to vary depending on a person’s values and preferences, and so the 
healthcare professional should spend more time discussing the options with 
the patient.
Good-Practice Points (GPP) √ Recommended best practice based on the clinical experience of the guideline 
development group.
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practice based on the guideline development group’s 
clinical experience. It was phrased as ‘is considered’ and 
‘should be referred to’.
Staff from relevant academic societies and other per-
sons concerned were invited to attend three rounds of 
public hearings on the draft guidelines (the Korean Acad-
emy of Rehabilitation Medicine, the Korean Society of 
Cardiology, and the Korean Society for Thoracic and Car-
diovascular Surgery), following which they were reviewed 
and modified.
The CPG management committee designated one in-
vestigator responsible for each topic. These individuals 
then finalized the guidelines together with the CPG writ-
ing committee. The process of identifying key questions 
and preparing evidence summaries and meeting tran-
scripts was used to reference the writing process. Internal 
revisions were made after the first review by the inves-
tigator in charge, and the CPG management committee 
then performed a final review. The CPG Committee at 
the Korean Academy of Medical Sciences was also asked 
to appraise the draft guidelines, and those comments will 
be taken into consideration in a future second revision.
Academic societies and associations for physicians 
caring for patients in CR will use the 2018 CPGs for CR 
in their professional development, as will health profes-
sionals in their consultations with patients and caregiv-
ers, and they will be used to inform various medical in-
stitutions’ decisions related to convalescence. Following 
their distribution, the authors will continue to respond to 
questions and obtain opinions from health professionals 
using the CPGs. A second edition will be developed once 
consensus has been reached on the need for further revi-
sions based on foreign CPGs and new evidence.
LITERATURE REVIEW AND RESULTS
This section reviews CR and secondary prevention pro-
grams for male and female adult patients admitted for 
ACS who survived after the acute phase treatment (e.g., 
ICU management, medical drug therapy, PCI, CABG). It 
considers in-hospital CR, the post-discharge CR process, 
and continuous risk factor management. It describes the 
rationale, timing, basic principles, and flow of CR, before 
reviewing the various methods used to assess CR. Exer-
cise therapy, the core component of CR, and the self-care 
of CVD risk factors needed for secondary prevention of 
CVD conclude this section (Table 5).
Introduction of cardiac rehabilitation
Although patients with ACS risk death while being 
transferred to a hospital and during treatment after onset 
of the disease, many patients make dramatic recoveries 
Table 5. Key recommendations of cardiac rehabilitation 
1. Introduction of cardiac rehabilitation
   -  CR programs must be included in the treatment of 
ACS (SOR of strong / LOE of 1++)
   -  CR exercise should be initiated as early as possible 
following acute phase treatment (SOR of strong / 
LOE of 1–)
2. Assessments of cardiac rehabilitation
   -  Cardiopulmonary exercise testing should be 
performed to assess patients’ cardiopulmonary 
exercise functions, prescribe exercise, and predict 
outcomes (SOR of strong / LOE of 2++)
   -  Interventions to increase self-efficacy and awareness 
of the need for CR are needed to increase CR 
participation (SOR of strong / LOE of 1++)
   -  Systematized automatic referrals and liaison systems 
should be considered to increase CR referral rates. 
(SOR of GPP / LOE of 2–)
3. Exercise therapy for cardiac rehabilitation
   -  CR should be initiated early after surgery, as an 
inpatient program for patients who undergo CABG 
(SOR of strong / LOE of 1++)
   -  Risk assessment and appropriate monitoring based 
on the risk assessment results should be performed 
to ensure patient safety during CR exercise programs 
(SOR of srong / LOE of 2++)
   -  CR programs should also be administered to patients 
aged 65 years and older (SOR of strong/ LOE of 1++)
4. Education for secondary prevention
   -  CR programs should include patient education (SOR 
of strong / LOE of 1++)
   -  Smoking cessation interventions should be 
provided for patients who smoke, and continuous 
interventions of more than 4 weeks should be 
considered (SOR of strong / LOE of 1++)
   -  ICT-based modalities should be considered to 
maintain the effects of education (SOR of conditional 
/ LOE of 1–)
CR, cardiac rehabilitation; SOR, strength of recommen-
dation; LOE, level of evidence; ICT, information & com-
munication technology.
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from the condition after treatment in the acute phase. 
Consequently, many patients, and even medical profes-
sionals, are excessively optimistic about the long-term 
prognosis and outcomes of this disease, and once the 
symptoms have abated after the acute phase treatment, 
many patients revert to the lifestyles they had adopted 
prior to disease onset, with a total disregard for risk factor 
management.
As reflected in their CPGs, many other countries have 
already accepted CR as an essential component of com-
prehensive treatment for ACS (LOE of 1++), including 
Scottish, British, and American guidelines [7,11-13]. Until 
recently, many studies analyzed the efficacy of CR in rela-
tion to CVD and patients’ mortality, recurrence, admis-
sion risk, and QOL. Scotland’s CPGs state that patients 
should be offered a CR program that includes an exercise 
component to reduce cardiovascular mortality, hospital 
readmissions, and improve patients’ QOL (SIGN 2017; 
SOR strong and LOE of 1++) [5]. England’s guidelines are 
that all patients (regardless of age) should be informed 
about and offered a CR program that includes an exercise 
component (NICE 2013) [6]. US guidelines state that all 
eligible patients with ACS, or patients’ whose status is 
immediately post CABG surgery or post-PCI, should be 
referred to a comprehensive outpatient CR program, ei-
ther prior to hospital discharge or during the first follow-
up office visit (AHA 2011; SOR of I / LOE of A) [7].
The Cochrane Review (2016) summarized the findings 
of a systematic literature review and meta-analysis of 
patients with AMI, patients who underwent revascular-
ization, such as CABG and PCI, patients with angina, and 
patients diagnosed with coronary heart disease (CHD) 
based on angiography. Exercise-based CR lowered car-
diovascular mortality (risk ratio [RR]=0.74; 95% confi-
dence interval [CI], 0.64–0.86) and risk for readmission 
(RR=0.82; 95% CI, 0.70–0.96), but did not significantly re-
duce the risk of re-infarction (RR=0.90; 95% CI, 0.79–1.04) 
or all-cause mortality (RR=0.96; 95% CI, 0.88–1.04) (LOE 
of 1–) [14]. In a systematic review of eight observational 
studies on the effects of CR published after the year 2000, 
CR lowered the all-cause mortality (adjusted odds ratio 
[OR]=0.47, 95% CI, 0.38–0.59) and cardiovascular mortal-
ity (adjusted OR=0.43; 95% CI, 0.23–0.79) of patients with 
acute MI (LOE of 1+) [15]. CR was initially focused on 
exercise therapy, but has since transitioned to become 
a comprehensive program that includes mental sup-
port, risk factor corrections, and education for lifestyle 
transformations. Behavioral change techniques (BCTs) 
include providing information about the outcomes of a 
behavior, educating patients on how to behave, encour-
aging outcome-related goal-setting, providing informa-
tion about specific behaviors to be performed at specific 
times and places, providing feedback, and training pa-
tients how to manage stress and control their emotions. 
Compared to the control group, which only received the 
usual care, BCT interventions demonstrated better out-
comes in smoking cessation (RR=0.89; 95% CI, 0.81–0.97), 
with significantly lower mortality risk (RR=0.82; 95% CI, 
0.69–0.97), and 3.13 mmHg lower SBP (95% CI, -5.11 to 
-1.15). However, the CHD risk was not significantly re-
duced with BCTs (LOE of 1+) [16].
A Korean study also reported that a CR group (10%, 7 
of 69 patients) had significantly lower recurrence rates 
(AMIs, readmission rates, need for reperfusion, mor-
tality rates) and significantly longer disease-free days 
(354±38.34 days vs. 316±99.96 days) compared to the 
control group (24%, 17 of 72 patients) [17].
Whether CR lowers mortality rates from heart disease 
is a critical question in relation to the need for CR. Al-
though the results of recent studies on the effects of CR 
have been partially inconsistent, multiple studies have 
reported that the exercise component of CR lowers car-
diovascular mortality and readmission rates, regardless 
of the type of CHD and type and setting of CR [14,18,19].
Scotland’s CPGs state that patients should be offered 
a CR program that includes an exercise component 
to reduce cardiovascular mortality, hospital readmis-
sions, and improve their QOL, and note that the exercise 
component of CR reduces cardiovascular mortality and 
hospital admissions, and improves health-related QOL, 
regardless of the type of CHD, the type of CR, or its setting 
(SIGN 2017; LOE of 1++) [5].
The 2016 Cochrane Review—an online collection of 
six databases that summarize high-quality, independent 
evidence to inform healthcare decision-making—sum-
marized the results of a systematic literature review and 
meta-analysis of randomized controlled trials (RCTs) 
involving patients with AMI, patients who underwent 
revascularization, such as CABG and PCI, patients with 
angina, and patients diagnosed with CHD based on an-
giography. Exercise-based CR lowered cardiovascular 
mortality (RR=0.74; 95% CI, 0.64–0.86) and risk for read-
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mission (RR=0.82; 95% CI, 0.70–0.96), but did not signifi-
cantly reduce the risk of all-cause mortality (RR=0.96; 
95% CI, 0.88–1.04) (LOE of 1–) [14]. In another systematic 
literature review and meta-analysis of 31 studies of 6,926 
patients published in 2017, over a 10-year follow-up, the 
comprehensive CR group had significantly lower car-
diovascular mortality compared to that of the usual care 
group (RR=0.74; 95% CI, 0.65–0.86; p<0.0001) (LOE of 
1+) [20]. In a meta-analysis of 18 studies including 7,691 
patients who underwent CABG or reperfusion after MI 
or were diagnosed with coronary stenosis based on coro-
nary angiography, the CR group had similar all-cause 
mortality (RR=1.00; 95% CI, 0.88–1.13), but significantly 
lower cardiovascular mortality compared to that of the 
control group (RR=0.42; 95% CI, 0.21–0.88) (LOE of 1+) 
[21].
Verifying whether CR improves patients’ QOL follow-
ing the onset of heart disease is key to patients’ abilities 
to return to their daily lives. Recent studies on the effects 
of CR found that the exercise component of CR improves 
these individuals’ QOL, regardless of the type of coro-
nary syndrome and type and setting of CR [14,18,19], and 
benefits the cardiopulmonary health and QOL of patients 
with heart failure with preserved ejection fraction [22,23].
Scotland’s CPGs state that patients should be offered a 
CR program that includes an exercise component to re-
duce cardiovascular mortality and hospital readmissions 
and improve patients’ QOL. These benefits are known to 
occur regardless of the type of CHD, the type of CR, or the 
setting (SIGN 2017; LOE of 1++) [5].
Meta-analysis could not be performed in a systematic 
literature review of 63 RCTs that examined exercise-
based CR in patients with coronary syndrome due to the 
heterogeneity of outcome measurement methods and 
reporting methods in 20 studies that assessed health-re-
lated QOL using verified general or disease-specific out-
come measurement methods. Nonetheless, most of these 
studies found an improvement in the QOL of those in 
the CR group. Further, 14 studies reported a higher QOL 
in one or more domains in the exercise-based CR group 
compared to the control group, and 5 studies reported a 
significantly higher QOL in more than 50% of domains in 
the CR group compared to those in the control group (LOE 
of 1–) [14].
RECOMMENDATION 
•  CR programs must be included in the treatment of 
ACS (SOR of strong / LOE of 1++)
Timing of cardiac rehabilitation
The Scottish CPGs (SIGN 2017) state that “all patients 
must be referred to CR to undergo individualized inter-
vention and treatment plans based on individualized 
assessment,” [5] regardless of the type of treatment they 
undergo after the onset of ACS, and notes that their treat-
ment should be comprehensive and individualized at 
the initiation of the rehabilitation program. There is not 
enough clinical evidence, however, to document the opti-
mum timing of exercise, a critical component of CR, and 
early exercise is often determined passively. We therefore 
reviewed evidence regarding the timing of CR exercise in 
existing guidelines and additional studies.
US guidelines are that all eligible patients with ACS or 
patients’ whose status is immediately post CABG surgery 
or post-PCI should be referred to a comprehensive out-
patient CR program either prior to hospital discharge or 
during the first follow-up office visit. Further, all eligible 
outpatients with the diagnosis of ACS, CAB surgery or 
PCI, chronic angina and/or peripheral artery disease 
in the past year should be referred to a comprehensive 
outpatient CR program (AHA 2011; SOR of I / LOE of A) 
[7]. England’s guidelines are that CR should be initiated 
as soon as possible after admission and before discharge 
from hospital. Patients should be invited to a CR session 
within 10 days of their discharge from hospital (NICE 
2013) [6].
Haykowsky et al. [24] reported that commencing and 
maintaining exercise training early after the onset of MI 
(within 1 week of onset) leads to benefits in left ventricu-
lar (LV) remodeling (LOE of 1+). Most studies examining 
the timing of CR analyzed the effects of exercise training 
on LV remodeling, and found that exercise training in the 
acute phase or early phases since onset produces positive 
outcomes. These studies describe the timing of the exer-
cise component of CR, as opposed to the timing of the CR 
per se. The risk of bias was low in clinical trials included 
in a 2016 meta-analysis that analyzed the impacts of the 
timing of exercise training on LV functions. These stud-
ies classified the timing of exercise training into an acute 
phase (6 hours to 7 days), a recovery phase (7 to 28 days), 
and a maintenance phase (≥29 days), and examined dif-
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ferences in the left ventricle ejection fraction (LVEF), 
LV end-systolic diameter, and peak VO2 of patients with 
reduced LV function after MI. Although results on the 
changes of LVEF and end-systolic diameter varied wide-
ly, exercise training in the acute phase led to significant 
improvements (more than moderate improvements) in 
LV end-systolic diameter, and peak VO2 that were also 
greater than those produced by exercise training begun 
in the recovery phase and the maintenance phase. In 
conclusion, exercise training had positive effects on LV 
remodeling and recovery of cardiopulmonary functions, 
with the greatest effects achieved when exercise training 
was initiated in the acute phase (LOE of 1–) [25]. In this 
context, we determined that it is more appropriate to pro-
vide recommendations for the timing of exercise training 
as opposed to the timing of CR.
RECOMMENDATION 
•  It is more appropriate to provide recommendations for 
the timing of exercise training than the timing of CR
•  CR exercise should be initiated as early as possible fol-
lowing acute phase treatment (SOR of strong / LOE of 1–)
The organization of cardiac rehabilitation
Because staff numbers, equipment, and facilities vary 
according to the size, capital, number of relevant medi-
cal professionals, and number of eligible patients in each 
institution, CR programs should be structured on basic 
concepts in consideration of organizational circum-
stances. The structure of a multidisciplinary team, and 
particularly the number of people on the team and the 
type of health care professionals, is directly dependent 
on the number of patients and contents of the program, 
the complexity of the patients being treated, the organi-
zation’s human resources policies, and the community 
resources available to deliver the program [4].
Scotland’s guidelines state that CR services should offer 
individualized exercise assessments, tailor the exercise 
components to individuals’ choices, and deliver them in 
a range of settings (SIGN 2017; SOR strong) [5]. Canada’s 
guidelines state that all CR programs must address site-
specific facilities’ equipment in conjunction with safety 
requirements and considerations, and all CR programs 
must have policies and procedures to address the man-
agement of environmental and medical emergency situa-
tions (CACR 2009) [4].
In a systematic literature review of 8 observational stud-
ies that compared patients participating in a CR program 
with those not participating in a CR program, CR reduced 
all-cause and cardiac-related mortality rates, and signifi-
cantly improved patients’ health-related QOL [26]. More 
than half of these studies adopted a multidisciplinary 
team approach, and structured their teams to provide 
interventions regarding exercise education, health-
related information and education, lifestyle modifica-
tions, mental health support, and social support (LOE of 
1–). A meta-analysis of 71 RCTs that reported the effects 
of comprehensive CR in coronary artery diseases (CAD) 
found a reduction of all-cause and cardiac-related mor-
tality, noncritical re-infarction and readmission rates, 
and also found that many types of professionals were 
involved in providing exercise and psychological treat-
ments, risk factor education and counseling (LOE of 1–) 
[15]. In a systematic literature review analyzing 63 studies 
investigating the effects of exercise-based CR on CHD, CR 
lowered cardiovascular mortality rates and risk of hospi-
tal admission, and the rehabilitation programs included 
strategies for exercise and risk factor education, behavior 
change, psychological support, and traditional risk factor 
management (LOE of 1–) [14].
In 2010, the Korean Society of Cardiac Rehabilitation 
discussed and adapted various Korean and foreign CR 
guidelines, including the American Association of Car-
diovascular and Pulmonary Rehabilitation (AACVPR) 
guidelines, and relevant studies that provided recom-
mendations for the basic facilities, equipment, and per-
sonnel required in Korea’s CR centers [27].
RECOMMENDATION 
•  CR programs should be comprehensive and multidis-
ciplinary (SOR of GPP / LOE of 1–)
Cost-effectiveness of cardiac rehabilitation
The cost-effectiveness of CR has been reported in mul-
tiple studies [14]. These authors consistently concluded 
that CR involves a more cost-effective use of healthcare 
resources relative to that of general treatments. This con-
clusion is based on foreign literature however, so high 
quality Korean studies are needed to assess the cost-
effectiveness of CR in Korea, based on the total cost of 
healthcare and the cost per quality-adjusted life year 
(QALY) analysis.
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Scotland’s guidelines state that interventions are con-
sidered to be cost effective if they fall below the common-
ly accepted UK threshold of £20,000 per QALY. However, 
no evidence of the cost-effectiveness of CR was identified 
in the UK, and additional higher-quality trials are needed 
to assess the cost-effectiveness of CR (SIGN 2017; SOR 
conditional) [5].
According to a systematic literature review analyzing 
63 RCTs involving exercise-based CR in patients with 
coronary syndrome, it was difficult to compare 7 studies 
on the cost of CR and overall health management costs 
due to differences in their currencies and study periods, 
and given that 4 studies used a QALY that ranged from 
$42,535 higher to $650 lower per QALY gained in the CR 
group compared to the control group (LOE of 1–) [14].
RECOMMENDATION 
•  Though CR programs are reported to lower health 
management costs in patients with CVD, high-quality 
Korean studies are needed to substantiate this, con-
sidering the differences of insurance systems and 
healthcare environments across countries (SOR of 
GPP / LOE of 1–)
Assessments of cardiac rehabilitation
Use individualized assessments to develop care plans 
and interventions
Patients referred to CR following MI are in diverse 
medical, social, and financial situations. Therefore, indi-
vidualized CR programs should be considered together 
with various factors, including differences of heart func-
tion such as cardiac output, comorbidities that hinder 
exercise, such as lung disease, arthritis, and low back 
pain, differences in lifestyle such as smoking and drink-
ing status, and patients’ ability to visit the hospital for 
CR according to employment status and distance from 
home. This is crucial to boosting participation and ad-
herence with the CR program and ultimately achieving 
its goal, namely reducing the recurrence of MI and mor-
tality rates. For this reason, the British Association for CR 
describes an individualized assessment of patient needs 
as an important component in the early phase of CR [28].
Scotland’s guidelines state that all patients referred to 
CR should undergo an individualized assessment that is 
used to create to a care plan and identify interventions 
specific to their needs. In addition, CR services should 
offer individualized exercise assessments, tailor the exer-
cise components of their programs to individual choice, 
and deliver them in a range of settings (strong) (SIGN 
2017; SOR of GPP, strong / LOE of 1+) [5].
In a prospective cohort study that compared a general 
CR and an individualized CR program, participation 
was about 30% higher in the individualized CR program 
(p<0.0001), and the risk for admission was significantly 
lower with the individualized CR program (RR=0.664; 
95% CI, 0.554–0.797) (LOE of 2+) [29]. A Cochrane Review 
of 19 RCTs (n=10,856) examined the effects of programs 
that consisted of goal setting and action planning based 
on individualized assessments of various chronic dis-
eases, such as heart failure, kidney failure, and diabetes, 
and found that individualized programs were more effec-
tive than those of the control group in lowering glycated 
hemoglobin (-0.24%; 95% CI, -0.35 to -0.14) and systolic 
blood pressure (-2.64 mmHg; 95% CI, -4.47 to -0.82), and 
improving depression (standardized mean differences 
[SMD]=-0.36; 95% CI, - 0.52 to -0.20) and self-efficacy 
(SMD=0.25; 95% CI, 0.07–0.43) (LOE of 1+) [30]. In a RCT 
of 132 patients admitted for a heart disease such as CAD, 
a higher percentage of patients agreed to be referred to a 
lifestyle adjustment program in the individualized assess-
ment group than in the conventional assessment group 
(27% vs. 5%) (LOE of 1+) [31]. In a RCT of 40 patients with 
ACS, the intervention group, members of which received 
educational components according to their needs at an 
early stage, showed significantly higher self-efficacy com-
pared to those in the control group, and a higher percent-
age of the intervention group participated in more than 
90% of outpatient CR sessions (47% vs. 21%) (LOE of 1+) 
[32]. In a RCT of patients with ACS, providing individual-
ized goals and plans (n=78) led to a high improvement 
in outcome indices that included self-efficacy, return to 
work or the recovery of pre-onset functions, readmission, 
and mortality, compared to the conventional method 
(n=105) (21.8%, n=17 vs. 10.5%, n=11; p=0.039) [33].
RECOMMENDATION 
•  Individualized CR plans should be tailored to indi-
vidual needs and be developed through individual 
assessments of patients referred to CR (SOR of strong / 
LOE of 1+)
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Psychological evaluations and interventions
Psychological symptoms such as depression, anxiety, 
and stress are common among patients with MI, and 
these symptoms can lead to recurrence, increased mor-
tality, and reduced QOL. At about 15% to 20%, the preva-
lence of depression among patients with MI is about 
three times higher than that of the general population 
[34,35], and similar prevalence rates are observed among 
patients who have undergone PCI or CABG [36]. De-
pression undermines secondary prevention by lowering 
adherence with treatment plans, such as drug therapies, 
lifestyle adjustments, and CR participation [37-39], and 
may increase medical costs [40] for patients with heart 
disease. Anxiety and stress have been associated with 
recurrence and mortality rates among patients with CAD 
[41,42]. For this reason, psychological assessments and 
interventions have recently been recognized as essential 
components of CR programs.
Scotland’s guidelines are that all patients should be of-
fered a psychological care package, based on a cognitive 
behavioral model (e.g., stress management, cognitive 
restructuring, and communication skills) as an integral 
part of CR (SIGN 2017; SOR of strong / LOE of 1++) [5]. 
US guidelines are that patients with recent CABG surgery 
or MI should be screened for depression, in collaboration 
with their primary care physicians and a mental health 
specialist (AHA 2011; LOE of B) [7]. Canada’s guidelines 
are that all CR patients should undergo screening for 
active and historical depression and anxiety at their in-
take assessment, and a qualified professional such as 
a psychologist or psychiatrist should refer individuals 
who screen positive for depression or anxiety for assess-
ment or treatment (CACR 2009) [4]. Japan observes that 
because the prevalence of depression and depressed 
states is high among patients with CAD, and depression 
has been reported to relate to increased morbidity and 
mortality from CD, so specialists should screen for and 
treat depression in this patient population. Screening for 
depressed moods or other psychological symptoms, as 
well as conducting psychological interventions for the 
prevention and treatment of depression, are expected 
to alleviate psychological symptoms, improve QOL, en-
hance adherence to treatment, and reduce the mortality 
and incidence of cardiovascular events (JCS 2012; LOE of 
B, C) [8].
A 2017 Cochrane meta-analysis reviewed 35 RCTs 
(n=10,703) with regard to the psychological interventions 
conducted for CAD, and found that they did not reduce 
all-cause mortality, revascularization, or incidence of 
nonfatal MI compared to conventional treatment, but 
they did significantly lower heart disease-related mor-
tality rates (RR=0.79; 95% CI, 0.63–0.98), and improved 
perceived depression (SMD=-0.27; 95% CI, -0.39 to 0.15), 
anxiety (SMD=-0.24; 95% CI, -0.38 to -0.09), and stress 
levels (SMD=-0.56; 95% CI, -0.88 to -0.24) (LOE of 1++) 
[43]. In a meta-analysis of 13 studies of the outcomes of 
psychological interventions in CVD patients, they were 
effective in reducing stress (Hedges’ g effect size=0.34; 
95% CI, -0.19 to 0.87), anxiety (effect size=1.04; 95% CI, 
0.53–1.54), and depression (effect size=0.67; 95% CI, 0.41–
0.92) (LOE of 1+) [44]. A RCT that compared early coun-
seling focused on psychological trauma and conventional 
stress counseling in 190 patients with ACS, found no sig-
nificant differences in psychological symptoms, mortality 
rates, or CVD-related readmission rates between the two 
groups (LOE of 1–) [45].
RECOMMENDATION
•  Patients referred to CR should be assessed for psy-
chological problems, such as anxiety, depression, and 
stress, and should be provided with psychological in-
terventions if abnormal findings are observed (SOR of 
strong / LOE of 1++)
Symptom-limited cardiopulmonary exercise test
The symptom-limited cardiopulmonary exercise test 
that provides useful information related to exercise 
prescriptions can be obtained by monitoring heart rate 
(HR), blood pressure (BP), symptoms, electrocardiogra-
phy (ECG), and gas analysis, while gradually increasing 
exercise load [46]. Assessing the risk of participation in 
exercise-induced CR programs based on changes in HRs, 
abnormal ECGs, changes in BP, and the onset of symp-
toms as a result of increasing exercise load can be used 
to develop safe and effective exercise prescriptions [47]. 
Aerobic exercise capacity, as measured with VO2max, was 
associated with CVD patients’ prognosis, and the effec-
tiveness of CR can also be evaluated on the basis of its 
improvement after CR. Thus, in the absence of contrain-
dications, the symptom-limited cardiopulmonary test is 
recommended for CR [7,8,47].
US guidelines recommend a risk assessment with a 
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physical activity history and/or an exercise test for all 
patients, to guide their prognosis and prescription (AHA 
2011; SOR of I / LOE of B) [7]. Canada recommends that a 
directly supervised graded exercise test (GXT) be part of 
the initial CR assessment prior to the initiation of therapy 
(CACR 2009) [4]. Japan recommends using a symptom-
limited exercise stress test on day 14–21 after onset to 
predict prognosis, prescribe exercise training programs, 
and assess the treatment efficacy of CR (JCS 2012; LOE of 
B) [8].
Symptom-limited cardiopulmonary exercise testing is 
currently accepted as a standard in CR programs for pa-
tients after ACS, so it is difficult to conduct a new RCT to 
directly compare the clinical outcomes of patients who 
undergo this testing and those who do not. Consequent-
ly, we could not find such clinical trials in our search. 
However, large cohort studies on CVD patients found that 
VO2max measured with cardiopulmonary exercise test-
ing or exercise testing-based risk score are strongly cor-
related with all-cause mortality or heart disease-related 
mortality with consistent dose-response correlations. 
This suggests that maximal cardiopulmonary exercise 
testing is a useful tool for predicting the outcomes and 
risks during exercise for patients with ACS (LOE of 2++) 
[44]. In a study of 100 patients who underwent coronary 
angioplasty due to MI, patients were randomly divided 
into an exercise testing group (n=50) and a non-exercise 
testing group (n=50); physicians permitted seven out of 
11 activities, including the return to work, earlier for the 
exercise testing group than for the non-exercise testing 
group (LOE of 1–) [48].
RECOMMENDATION
•  Cardiopulmonary exercise testing should be per-
formed to assess patients’ cardiopulmonary exercise 
functions, prescribe exercise, and predict outcomes 
(SOR of strong / LOE of 2++)
Submaximal exercise test (6-minute walk test)
The symptom-limited exercise test is recommended to 
assess exercise capacity and risk, prescribe exercise, and 
predict outcomes for patients undergoing CR [7,8,46]. 
However, exercise, ECG, gas analysis equipment, and 
adequate space are needed to conduct this standard car-
diopulmonary exercise testing, and the associated costs 
hinder the universal application of this testing across all 
medical institutions [49]. Where maximal exercise testing 
is difficult, a submaximal exercise test, such as a 6-min-
ute walk test, is commonly recommended [50,51], and a 
6-minute walk distance is used to set exercise intensity 
and evaluate the effectiveness of CR [52,53]. In Korea, the 
6-minute walk test is generally used as a submaximal ex-
ercise test, so recommendations in consideration of the 
validity, reliability, and responsiveness of the 6-minute 
walk test are needed.
Japan’s guidelines state that a submaximal exercise test 
conducted on day 4 after onset or thereafter should be 
used to predict prognosis, prescribe exercise-training 
programs, and assess treatment efficacy (JCS 2012; LOE 
of B) [8].
A 2012 systematic review of studies of the 6-minute 
walk test included six studies on validity, one study on 
reliability, and 11 studies on responsiveness [54]. The 
maximum metabolic equivalents (METs) obtained from 
the 6-minute walk test and symptom-limited exercise test 
were more than moderately correlated, and the maxi-
mum heart rate obtained from the 6-minute walk test 
and symptom-limited exercise test were also more than 
moderately correlated. Changes in reliability ranged from 
2% to 8%, but the intraclass correlation coefficient (ICC) 
was 0.97, based on which level of evidence was evalu-
ated to be moderate. In a meta-analysis of studies on the 
responsiveness of the 6-minute walk test in CR, the mean 
difference of a 6-minute walk distance before and after 
treatment was 60.43 m (95% CI, 54.57–66.30; p<0.001), 
indicating a high responsiveness (LOE of 2+). In a subse-
quent study, a repeated 6-minute walk test within 1 week 
after onset of MI had high reliability (ICC=0.879; 95% 
CI, 0.785–0.939), and the ICC for HR, rate of perceived 
exertion (RPE), measured using the Borg scale, and BP 
ranged from 0.880 to 0.934, also showing high reliability 
(LOE of 2+) [55]. Hanson et al. [56] found a high reliability 
for the 6-minute walk test (ICC=0.94), but the 6-minute 
walk distance tended to increase with subsequent tests, 
suggesting the need to consider this fact when assess-
ing treatment responsiveness (LOE of 2+). A moderate 
correlation between 6-minute walk distance and VO2max 
was found in a recent study of 49 patients referred to CR 
(r=0.56, p<0.01) (LOE of 2++) [57].
RECOMMENDATION
•  A submaximal exercise test, such as a 6-minute walk 
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test, should be considered when symptom-limited ex-
ercise testing is difficult (SOR of conditional / LOE of 
2+)
Strategies to improve cardiac rehabilitation participa-
tion
Despite the effectiveness of CR in patients with ACS, the 
problem of low CR participation lingers. In the US, CR 
participation among patients with MI is about 35%, and 
20%–30% in Europe, while that in Japan is low, at about 
4%–8% [58]. A recent Korean study also found a hospital-
based CR participation rate of about 30% among patients 
with ACS in three university hospitals, and various fac-
tors that included distance, cost, time, comorbidity, and 
perceptions of CR were identified as hindering factors 
[59]. Therefore, effective strategies that could increase 
early uptake or participation in and adherence to CR are 
essential. In the United States, the Million Heart Project 
has been undertaken to lower recurrence, readmission, 
mortality, and medical costs among patients with ACS by 
increasing their CR participation based on grounds for 
effective strategies [60].
Scotland’s guidelines are that interventions to improve 
self-efficacy should be considered for inclusion in a 
CR program. Further, the strategies associated with in-
creased uptake in at least one trial were: (1) structured 
telephone calls/visits by a nurse/therapist after hospital 
discharge; (2) early appointments to CR; (3) motivational 
letters based on the theory of planned behavior; (4) CR 
programs tailored for women; and (5) intermediate phase 
programs (self-management, instruction, and exercise 
monitoring) for older patients (SIGN 2017; SOR of condi-
tional / LOE of 1++) [5]. Canada recommends maximiz-
ing the number of patients who may benefit from CR pro-
grams by developing systematized, preferably automated, 
referral mechanisms that are sensitive to socioeconomic 
and ethno-cultural diversity with key patient care part-
ners and other CVD stakeholders. An automated referral 
process should be used to significantly increase referrals 
from acute care to CR and subsequent enrollment (CACR 
2009) [4].
A 2014 Cochrane Review of RCTs on CR participation 
among CVD patients included 10 studies on early CR par-
ticipation (n=1,338) and eight studies on CR maintenance 
(n=1,167), but a meta-analysis could not be performed 
due to the varying types of treatment involved [61]. Eight 
out of 10 studies and 3 out of 8 studies, however, found 
a significant increase in CR participation and mainte-
nance, respectively. Strategies that increased CR partici-
pation included structured phone interviews or house 
visits after discharge [62-65], early visits to rehabilitation 
programs, [66] and letters that recommended CR partici-
pation [67]. Three studies that observed an increase in CR 
maintenance rates used physical monitoring based on 
daily journals, goal setting, and execution plans as strate-
gies (LOE of 1++) [68-70]. In a RCT of 141 patients with 
ACS, physical activity rates increased in the intervention 
group that received motivating counseling compared to 
the control group (LOE of 1+) [71]. In a RCT that com-
pared a female-only CR program and a mixed-gender CR 
program, there were no significant differences in partici-
pation rates between the two groups (LOE of 1++) [72]. In 
a RCT of 825 patients with ischemic heart disease or heart 
failure, participants were divided into two groups, one 
of which received instructions on learning and coping 
strategies and another that participated in conventional 
CR program strategies. The results showed that a higher 
percentage of the former group participated in more than 
75% of the CR sessions (80% vs. 73%; OR=1.48; 95% CI, 
1.07–2.05) (LOE of 1+) [73].
In a systematic literature review of 14 observational or 
intervention studies on the use of systematized automatic 
referrals and a liaison system to boost CR participation, 
meta-analysis revealed that the CR participation rate was 
highest when both systematized automatic referrals and 
a liaison system were applied (66%; 95% CI, 54%–77%), as 
opposed to using only the conventional CR referral sys-
tem (24%; 95% CI, 18%–32%), only the systematized auto-
matic referral system (45%; 95% CI, 33%–57%), or only the 
liaison system (44%; 95% CI, 35%–53%) (LOE of 2–) [74].
RECOMMENDATION
•  Interventions to increase self-efficacy and awareness 
of the need for CR are needed to increase CR partici-
pation (SOR of strong / LOE of 1++)
•  Systematized automatic referrals and liaison systems 
should be considered to increase CR referral rates (SOR 
of GPP / LOE of 2–)
Strategies to maintain long-term physical activities
Maintaining physical activities is important to reducing 
CVD recurrence rates and improving patients’ QOL in the 
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long-term, after undergoing exercise-based CR. Although 
fitness is improved and maintained for a certain amount 
of time after participating in a CR program [75], these ef-
fects are often not translated into maintaining physical 
activities in the long-term [76,77]. In a Korean study ad-
ministering physical activity surveys before and after the 
onset of MI, 37% of the patients who were active prior to 
MI became inactive after onset, and 11% of the patients 
who were inactive prior to MI maintained physical activi-
ties after onset, thereby suggesting the need for strategies 
to promote the maintenance of physical activities in the 
long-term [78].
Scotland’s guidelines are that psychoeducation (goal 
setting, self-monitoring) should be considered for pa-
tients in CR to facilitate adherence to physical activities, 
and noted that the interventions reported to be of benefit 
were: (1) goal setting, (2) action planning, and (3) using 
daily diary entries to monitor activities (SIGN 2017; SOR 
of conditional / LOE of 1++) [5].
In a meta-analysis of 209 patients in four studies, psy-
chological education (using strategies such as goal set-
ting, problem solving, and self-monitoring) led to greater 
long-term physical activities compared to those pro-
moted by simple education about exercise and risk fac-
tors (SMD=0.62; 95% CI, 0.30–0.94) (LOE of 1++) [79]. In a 
systematic literature review of strategies used to maintain 
physical activities in the long-term, one study examined 
the effects of a problem-based learning strategy, but the 
study failed to find any significant effects (LOE of 1+) 
[80]. Further, a study on improving self-efficacy also did 
not find significant differences [81], while one RCT that 
used self-monitoring observed significant effects [82]. 
In a recent RCT of 47 patients with CVD, no significant 
differences in the maintenance of physical activities 1 
year after the program were found between a voluntary, 
incremental physical activity program and the existing 
supervised exercise program (LOE of 1+) [83]. However, 
the addition of group education regarding exercise based 
on the use of a pedometer and face-to-face counseling to 
the conventional CR program significantly increased the 
duration of patients’ continuous moderate to vigorous 
exercise 1 year after the program (LOE of 1+) [84].
RECOMMENDATION
•  Psychological education strategies (including goal set-
ting and self-monitoring) should be used to increase 
CR maintenance rates (SOR of strong / LOE of 1++)
Exercise therapy for cardiac rehabilitation
Timing of cardiac rehabilitation in the case of coronary 
artery bypass surgery
Early CR is usually recommended if PCI is performed 
for ACS. In cases of CABG, CR may be delayed due to 
concerns about general deconditioning and the recovery 
of the sutured site after sternotomy. Thus, we propose 
appropriate timing for CR in cases involving CABG for 
ACS.
US guidelines recommend CR for all patients after 
CABG, with the referral ideally performed early post-
operatively during the surgical hospital stay (AHA 2015; 
SOR of I / LOE of A) [85], and all eligible patients with 
ACS, or those whose status is immediate post-CAB sur-
gery or post-PCI should be referred to a comprehensive 
outpatient CR program either prior to hospital discharge 
or during the first follow-up office visit (AHA 2011; SOR 
of I / LOE of A) [7].
Patients with ACS who underwent CABG and partici-
pated in CR showed significantly reduced mortality rates, 
CVD incidence, readmission rates, and length of hospital 
stays, compared to those in the control group [86,87]. Ac-
cording to AHA recommendations in 2015, CR is recom-
mended for all patients who undergo CABG, and being 
referred to CR as an inpatient early after surgery is ideal 
[85]. Furthermore, according to AHA recommendations 
made in 2011, all patients who undergo CABG should 
begin CR while hospitalized, and must be referred imme-
diately after discharge or at the first outpatient visit for a 
more comprehensive outpatient-based CR program [7].
A systematic review of nine randomized controlled 
studies on the effects of CR after CABG on patients with 
ACS found that the CR group showed improved qual-
ity of life and reduced cardiovascular risk factors [88]. 
However, this study could not systematically analyze the 
effects of specific rehabilitation regimens, since the type, 
intensity, and frequency of exercise varied in different 
CR programs across the studies, and diverse assessment 
parameters were used to analyze the effects of CR (LOE 
of 1–). It has been reported in Korea that beginning CR in 
the hospital after CABG leads to lower resting heart rates 
and increased 6-minute walking distances at the time of 
discharge and 1 month after surgery [89].
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RECOMMENDATION
•  CR should be initiated early after surgery, as an inpa-
tient program for patients who undergo CABG (SOR of 
strong / LOE of 1++)
Aerobic exercise program
CR programs encompass the management of various 
risk factors that increase the risk of CVD. In particular, 
interventions for physical activities are a major compo-
nent of CR programs [90]. Among various interventions 
for physical activities, we presented published evidence 
from aerobic exercise programs, and reviewed the differ-
ent effects of CR according to the types of aerobic exercise 
involved.
Scotland’s guidelines are that aerobic and resistance 
exercises should be considered part of the exercise pre-
scription for patients attending CR (SIGN 2017; SOR of 
conditional / LOE of 1++) [5]. Canada recommends that 
patients in CR engage in aerobic and resistance exercise 
3–5 times per week, at 40%–85% of their HR reserve, for 
20–40 minutes per session. Each exercise session should 
include an appropriate warm-up and cool-down pe-
riod. These guidelines further note that regardless of the 
form of interval training, there is compelling evidence 
that interval training can lead to improvements in peak 
VO2, functional status, and overall QOL. Accordingly, 
CR programs have increasingly used interval training as 
an alternative to traditional continuous aerobic training 
(CACR 2009) [4].
The exercise component of CR lowers cardiovascular 
mortality and readmission rates while increasing QOL 
[91]. Though the methods, frequencies, durations, and 
intensities of exercise vary widely across the studies con-
ducted, nonetheless, studies have reported that CR is 
effective, regardless of specific frequency, duration, in-
tensity, and place of exercise (LOE of 1++) [18,19,92]. The 
SIGN 2017 recommends that aerobic exercise should be 
included in exercise prescriptions for patients participat-
ing in CR [5].
In 18 RCTs that compared aerobic exercise-based CR 
and control groups among patients who underwent PCI 
or CABG for ACS [93], the aerobic exercise group showed 
reduced systolic BP (95% CI, -6.67 to -0.91), increased 
high-density lipoprotein (HDL; 95% CI, 1.24–6.43), and 
reduced low-density lipoprotein (LDL; 95% CI, -10.35 to 
-0.73) compared to the control group. Furthermore, peak 
VO2 (95% CI, 2.41–4.53) and LVEF (95% CI, 0.26–4.93) 
were improved when aerobic exercise was performed. 
However, there were no significant differences in diastol-
ic BP, total cholesterol, and triglycerides between the two 
groups. Regarding the effects of aerobic exercise accord-
ing to duration, exercise for 8 to 12 weeks led to lower 
systolic BP at rest and significantly higher peak VO2 com-
pared to the conventional treatment group, and exercise 
for more than 12 weeks led to positive effects on HDL, 
LDL, triglycerides, peak VO2, and LVEF. Regarding the 
amount of exercise per week, 60–90 minutes of exercise 
per week had positive effects on systolic BP, HDL, triglyc-
erides, peak VO2, and LVEF, and there were no additional 
effects, even when exercise was performed more than 90 
minutes per week (LOE of 1–).
In a systematic literature review comparing the effects 
of CR with high-intensity interval training (HIT) and 
that with moderate-intensity continuous training (MCT) 
[94], HIT led to greater changes of peak VO2 than did 
MCT (mean difference [MD]=1.78; 95% CI, 0.45–3.11), 
while MCT led to lower resting HRs (MD=-1.80/min; 
95% CI, 0.71–2.89) and body weight (MD=-0.48 kg; 95% 
CI, 0.15–0.81) than did HIT. There were no differences in 
changes to blood glucose, triglycerides, and HDL after 
exercise between the two exercise groups (LOE of 1+). A 
Korean study also reported that HIT (1–2 times a week for 
9–10 weeks) led to a greater increase in peak VO2, and a 
6-minute walking distance led to a greater reduction in 
perceived depression and fatigue in patients with low to 
moderate-risk stratification for exercise-related cardio-
vascular adverse events [95,96].
RECOMMENDATION
•  CR exercise programs should include aerobic exercise 
(SOR of strong / LOE of 1++)
•  High-intensity interval training may obtain better re-
sults than aerobic exercise (SOR of conditional / LOE 
of 1+)
Resistance exercise program
CR programs encompass the management of various 
risk factors that increase the risk of CVD. In particular, 
interventions for physical activities are a key component 
of CR [90]. Among different types of physical activities, 
we presented evidence of resistance training for CR, and 
reviewed the different effects of CR according to types of 
Chul Kim, et al.
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resistance exercise.
Scotland recommends that aerobic and resistance ex-
ercises be considered part of the exercise prescriptions 
for patients attending CR (SIGN 2017; SOR of conditional 
/ LOE of 1++) [5]. US guidelines are that it is reasonable 
for a clinician to recommend complementary resistance 
training at least 2 days per week [5] (AHA 2011; SOR of IIa 
/ LOE of C) [7]. Canada in turn comments that patients in 
CR may safely derive fitness benefits from a supervised 
program of resistance training, and resistance training 
should be offered to all eligible CR participants (CACR 
2009) [4].
The exercise component of CR lowers cardiovascular 
mortality and readmission rates while increasing pa-
tients’ QOL [91]. The methods, frequencies, durations, 
and intensities of exercise vary widely across studies, 
however, it has been reported that CR is effective, regard-
less of the specific frequency, duration, intensity, and 
place of exercise (LOE of 1++) [18,19,92].
The SIGN 2017 recommends the inclusion of resistance 
training in exercise prescriptions for CR [5], and the AHA 
2011 reports that resistance exercise improves muscle 
strength, endurance, fitness, independence, and QOL, 
regardless of the presence of CVD [7]. One limitation of 
these studies on the reported effects of resistance train-
ing, however, was that they were generally small-scale 
studies involving low-risk groups for exercise-related 
adverse cardiovascular events. Thus, the AHA (2011) 
presents the absolute and relative contraindications of 
resistance exercise [97] (Table 6).
In a systematic review analyzing the effects of progres-
sive resistance exercise in CR programs, both progressive 
resistance exercise and aerobic exercise led to increased 
peak VO2 and fitness, with no significant differences be-
tween the two types of exercise. Although the improve-
ment of peak VO2 did not differ between the aerobic 
exercise plus resistance exercise group and the aerobic 
exercise only group, the aerobic exercise plus resistance 
exercise group had greater improvements in maximal 
exercise capacity. When progressive resistance exercise 
was performed, there was a significant increase in upper 
and lower limb muscle strength compared to the con-
trol group. When both resistance and aerobic exercises 
were performed, there was a significant improvement in 
lower limb muscle strength compared to aerobic exercise 
alone. Regarding types of exercise, the combined exercise 
group showed significant improvements when isotonic 
exercise was performed, but the combined exercise group 
and the aerobic exercise group did not significantly differ 
in muscle strength improvements when isokinetic and 
isometric exercises were used. For lower limb muscles, 
combining isotonic resistance with aerobic exercises led 
to significantly better improvements in lower limb mus-
cle strength compared to the effects of using only aerobic 
Table 6. Absolute and relative contraindications to resistance training
Contraindications
Absolute Unstable coronary heart disease
Decompensated heart failure
Uncontrolled arrhythmias
Severe pulmonary hypertension (mean pulmonary arterial pressure >55 mm Hg)
Severe and symptomatic aortic stenosis
Acute myocarditis, endocarditis, or pericarditis
Uncontrolled hypertension (>180/110 mmHg)
Aortic dissection
Marfan syndrome
High-intensity resistance training (80%–100% of 1RM) in patients with active 
proliferative retinopathy or moderate or worse non-proliferative diabetic retinopathy
Relative (should consult 
a physician before 
participation)
Major risk factors for coronary heart disease
Diabetes at any age
Uncontrolled hypertension (>160/100 mmHg)
Low functional capacity (<4 metabolic equivalents of task)
Musculoskeletal limitations
Individuals with implanted pacemakers or defibrillators
RM, repetition maximum.
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exercise (LOE of 1–) [98].
In a systematic review of three clinical trials that com-
pared the effects of eccentric and concentric exercises in 
patients with acute MI, there were no significant differ-
ences in peak VO2 and 6-minute walk test results between 
the two groups (LOE of 1–) [99].
In a systematic literature review of studies analyzing the 
effects of CR according to the intensity of resistance exer-
cise, the amount of VO2max increase was greater when low-
moderate-intensity resistance exercise (<70% 1RM or ≥12 
repetition/set) and aerobic exercise were combined, than 
when aerobic exercise was performed alone. When per-
formed for less than 12 weeks, combined exercise led to a 
greater increase in VO2max than did aerobic exercise alone, 
but when performed for more than 12 weeks, studies 
could not find significant differences in the increases in 
VO2max between the two groups. One study that examined 
high-intensity exercise (≥70% 1RM or <12 repetition/set) 
did not find differences between the two exercise meth-
ods. Combined exercise led to superior enhancements in 
muscle strength compared to those with aerobic exercise, 
regardless of the intensity and duration of exercise (LOE 
of 1+) [100].
RECOMMENDATION
•  CR programs should include resistance (strengthen-
ing) exercises (SOR of conditional / LOE of 1++)
Safety issues of exercise training in cardiac rehabilitation
The safety of patients who have experienced ACS must 
be ensured during CR. To this end, it is universal practice 
to assess patients’ cardiac states after ACS, stratify risk for 
exercise-related cardiovascular adverse events through 
cardiopulmonary exercise testing, and have patients per-
form ECG-monitored exercise at the hospital for a certain 
period early after onset.
With regard to safety issues related to CR and exercise, 
US recommendations are that all patients receive a risk 
assessment with a physical activity history and/or an ex-
ercise test to guide prognoses and prescriptions, and the 
clinician should counsel patients to report and be evalu-
ated for symptoms related to exercise (AHA 2011; SOR of 
I / LOE of B, C) [7]. Canada advises that risk stratification 
is the key to safe and effective exercise prescriptions, and 
all patients entering CR programs must have a medical 
assessment and undergo determination of their cardio-
metabolic fitness prior to the initiation of therapy. A 
directly supervised GXT is recommended as part of the 
initial CR assessment prior to the initiation of therapy, 
and the provision of continuous EKG telemetry should 
be at the discretion of the CR program medical director. 
Patients in CR are encouraged to wear a heart rate moni-
tor during physical activity and exercise, and follow the 
target heart rates prescribed for them (CACR 2009) [4].
Findings such as VO2max, duration of exercise testing, 
presence of angina symptoms, and ECG abnormalities 
from cardiopulmonary exercise testing are helpful for 
predicting long-term outcomes such as mortality for pa-
tients who underwent PCI or CABG for ACS [101-105]. 
Furthermore, demographic factors and CVD history, 
such as sex, age, BMI, smoking, systolic BP, total choles-
terol, HDL, hypertension, diabetes, and drug history are 
known to be predictors of CVD recurrence and mortality 
[4,106].
Therefore, risk stratification for exercise-related car-
diovascular adverse events based on history and cardio-
pulmonary exercise testing is important for patients who 
undergo PCI or CABG [7]. Risk stratification is critical for 
ensuring the effectiveness and safety of exercise prescrip-
tions, and therefore, cardiopulmonary exercise testing is 
recommended prior to beginning an initial CR exercise 
program [4]. The incidence of heart attacks when con-
ducting exercises such as jogging, swimming, playing 
tennis, and engaging in cross country skiing is reported 
to be higher in the heart disease population than in the 
population without heart disease, with one case per 
12,000–121,955 hours, and one case per 375,000–888,000 
hours, respectively [107]. However, appropriate exercise 
programs significantly lower the disease-related mor-
tality of patients with heart disease, so recommending 
aggressive CR exercise training to these patients is a rea-
sonable decision in which the benefits far outweigh the 
harms. The type and intensity of exercise and monitoring 
during exercise are known to have a serious impact on 
exercise-related deaths, and continuous ECG monitoring 
markedly lowers the incidence of heart attacks during ex-
ercise [107]. 
According to one Korean report, there were 17 cases of 
angina symptoms without ECG anomalies, 31 cases of 
ECG anomalies without angina symptoms, 10 cases of 
ECG anomalies with angina symptoms, and 10 cases of 
temporary blood pressure instability during 13,934 hours 
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of CR by 975 patients over a 10-year period, but during 
this time there was not a single major adverse cardiac 
event, such as a death or AMI [108].
RECOMMENDATION
•  Risk assessment and appropriate monitoring based on 
the risk assessment results should be performed to en-
sure patient safety during CR exercise programs (SOR 
of strong / LOE of 2++)
Home-based cardiac rehabilitation
Home-based CR does not refer to an exercise per-
formed alone by the patient at home; it is a form of exer-
cise performed at home after medical professionals have 
assessed the patient’s cardiac functions at the hospital 
through exercise testing, and the patient has been given 
an exercise prescription and education about risk fac-
tor management. Effective home-based CR is based on 
continuous bidirectional communication with the medi-
cal team, and continuous follow-up assessments. Owing 
to recent advances in information and communication 
technologies (ICTs) and medical technologies, studies 
are continuing to examine new approaches to home-
based CR and their effects. Hence, we reviewed relevant 
evidence and prepared a recommendation tailored to the 
circumstances in Korea.
Scotland’s guidelines state that an exercise component 
in CR reduces cardiovascular mortality and hospital ad-
missions, and improves health related QOL regardless of 
the type of CHD, type of CR, or setting. Benefits appear 
to be independent of a specific frequency, duration, or 
intensity of exercise, or whether it takes place in a hos-
pital, home, or community setting. Further, in home-
based CR programs, BCTs such as social supports and 
goal setting were shown to be effective in reducing CVD 
risk factors, with results comparable to those of hospital- 
or center-based programs. It concluded that there is little 
difference between home- and center-based CR in terms 
of the number of program withdrawals (SIGN 2017; LOE 
of 1++) [5]. US guidelines are that a home-based CR pro-
gram can be substituted for a supervised, center-based 
program for low-risk patients (AHA 2011; SOR of I / LOE 
of A) [7]. Canada advises that CR programs should follow 
comprehensive program models, both home-based and 
institution-based, and integrate the core program com-
ponents presented within its guidelines (CACR 2009) [4].
Previous studies have proposed several methods of 
home-based CR, including one in which patients per-
form CR at home by themselves after undergoing a cardi-
ac function assessment at the hospital and being given an 
exercise prescription, with periodic visits from a therapist 
to provide further instructions on CR. Another approach 
involves teaching patients to exercise using a brochure or 
phone, and monitoring their adherence [109].
A systematic literature review that analyzed the effects 
of home-based CR and hospital-based CR found no dif-
ferences between the two groups in total mortality at 12 
months after onset (RR=1.19; 95% CI, 0.65–2.16), fitness 
at 12 months after onset (MD=-0.13; 95% CI, -0.28 to 
0.02), fitness at 12 to 24 months after onset, quality of life 
parameters at 24 months, CR completion rates, and total 
cholesterol, LDL, triglycerides, systolic BP, diastolic BP, 
and smoking cessation rates at 3 months and 12 months 
(LOE of 1+) [110,111]. Furthermore, home-based CR and 
hospital-based CR had equal effects on maximum heart 
rate and weight loss (LOE of 1–) [111]. Similarly, both CR 
programs had equal effects on physical and emotional 
components of QOL as well as on depression (LOE of 1–) 
[111]. Regarding anxiety, one study reported that home-
based CR and hospital-based CR had similar levels of ef-
fectiveness [111], and another study reported that home-
based CR was slightly more effective (LOE of 1–) [112]. 
Regarding blood HDL, one study found increased blood 
HDL after hospital-based CR, [110] while another study 
found hospital-based CR to be more effective, though the 
statistical significance of the difference was unclear [111], 
thus calling for additional analysis (LOE of 1+). Behav-
ioral change techniques such as social supports and goal 
setting during home-based CR programs are effective in 
decreasing cardiovascular risk factors, and the levels of 
effects were similar to those of hospital-based CR pro-
grams (LOE of 1++) [113].
A report conducted in Korea suggested that home-
based CR programs using a mobile ECG data transmis-
sion device (HeartCall) led to improvements in the 
participants’ fitness and QOL [114]. Owing to recent 
advances in ICTs, researchers in Korea are attempting to 
study CR equipment based on smart devices and sensors, 
and additional studies are needed to investigate the clini-
cal effects of home-based CR programs using these tech-
nologies [115,116].
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RECOMMENDATION
•  Home-based CR programs may replace hospital-based 
CR programs for low-risk patients (SOR of conditional 
/ LOE of 1++)
Cardiac rehabilitation for elderly patients
The need for CR is also growing due to aging and the 
subsequent rise of coronary syndromes among those 
aged 65 years and older. In many cases, however, the el-
derly engage in fewer daily physical activities, and have a 
low level of participation in CR exercise programs due to 
other comorbidities. Based on our review of the relevant 
literature, we developed recommendations for CR for the 
elderly.
Canada’s guidelines state that elderly patients with CAD 
will benefit from and should participate in CR programs 
that include both aerobic and resistance training (CACR 
2009) [4].
One-year survival rates for acute MIs is known to de-
cline with advancing age [117]. There is also a report 
that those aged 65 years or older who have had MIs show 
lower VO2max, exercise testing durations, depression in-
dexes, and grip strength compared to those with other 
heart diseases [118]. According to an article that reviewed 
various studies observing the effects of CR by age, CR 
improves aerobic fitness and physical functioning scores 
equally, and lowers body fat percentages and LDL/HDL 
ratios in patients 65 years and older similarly to its effects 
on patients under the age of 65 [119]. Even among the 
superaged over 75, CR can lead to functional improve-
ments, and for this group it is important to initiate CR 
aggressively in the acute phase, immediately after being 
admitted for heart disease, and continuing into hospital-
centered outpatient CR after discharge [120]. Therefore, 
elderly patients with CAD must also be provided with 
and be motivated to participate in CR that is comprised 
of aerobic and resistance exercise [4]. A systematic litera-
ture review that analyzed the effects of resistance training 
on elderly (≥65 years) patients and mid-aged patients 
with CAD also found that resistance training improves 
upper and lower limb muscle strength, exercise capacity, 
and mobility equally in both patient groups (LOE of 1++) 
[121].
Although no Korean study has analyzed the effects of 
CR in those aged 65 years and older, it has been reported 
that CR improves VO2max and anaerobic thresholds in MI 
in patients aged 60 years and older [122].
RECOMMENDATION 
•  CR programs should also be administered to patients 
aged 65 years and older (SOR of strong / LOE of 1++)
Education for secondary prevention
Need for educational components in cardiac rehabilita-
tion
The British Association for Cardiovascular Prevention 
and Rehabilitation (BACPR) defines CR as the collection 
of all behaviors aiming to delay or reverse disease prog-
ress by rectifying health behaviors and returning to an 
ideal social life or preserving social functions [123]. Other 
CR guidelines use similar definitions, and thereby con-
firm that existing CR programs are oriented to providing 
a comprehensive program that consists of secondary pre-
vention and improvements in patients’ QOL, as opposed 
to simply focusing on their rehabilitation with reduced 
motor functions.
Behavioral interventions that focus on directing pa-
tients’ health behaviors in a desirable direction are need-
ed with regard to various aspects such as physical activi-
ties, diet, smoking cessation, body weight management, 
stress management, and psychological problems, and 
there is high demand for CR programs that encompass 
these factors, though they are not adequately addressed 
in conventional clinical practices. Furthermore, although 
maintaining various drug therapies such as statins, an-
tiplatelets, and beta-blockers is well supported by evi-
dence and plays an important role, the issue of whether 
patients are actually adhering to these drug therapies is 
influenced by diverse factors that involve the patients, 
medical teams, prescriptions, and healthcare systems. 
There is evidence suggesting that the ideal state has not 
yet been reached, and CR programs must also address 
this shortcoming.
Providing knowledge about a patient’s disease, subse-
quent treatments, the expected effects and needs, pre-
cautions and self-care efforts is important for assessing 
their effects on patient outcomes, but also has ethical im-
plications in terms of ensuring patients’ rights to know.
Scotland’s guidelines reviewed the evidence for what 
was at that time called ‘comprehensive rehabilitation’. 
This term was used to define the prevalent model of CR, 
which consisted of two components, exercise and educa-
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tion. They concluded that when helping patients make 
lifestyle changes, CR programs should place comparable 
emphasis on each of the lifestyle risk factors (SIGN 2017; 
SOR of strong) [5]. England’s guidelines observed that 
comprehensive CR programs should include health edu-
cation and stress management components (NICE 2013; 
SOR of I) [6]. Japan has recommended that CR programs 
include patient education sessions (JCS 2012; SOR of I / 
LOE of A) [8].
In a review of 6 RCTs that compared exercise-only 
groups and exercise and education groups of patients 
with CAD, exercise and education about risk factors in-
creased patients’ levels of physical activities over 6–12 
months, but their effects on smoking and diet were not 
clear; the strategies employed here included goal setting, 
problem solving, self-monitoring, and role-modeling 
(LOE of 1++) [79]. Other results indicated that similar 
strategies were effective after participating in a CR pro-
gram (limited to exercise training), and even when not 
participating in a CR program (LOE of 2–) [124].
In a systematic review of patients with ACS, only one 
RCT examined the effects of an intervention aimed to in-
crease self-efficacy. This trial reported that there were no 
significant differences in the levels of physical activities 
between the intervention and conventional treatment 
groups at 6 months (LOE of 1+) [77]. However, when the 
results of all qualitative studies on patients with heart 
failure were combined, patients’ responses to their bodily 
changes and the extent of encouragement to exercise 
received from friends and family members were associ-
ated with their levels of physical activity, suggesting that 
enhancing self-efficacy and helping patients have posi-
tive expectations of their results may be important factors 
for inducing behavioral change (LOE of 1+) [125]. In a 
systematic literature review of studies that analyzed the 
effects of home-based CR programs, 10 out of 11 RCTs 
found that behavior change techniques were useful in 
lowering controllable CVD risk factors, and the tech-
niques used included social support, goal setting, and 
self-monitoring (LOE of 1++) [113].
When articles published after the publication of existing 
CPGs were searched, of 22 clinical trials, one study found 
that the effects of educational interventions were appro-
priate to answering the key question (LOE of 1+) [126]. 
Most clinical trials included in this study had low risk of 
bias, and educational interventions varied widely, from 
40-minute interviews with 15-minute phone follow-ups, 
to 4-week programs with 11 months of follow-up ses-
sions. Most studies reported only all-cause mortality, and 
few studies compared mortality rates by cause of death. 
There were significant differences in CVD mortality rates 
according to educational levels, suggesting that educa-
tional interventions may be effective, but there were only 
two relevant studies, and the level of evidence is low. The 
two groups did not significantly differ in all-cause mor-
tality, MI, revascularization rates, and admission rates, 
and the educational intervention group tended to show 
higher QOL indices, though they were not consistently 
high across all indices.
Because the effects of educational interventions are 
more indirect—as in altering patient behaviors—as op-
posed to influencing the outcomes of CVD directly, they 
may vary greatly according to the patient population’s 
characteristics, the method/intensity/duration of an in-
tervention, and whether patients accepted the interven-
tions. It is difficult to conclude that simply summing the 
results alone could describe the effects of educational 
interventions in their entirety. Furthermore, there are 
cases in which the control group may alter its behaviors 
independently, thereby diluting the effects of interven-
tions. When interpreting the results, therefore, the effects 
of educational interventions are much more difficult to 
substantiate than those of drug therapies or procedures. 
Given this background, we strongly recommend that pa-
tient education be included in CR programs, despite the 
low evidence level supporting the effects of educational 
interventions, and the low effects these interventions are 
documented to have in the literature.
RECOMMENDATION
•  CR programs should include patient education (SOR 
of strong / LOE of 1++)
Contents of patient educational programs
Existing CPGs for CR make recommendations about 
the information that should be provided to patients, that 
is, the contents to be included in patient education. Sup-
porting evidence is thin, however, and there is a lack of 
adequate evidence to support each specific item.
With regard to the content of patient education materi-
als, one study reported that many patients voluntarily 
stopped taking prescribed medicines, and even those 
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who continued to take them often took them irregularly, 
with adherence rates merely reaching an average of 50% 
in the long-term [127]. Several drugs such as statins and 
antiplatelets provide firm evidence of improved out-
comes from ACS. Helping patients adhere to these drug 
therapies is crucial for secondary prevention, and CR 
programs may serve as an opportunity to achieve this 
end.
Scotland’s guidelines recommend discussing the im-
pacts of a cardiac event/coronary heart disease on emo-
tional well-being throughout CR, advising patients about 
the purpose and use of secondary prevention medication 
and encourage concordance, while linking patients to 
other information sources, peer support, and support 
groups. Prior to hospital discharge following a cardiac 
event, verbal and written information on diagnosis, chest 
pain management—including how to use the glyceryl 
trinitrate (GTN) spray—advice on driving, returning to 
work, and appropriate daily activities should be provid-
ed, including information such as booklets from the Brit-
ish Heart Foundation or Chest, Heart & Stroke Scotland. 
Future treatments, interventions, and appointments 
should be discussed, along with the purpose of CR, and a 
contact number for the CR unit should be provided. The 
benefits of smoking cessation should be discussed if ap-
propriate. At the CR assessment, information appropri-
ate to the needs and choices of the patient with regard to 
activities, exercise, smoking cessation, weight manage-
ment, diet, and common emotional adjustment reactions 
to ill health should be provided, and the patient should 
be advised of the benefits of continuing to exercise long 
term, and assured that it can be undertaken safely and ef-
fectively in any setting. The patient should also be given 
a contact number for ongoing person-centered advice 
(SIGN 2017) [5,8].
Japan encourages (1) teaching the patient how to man-
age chest pain, and providing contact information in the 
event unmanageable chest pain occurs; (2) instructing 
the patient on the use of nitroglycerin sublingual tablets 
or sprays; (3) encouraging the patient and his/her family 
members to learn how to perform cardiopulmonary re-
suscitation; (4) explaining the patient’s coronary risk fac-
tors; (5) motivating the patient to participate in CR and 
improving their lifestyle; and (6) encouraging the patient 
to stop smoking and maintain a tobacco-free lifestyle (JCS 
2012) [8].
The authors did not review the level of evidence for 
specific educational content, but did review evidence 
concerning adherence to drug therapies by reviewing the 
published literature. SIGN 2017 found that most studies 
with high levels of evidence and high effects used multi-
faceted and complex interventions, including intensive 
education and counseling by various medical and non-
medical experts, continuous treatment support, as well 
as family and coworker support, and given that the het-
erogeneity across studies was high, concluded that it was 
difficult to present specific recommendations (LOE of 
1++) [127].
Other evidence showed that early interventions by a 
nurse and those in which the physician in charge was 
provided with information about a patient’s adherence to 
drug therapy were effective albeit to a small extent [128]. 
Multiple recent studies, as well as new studies, are con-
tinuing to investigate the effectiveness of mobile health 
using cell phone messages or smartphone applications, 
and systematic reviews of completed studies found that 
these techniques are effective to some degree (LOE of 
1–) [129-132]. Even so, there is significant heterogeneity 
regarding the methods involved, so it is difficult to make 
specific recommendations about the interventions that 
should be used to improve adherence.
Medication adherence remains a crucial issue that can-
not be neglected, necessitating that CR teams confirm 
and evaluate whether patients are adhering to their pre-
scribed medications. CR programs have great potential 
to provide a tool for checking and improving patients’ 
adherence, but additional studies are needed to confirm 
which interventions should to be integrated in CR pro-
grams to effect this outcome.
RECOMMENDATION
•  The recommendations in SIGN 2017 should be largely 
accepted regarding educational contents (SOR of GPP 
/ LOE of 2+) (Table 7)
Education for smoking cessation
The importance of smoking cessation by patients with 
ACS and the general population is undoubtable. Howev-
er, there is currently inadequate evidence documenting 
the specific benefits of smoking cessation interventions 
in CR programs, and existing structures and intensities of 
such interventions are inadequate. These interventions 
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require additional staff resources, and because the avail-
ability of these resources varies across hospitals in Korea, 
each organization’s circumstances must be considered 
when including this intervention. In general, an ade-
quate intensity of intervention is most likely to determine 
the effects of a behavioral therapy, so we recommend an 
appropriate follow-up period. Nonetheless, programs 
should be designed on the basis of the human resources 
available, the extent to which these resources could be 
dedicated to CR programs or educational efforts that in-
clude smoking cessation, and the expected outcomes.
Scotland’s guidelines recommend that CR patients who 
smoke should be offered smoking cessation interventions 
that extend over more than 4 weeks. These interventions 
should include telephone contact, behavioral support, 
and self-help materials (SIGN 2017; SOR of strong / LOE 
of 1++) [5]. US recommendations are that tobacco users 
should be advised to stop smoking at every visit, patients 
should receive counseling and help developing a plan to 
stop smoking that may include pharmacotherapy and/
or referral to a smoking cessation program (AHA 2011; 
SOR of I / LOE of A), and all patients should be advised 
at every office visit to avoid exposure to environmental 
tobacco smoke at work, home, and in public places (LOE 
of B) [7].
A systematic review of published studies found that 
psychosocial interventions were effective in achieving 
smoking cessation [133]. It is known that behavioral ther-
apies, phone support, and self-help have similar effects, 
but most programs combined two or more approaches. 
The effects are closely associated with the duration of 
interventions, but programs that lasted for more than a 
month after initial contact (RR=1.28; 95% CI, 1.17–1.40), 
were more effective than those that lasted for less than a 
month (RR=1.01; 95% CI, 0.91–1.12) (LOE of 1++). Phone 
support interventions were also found to be very effective 
in promoting smoking cessation (RR=1.32; 95% CI, 1.07–
1.62). The current review includes both CR programs that 
included phone support interventions and those that did 
not (LOE of 1–) [134].
In a systematic review of studies that assessed interven-
tions begun during patients’ hospital stays and continued 
during outpatient visits, only those that extended over 
more than 1 month were effective. Diverse CVD patients 
were studied, and some were offered nicotine replace-
ment therapies (LOE of 1++) [135]. A review of studies 
based on interventions delivered by nurses found them 
to be effective. These interventions included counseling 
sessions where patients’ were encouraged to stop smok-
ing, benefits and factors that hindered smoking cessation 
were reviewed along with coping strategies, and follow-
up visits were incorporated. This review noted that five 
Table 7. Education contents for cardiac rehabilitation in SIGN 2017 [5]
Education contents
Throughout entire  
CR program
-  Education about the effects of cardiovascular events/coronary artery disease, such as 
myocardial infarction, on psychological/emotional state 
-  To promote secondary prevention, explain the purpose and need for the prescribed 
medications and encourage patients to adhere to prescription-guide patients to additionally 
obtain appropriate information
Before discharge -  Provide information about disease and other precautions : Name of diagnosis, how to 
respond to chest pain (including nitroglycerin sublingual tablet or spray), recommendations 
about appropriate daily activities and driving, return to work 
- Provide additional relevant educational materials 
- Inform about upcoming treatments, interventions, and appointments 
- Purpose and need for CR program. How to contact the CR team 
- (For smokers) Importance of smoking cessation
When assessing CR -  Additional education according to patient needs: Physical activity, exercise, smoking 
cessation, weight management, nutritional education, psychological/emotional response to 
disease 
-  Needs for and benefits of maintaining exercise habits in the long-term; can perform exercise 
safely and effectively at the appropriate intensity
- Ways to contact the CR team when in need of advice or support
SIGN, Scottish Intercollegiate Guidelines Network; CR, cardiac rehabilitation.
Recommendations for Cardiac Rehabilitation and Secondary Prevention After Acute Coronary Syndrome
379www.e-arm.org
studies found significant effects associated with CR pro-
grams that had an educational component (RR=1.35; 95% 
CI, 1.14–1.59). Interventions led by a nurse responsible 
for CR and health education components delivered over 
several sessions were more effective than interventions 
led by a nurse who was also involved in other tasks (LOE 
of 1+) [136]. Combining therapy with face-to-face or 
phone behavioral interventions increased the success 
rates of patients undergoing nicotine replacement thera-
py by 10%–25% (LOE of 1++) [137].
Regarding evidence published after the publication of 
CPGs, Franck et al. [138] conducted a systematic review 
of seven studies with a patient population similar to 
that in this study. It included three intervention studies 
focused on counseling, and four studies that combined 
drug therapy with counseling. Of the studies that used 
drug therapy, only the one that used varenicline found a 
significant increase in the smoking abstinence rate, and 
three behavioral intervention studies that significantly 
improved the rate of smoking abstinence at 6 months and 
12 months were assessed as having problems with gen-
eralizability. All-cause mortality was not reduced, and 
there were no significant differences in the recurrence 
of MI, revascularization, and readmission. Two stud-
ies documented a significant decrease in cardiovascular 
events. Though there was a tendency to improve QOL, 
this improvement was not consistent across all indices. 
If limited to the additional evidence, smoking cessation 
interventions do seem useful for ACS, but there is not a 
high level of evidence supporting this supposition (LOE 
of 1–).
RECOMMENDATION
•  Smoking cessation interventions should be provided 
for patients who smoke, and continuous interventions 
of more than 4 weeks should be considered (SOR of 
strong / LOE of 1++)
Diet program for patients with cardiovascular disease 
(proposal by the Korean Society of Clinical Nutrition)
The diet program for CR patients proposed by the Ko-
rean Society of Clinical Nutrition aims to help these indi-
viduals maintain a healthy weight, appropriate blood lip-
id levels, and blood pressure. Since diet programs must 
consider a country’s general meal patterns and cultural 
backgrounds, it is inappropriate to follow existing Ameri-
can or European recommendations, and it is unrealistic 
to review the levels of evidence for each specific item, as 
is the case with educational contents. We therefore pres-
ent GPPs in collaboration the Korean Society of Clinical 
Nutrition.
These guidelines were developed on the basis of re-
cently revised major dietary guidelines related to CVD 
prevention and rehabilitation in Korea and abroad [4-
6,9,139-142]. The Mediterranean diet, one of the most 
widely accepted healthy dietary patterns, has been re-
ported to lower CVD risks in 5-year meta-analyses of 
RCTs and cohort studies [143,144], and has also been 
reported to significantly lower morbidity and mortality in 
CVD secondary prevention intervention studies that in-
clude comprehensive nutritional interventions [145-147]. 
More systematic studies are needed, however, since there 
are few relevant Korean data that can be used to propose 
levels of evidence and assess the strengths of recommen-
dations for each item in this dietary guideline.
RECOMMENDATION
•  Diet programs should be designed with reference to 
the following guidelines (SOR of GPP / LOE of 2+) 
(Table 8)
Recommendations for food supplements
As is true among patients with other acute or chronic 
diseases, many patients with CVD take food supplements 
and are interested in them. Often they also consult their 
physicians about them, and physicians must respond ap-
propriately, thereby necessitating a review of evidence 
regarding the use of food supplements. Patients are in-
terested in or take diverse types of food supplements, but 
it is impossible to address all of them in detail. For this 
reason, we developed a recommendation for the food 
supplements most commonly encountered in practice: 
omega-3 fatty acids, polycosanol, and antioxidants. Al-
though the available evidence is inadequate, by carefully 
generalizing these recommendations, it was possible to 
give levels of recommendations for food supplements 
(LOE of 4).
Omega-3 fatty acids
England advises physicians not to offer or advise people 
to use the following to prevent another MI: omega-3 fatty 
acid capsules and/or foods supplemented with omega-3 
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fatty acid. There is, however, no evidence of harm if 
people choose to take these capsules or foods. It further 
advises people not to take supplements containing beta-
carotene, and does not recommend antioxidant supple-
ments (vitamins E and/or C) or folic acid to reduce car-
diovascular risk (NICE 2013) [6].
Patients who had MIs and take omega-3 supplements 
or increase the α-Linolenic acid (ALA) content in their 
diet for secondary prevention will not experience nega-
tive consequences. Further, omega-3 or ALA does not 
have a harmful effect on lipid metabolism, and may also 
reduce triglycerides [148]. However, there is no clear 
evidence suggesting that they influence cardiovascular 
events or all-cause mortality (LOE of 1++) [149].
There have been reports of relatively mild adverse 
events, such as diarrhea, nausea, delayed hemostasis, 
and allergies after taking omega-3 as food supplements, 
but omega-3 lowers triglycerides and increases HDL-
cholesterol. Several clinical trials and meta-analyses, 
however, found little evidence suggesting that taking 
Table 8. Diet program for cardiac rehabilitation program 
Item Contents Notes
Diet pattern Diversify food groups within the appropriate 
total energy consumption to maintain a 
healthy weight, including whole grains, 
vegetables, fruits, fish (blue-backed fish), 
poultry, beans, and nuts.
Major foreign guidelines prioritize a guideline for 
overall diet patterns. Korean guidelines do not 
provide instructions about diet patterns, but it would 
be desirable to include one, owing to the nature of 
the diet culture. However, considering Koreans’ food 
culture, we did not mention dairies (low fat).
Fat [141] Limit total fat intake to 30% of total energy 
intake. Limit saturated fat intake to 7% of 
total energy intake. Replace saturated fats 
with monounsaturated fatty acid (MUFA) 
and polyunsaturated fatty acid (PUFA), and 
limit omega-6 PUFA to 10% of total energy 
intake. Limit trans-fat intake to 1% of total 
energy intake. 
Generally, accept the recommendations of the Korean 
Society of Lipid and Atherosclerosis (KSLA) guideline 
(However, to increase the emphasis on MUFA, we 
revised the guideline to separately mention MUFA 
and PUFA). 
Cholesterol 
[141,175]
Limit daily cholesterol intake to 300 mg. Recently, multiple foreign guidelines tend to delete a 
guideline for cholesterol. However, we included this, 
as some foreign guidelines still limit daily cholesterol 
intake to 200–300 mg, and the Korean nutrient 
standard and KSLA guideline limits daily cholesterol 
intake to 300 mg.
Salt [176,177] Limit daily salt intake to 5 g (daily sodium 
intake to 2 g). 
Daily salt intake ranges from 4–6 g in foreign 
guidelines. To remain consistent with the Korean 
nutrient standard, we set daily salt intake to 5 g. 
Fibers 
[178,179]
Eat enough whole grains and vegetables to 
keep daily fiber intake above 25 g. 
European guidelines set daily fiber intake to 30-45 g, 
but Canadian, American, and Korean guidelines set 
the cutoff to 25 g. 
Sugars Limit added sugar (sugars added during 
cooking or processing) intake to 10% of 
total energy intake. 
Most foreign major guidelines include a phrase about 
limiting sugar-sweetened beverages in their diet 
pattern guideline. Because sugar intake is on the 
rise recently, it is valid to include sugar intake in the 
guideline. As with the added sugar standard in the 
Korean nutrient standard, added sugars are limited 
to 10% of total energy intake. 
Alcohol [142] It is desirable to avoid drinking. In unavoidable cases, alcohol should be limited to 
2 shots a day for men (20 mg) and 1 shot a day for 
women (10 mg). Alcohol intake should be minimized 
to control blood pressure and body weight. 
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omega-3 lowers all-cause mortality, cardiovascular 
events, or cardiovascular mortality, the incidence of 
CAD, cerebrovascular disease, or arrhythmia [149-152]. 
An ALA-rich diet did not lower all-cause mortality or 
cardiovascular mortality, and its effects on the incidence 
of stroke were not clear. It did, however, slightly reduce 
deaths from CAD and the incidence of arrhythmia [149].
Polycosanol
In a study that assessed the effects of policosanol in 
patients with hyperlipidemia, polycosanol lowered total 
cholesterol and LDL-cholesterol and increased HDL-
cholesterol with no significant effects on triglycerides 
or body weight [153]. Patients with a history of CAD 
must take high-dose statins for secondary prevention 
purposes, however, in cases where side effects included 
poor drug adherence and necessitated the use of low-
dose statins, combining low-dose statins with Armolipid 
Plus (red yeast rice, policosanol, berberine, folic acid, 
coenzyme Q10, astaxanthin complex) led to a greater 
reduction of LDL-cholesterol and higher achievement of 
targeted LDL-cholesterol rates without differences in ad-
verse events (LOE of 1–) [154].
Another study that assessed the safety and effects of 
adding polycosanol for patients receiving antiplatelets 
after drug eluting stent insertions found that adding 
polycosanol did not significantly elevate cardiovascular 
events, deaths, or bleeding tendencies (LOE of 1–) [155]. 
However, findings on the association of polycosanol and 
improvements in dyslipidemia are inconsistent [156], and 
there have been no clinical trials on the long-term clini-
cal outcomes or secondary prevention outcomes related 
to polycosanol intake in patients with CAD.
Antioxidants
Vitamin E, beta-carotene, and vitamin C are antioxi-
dants widely used as food supplements. Vitamin C has 
been found to delay the progression of early atheroscle-
rosis, with no benefits for atherosclerosis in later stages in 
vitro. A meta-analysis of the effects of these antioxidants 
on major cardiovascular events found that there were 
no significant differences between these antioxidants 
and placebos in major cardiovascular events, that is, MI, 
stroke, all-cause mortality, heart disease-related mortal-
ity, revascularization rates, CAD, and heart failure [157]. 
Further, antioxidants did not prevent cardiovascular 
events in women (LOE of 1++) [158,159].
It has been reported that vitamin E lowers the incidence 
of MI and stroke in patients aged 65 years or older [160], 
but this was only observed in a RCT that involved supple-
ments manufactured by a pharmaceutical company, and 
there is a lack of evidence suggesting that it has preven-
tive effects against CVD (LOE of 1++) [157,161]. Given 
published findings and the results of the analyses con-
ducted in developing these CPGs, there is not sufficient 
evidence to conclude definitively that omega-3, polyco-
sanol, and antioxidants have benefits for the secondary 
prevention of CAD.
It would clearly be harmful if patients overestimated 
the effects of these food supplements and deluded them-
selves into thinking they were undergoing adequate 
treatment, and so paid less attention to adhering to other 
established measures for secondary prevention, that is, 
taking prescribed medicines, exercising, and giving up 
smoking. Therefore, healthcare professionals must inter-
vene aggressively in this matter (LOE of 4).
RECOMMENDATION
•  Food supplements are not recommended for second-
ary prevention of CAD (SOR of conditional)
ICT-based modality for patient education
ICTs (e.g., phones, cell phones/smartphones, mobile 
apps, tablet computers, the Internet, biosensors) are now 
widely used in healthcare. The World Health Organiza-
tion defines medical and public health practice using 
mobile devices (e.g., cell phones, patient monitoring 
devices, personal digital devices, other wireless devices) 
as mobile health (mHealth) [162], though its definition is 
still vague, and it is often confused with electronic health 
(eHealth) and telehealth. This technology can, however, 
help overcome factors that limit participation in CR, such 
as distance, traveling, scheduling, access to caregivers, 
and costs. These technologies can increase access to 
home-based CR, enable two-way communications with 
experts and monitoring by experts, and is also helpful for 
hospital-based programs. In particular, mHealth is very 
useful for managing chronic diseases such as CVD, by 
increasing a patient’s knowledge and awareness of their 
disease, and providing appropriate education to induce 
and maintain good self-care.
As of 2015, Internet usage rates and smartphone pen-
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etration rates among adults in advanced countries 
worldwide were 87% and 68%, respectively. At 94% and 
88%, respectively, these rates are highest in South Korea. 
Although there is a great gap in developing countries, 
which have rates of about 54% and 37% respectively, 
rates in these countries are rising sharply [163]. As of 
2017, 50% of global Internet traffic was on mobile devices 
(smartphones or tablet computers) [164], and mHeatlh 
apps were estimated to have been downloaded 3.7 bil-
lion times [165]. In other words, the Internet and mobile 
digital devices based on ICTs that are already a routine 
part of our daily lives are widely used for health-related 
purposes.
Scotland’s guidelines are that technology-based inter-
ventions should be considered for patients participating 
in CR, and psychoeducation (goal setting, self-monitor-
ing) should be considered for patients in CR to facilitate 
adherence to engaging in physical activities (SIGN 2017; 
SOR of conditional / LOE of 1++) [5].
The results of ICT-based interventions intended to pro-
mote exercise are not consistent [111,166]. An Australian 
patient-centered program that consisted of a 1-hour 
initial consultation followed by 3 months of repeated 
phone follow-ups significantly reduced total cholesterol 
(mean 154.7±3.9 vs. 181.8±3.9 mg/dL; p<0.001), systolic 
BP (mean 131.6±1.8 vs. 143.9±2.3 mmHg; p<0.001), and 
BMI (mean 28.9±0.7 vs. 31.2±0.7 kg/m2; p=0.025) [166]. 
In another multicenter RCT in Australia, goal setting with 
6 months of phone follow-ups led to a greater reduction 
in total cholesterol (MD=21 mg/dL and 95% CI, 16–25 
mg/dL vs. MD=7 mg/dL and 95% CI, 3–11 mg/dL), body 
weight, BMI, dietary fat intake, saturated fat intake, and 
anxiety [166]. These interventions, which had efficacies 
similar to those of traditional CR, may serve as alterna-
tives for patients who cannot participate in hospital-
based CR, or those who simply prefer this method (LOE 
of 2+) [111,166]. In a RCT that used exercise prescriptions 
and behavior support over the Internet and text messages 
(4–6 per week for 24 weeks) for patients with ischemic 
heart disease (mean age, 60 years), this intervention did 
not improve exercise capacity (VO2max), but significantly 
increased leisure activities (MD=110.2 min/week; 95% 
CI, -0.8 to 221.3; p=0.05) and walking time (MD=151.4 
min/week; 95% CI, 27.6–275.2; p=0.02). In addition, pa-
tients’ self-efficacy and QOL were significantly improved 
(LOE of 1++) [167]. The use of digital pedometers in a 
small-scale RCT significantly increased the total number 
of physical activities, walking time, and walking frequen-
cy of patients undergoing CR (LOE of 1+) [168].
Combining physical activities with video games in-
creased involvement in physical activities and improved 
QOL, well-being, and symptoms of depression in pa-
tients with stroke or heart failure aged 50 years or older. 
These attempts were evaluated to be safe and fun (LOE 
of 2+) [169]. Internet-based interventions, such as web-
sites that provided individual instructions, also improved 
the number of steps and exercise capacity of patients in 
distant locations, or those who had decided not to par-
ticipate in hospital-based CR (LOE of 1++) [71,170,171]. 
In a home-based RCT that provided a web-based reha-
bilitation program for patients with angina, at the 6-week 
follow-up the intervention group showed an average in-
crease of 497 steps daily, while the control group showed 
an average decrease of 861 steps daily (LOE of 1+) [170]. 
Patients who were provided with 6 months of online 
personal instruction called CardioFit, an Internet-based 
system developed to promote physical activities in pa-
tients with CAD, increased the amount of physical activi-
ties they engaged in and their QOL at 6 months and 12 
months (LOE of 1++) [172]. In addition, the intervention 
group, which used an Internet-based virtual CR program 
for 4 months, showed a significant increase in maximum 
treadmill duration (45.7 seconds; 95% CI, 1.04–90.48) at 
16 months, compared to that of the control group. The 
intervention group also had decreased total cholesterol, 
LDL-cholesterol, and dietary saturated fat intake (LOE 
of 1++) [171]. Home-based multilateral CR models using 
ICT were associated with improvements in CVD risk fac-
tors comparable to those of traditional hospital-based CR 
programs [166]. Thus, these CR models may be integrated 
into traditional treatment models, and increase the num-
ber of options available to patients (LOE of 2+).
A recent study reviewed and meta-analyzed 10 clinical 
trials of 607 patients in 5 countries about the utility, ac-
ceptance, and usefulness of mobile apps for self-care of 
CVD and management of risk factors [173]. The mobile 
app group showed improvements in readmission rates, 
disease knowledge, psychosocial well-being, BMI, waist 
circumference, cholesterol and fitness, physical activi-
ties, drug adherence, and smoking cessation rates [173]. 
However, many of these studies were small-scale, had a 
short study period, had no blinding due to the nature of 
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the intervention, and used biased data, thereby neces-
sitating additional studies to address these shortcom-
ings. Nevertheless, these studies confirmed the potential 
mobile apps had for inducing behavioral changes and 
ameliorating CVD risk factors. These findings allude to 
the usefulness of mHealth as a healthcare delivery sys-
tem that improves access to CR for patients who have dif-
ficulty participating in traditional hospital-based CR (LOE 
of 1–).
Maintaining medication adherence is critical for the 
secondary prevention of CVD, and is associated with re-
admission, disease onset, mortality, and increased medi-
cal costs [174]. Hence, behavioral interventions such as 
education and counseling intended to enhance medica-
tion adherence are essential components of CR. In this 
context, study findings that ICT-based interventions are 
useful in improving medication adherence for patients 
with CVD, as with other chronic diseases are mounting. 
A recent meta-analysis of RCTs used mHealth devices for 
CVD patients had medication adherence as its primary 
outcome. According to this meta-analysis of 10 clinical 
trials (1–18 months of follow-up), using text messages, 
Bluetooth-electronic pillboxes, online messaging plat-
forms, and conversational voice calls all enhanced drug 
adherence, though the degrees of improvement varied 
[130]. This meta-analysis was also limited because it ana-
lyzed mostly small-scale studies with short-term follow-
ups and self-reported results, but the results nevertheless 
suggest that mHealth tools may be useful for improving 
drug adherence among CVD patients (LOE of 1–).
RECOMMENDATION
•  ICT-based modalities should be considered to main-
tain the effects of education (SOR of conditional / LOE 
of 1–)
DISCUSSION AND CONCLUSION
According to a 2016 Statistics Korea report [3], CVD is 
the second leading cause of death in Korea, and most of 
these events involve ACS [1,2]. This high mortality rate 
encompasses not only deaths at the time of onset, but 
also deaths from recurrence and complications over a 
short or long-term following initial onset, but unfor-
tunately, relevant statistics are lacking in Korea. ACS 
clinically manifests as an acute condition, but pathologi-
cally, it is actually an onset of chronic atherosclerotic 
vascular disease that has been slowly progressing over a 
long period. Therefore, even following appropriate treat-
ment in the acute phase, patients are left with a chronic 
atherosclerotic vascular condition, so lifelong treatment 
and management is essential after discharge [4]. Many 
patients, moreover, have difficulty managing risk factors 
on their own, and continuing with appropriate levels of 
physical activity after discharge due to tachycardia, an-
gina, arrhythmia, orthostatic hypotension, and reduced 
fitness. In particular, older patients and those with com-
plications are faced with markedly reduced exercise ca-
pacity, which, if it persists, will allow the CAD to progress, 
and lead to adverse outcomes in the long-term—5 years 
and 10 years after onset (e.g., quality of life, recurrence, 
readmission, death).
A widely used treatment method worldwide, the effects, 
safety, and recommendations associated with CR are 
well established. Several countries have developed their 
own CPGs in consideration of their circumstances [4-9], 
but CR is still largely an unknown in Korea, due to a lack 
of awareness among patients and medical professionals, 
as well as a lack of relevant experts and facilities. On a 
positive note, in 2008, CR programs were implemented 
at 11 university hospitals as part of the government-led 
Regional Cardio-Cerebrovascular Center Project; three 
additional medical facilities will be added in 2019, after 
which 14 CR hubs will be fully operational. In addition, 
with the growing acceptance of CR nationwide and the 
introduction of CR insurance benefits, 40 medical insti-
tutions nationwide have established CR programs, and 
a growing number of medical institutions are preparing 
to offer CR. Large gaps remain among Korean medical 
facilities administrating CR, however, due to the lack of 
a standardized concept, purpose, and application. Fur-
thermore, CPGs that document standards, principles, 
and methods are needed to direct medical facilities that 
aim to establish new CR programs, even as demands for 
CPGs are growing in the field.
The purpose of the CPGs proposed in this paper—the 
first in Korea—is to present published evidence of the 
need for and rationale of CR, and the strength of recom-
mendations that medical professionals treating CVD 
could make with regard to CR to their patients, with 
strong confidence and a sense of duty. We hope that this 
goal has been achieved, and that the following CPGs will 
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be used to promote CR in Korea, ultimately enriching 
people’s health and enhancing medical-economic effi-
ciencies by markedly improving the short- and long-term 
outcomes of ACS (e.g., QOL, recurrence, readmission 
rates, reoperations, and mortality).
Recommendations for Korea’s CPGs
1. Introduction of Cardiac Rehabilitation
   •  CR programs must be included in the treatment of 
ACS (SOR of strong / LOE of 1++)
   •  It is more appropriate to provide recommendations 
for the timing of exercise training than the timing of 
CR
   •  CR exercise should be initiated as early as possible 
following acute phase treatment (SOR of strong / 
LOE of 1-)
   •  CR programs should be comprehensive and multi-
disciplinary (SOR of GPP / LOE of 1-)
   •  Though CR programs are reported to lower health 
management costs in patients with CVD, high-qual-
ity Korean studies are needed to substantiate this, 
considering the differences of insurance systems 
and healthcare environments across countries (SOR 
of GPP / LOE of 1-)
2. Assessments of Cardiac Rehabilitation
   •  Individualized CR plans should be tailored to indi-
vidual needs and be developed through individual 
assessments of patients referred to CR (SOR of 
strong / LOE of 1+)
   •  Patients referred to CR should be assessed for psy-
chological problems, such as anxiety, depression, 
and stress, and should be provided with psychologi-
cal interventions if abnormal findings are observed 
(SOR of strong / LOE of 1++)
   •  Cardiopulmonary exercise testing should be per-
formed to assess patients’ cardiopulmonary exercise 
functions, prescribe exercise, and predict outcomes 
(SOR of strong / LOE of 2++)
   •  A submaximal exercise test, such as a 6-minute walk 
test, should be considered when symptom-limited 
exercise testing is difficult (SOR of conditional / LOE 
of 2+)
   •  Interventions to increase self-efficacy and aware-
ness of the need for CR are needed to increase CR 
participation (SOR of strong / LOE of 1++)
   •  Systematized automatic referrals and liaison systems 
should be considered to increase CR referral rates. 
(SOR of GPP / LOE of 2-)
   •  Psychological education strategies (including goal 
setting and self-monitoring) should be used to in-
crease CR maintenance rates (SOR of strong / LOE of 
1++)
3. Exercise Therapy for Cardiac Rehabilitation
   •  CR should be initiated early after surgery, as an in-
patient program for patients who undergo CABG 
(SOR of strong / LOE of 1++)
   •  CR exercise programs should include aerobic exer-
cise (SOR of strong / LOE of 1++)
   •  High-intensity interval training may obtain better 
results than aerobic exercise (SOR of conditional / 
LOE of 1+)
   •  CR programs should include resistance (strengthen-
ing) exercises (SOR of conditional / LOE of 1++)
   •  Risk assessment and appropriate monitoring based 
on the risk assessment results should be performed 
to ensure patient safety during CR exercise programs 
(SOR of strong / LOE of 2++)
   •  Home-based CR programs may replace hospital-
based CR programs for low-risk patients (SOR of 
conditional / LOE of 1++)
   •  CR programs should also be administered to pa-
tients aged 65 years and older (SOR of strong / LOE 
of 1++)
4. Education for Secondary Prevention
   •  CR programs should include patient education (SOR 
of strong / LOE of 1++)
   •  The recommendations in SIGN 2017 should be 
largely accepted regarding educational contents 
(SOR of GPP / LOE of 2+) (Table 7)
   •  Smoking cessation interventions should be provided 
for patients who smoke, and continuous interven-
tions of more than 4 weeks should be considered 
(SOR of strong / LOE of 1++)
   •  Diet programs should be designed with reference to 
the following guidelines (SOR of GPP / LOE of 2+) 
(Table 8)
   •  Food supplements are not recommended for sec-
ondary prevention of CAD (SOR of conditional)
   •  ICT-based modalities should be considered to main-
tain the effects of education (SOR of conditional / 
LOE of 1–)
Despite their clinical importance and benefits, it is 
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practically difficult to design high-quality RCTs for CR, 
which requires a long-term behavioral correction. These 
CPGs were developed with reference to foreign CPGs 
in consideration of the latest medical technologies and 
circumstances in Korea, and will suffice to present stan-
dards for CR programs in Korea for the next 3–4 years. 
Furthermore, they will contribute to improving people’s 
health, as well as advancing national health policies, by 
optimizing fitness, improving the QOL, and bettering 
outcomes after the discharge of patients with ACS. In 
the future, CR experts in relevant academic associations 
should continue to develop CPGs for CR in relation to 
heart failure, heart valve disease, congenital heart dis-
ease, arrhythmic disease, and other heart and peripheral 
vascular deformities.
In conclusion, these Korean CPGs for CR present lev-
els of evidence and assess the relative strengths of the 
various recommendations made for the fundamental 
components of CR, which should no longer be treated 
as alternative medicine with insufficient efficacy and 
evidence. We expect that CR will become an essential 
prescription whose benefits far outweigh its possibility 
for inflicting harm, and must be recommended and en-
couraged by physicians for most patients. Promoting CR 
is difficult when it is solely based on the efforts of medi-
cal institutions. Government-led strategies and support 
are crucial to ensuring that patients who are treated in 
the acute phase maintain healthy lifestyles, engage in 
appropriate physical activities, and adequately care for 
themselves. This is the fundamental purpose and direc-
tion of Korea’s Act on the Prevention and Management of 
Cardio-Cerebrovascular Diseases.
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APPENDIX
*The following process was used in the literature search and review for each key question:
1. Searching Strategies
2. Flow Chart of the Study Selection Process
3. Finally Included Studies
4. Evidence Table for Assessment of Risk of Bias and Quality
1. INTRODUCTION OF CARDIAC REHABILITATION
The following are the basic searching strategies used for all key questions of the introduction part in the Cochrane 
Library. These basic searching strategies were combined with the specific searching strategy for each question using 
AND.
#1 MeSH descriptor: [Cardiac Rehabilitation] explode all trees
#2 ((*cardia* or heart*) and *habilitation*):ti,ab,kw 
#3 #1 or #2 
#4 MeSH descriptor: [Myocardial Ischemia] explode all trees
#5 ((myocard* or heart* or coronary or cardia*) and (infarct* or isch* or attack*)):ti,ab,kw 
#6 (“acute coronary syndrome” or ACS):ti,ab,kw 
#7 (angina or stenocardia*):ti,ab,kw 
#8 MeSH descriptor: [Myocardial Revascularization] explode all trees
#9 ((Myocard* or cardi* or coronary) and (Revascular* or angioplast*)):ti,ab,kw 
#10 ((coronary or rotational) near atherectom*):ti,ab,kw 
#11 (“coronary artery bypass” or CABG or “aortocoronary bypass” or “coronary bypass”):ti,ab,kw 
#12 MeSH descriptor: [Percutaneous Coronary Intervention] explode all trees
#13 (“percutaneous coronary intervention*” or PCI):ti,ab,kw 
#14 (percutaneous next coronary near/2 (interven* or revascular*)):ti,ab,kw 
#15 (stent* and (heart or cardiac*)):ti,ab,kw 
#16 coronary near (disease* or bypass or thrombo* or angioplast*):ti,ab,kw 
#17 (PTCA or “percutaneous transluminal coronary angioplasty”):ti,ab,kw 
#18 MeSH descriptor: [Heart Bypass, Right] explode all trees
#19 (“heart manual”):ti,ab,kw 
#20 (arrhythmia* or dysrhythmia* or bradycardia* or tachycardia*):ti,ab,kw 
#21 (cardiopulmonary next arrest* or cardio-pulmonary next arrest*):ti,ab,kw 
#22 heart failure:ti,ab,kw 
#23 ((heart or cardiac or coronary) near/3 transplant*):ti,ab,kw 
#24 {or #4-#23} 
#25 (arthritis* or cancer* or stroke* or kidney* or “obstructive pulmonary” or claudication* or fracture* or 
Parkinson*):ti,ab,kw 
#26 #24 not #25 
#27 MeSH descriptor: [Rehabilitation] explode all trees
#28 (rehabilitat* or *habilitation):ti,ab,kw 
#29 MeSH descriptor: [Physical and Rehabilitation Medicine] explode all trees
#30 MeSH descriptor: [Health Facilities] explode all trees
#31 MeSH descriptor: [Rehabilitation Nursing] explode all trees
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#32 {or #27-#31} 
#33 #26 and #32 
#34 #33 or #3 
#35 (muscle* or asthma* or neuromuscular* or neurodevelopment* or amputation* or ataxia* or “pulmonary hy-
pertension” or coma* or “complex regional pain syndrome”):ti,ab,kw 
#36 #34 not #35
The same Cochrane Library searching strategy was used for KQ1 (“Should cardiac rehabilitation be an integral com-
ponent of the care of acute coronary syndrome?”) and KQ4 (“When should cardiac rehabilitation exercise begin?”). 
The following is the final searching strategy, including the basic CR searching strategy:
Searching Strategies
#37 MeSH descriptor: [Activities of Daily Living] explode all trees
#38 MeSH descriptor: [Exercise] explode all trees
#39 MeSH descriptor: [Exercise Therapy] explode all trees
#40 (exercise* near/2 (rehabilitat* or therap* or training or program* or activit* or toleran* or prescribe* or pre-
scription* or structure* or unstructure* or un-structure* or supervise* or unsupervise* or un-supervise* or 
guided or unguided or dynamic or regime*)):ti,ab,kw 
#41 (physical near/2 (exercise* or educat* or training or program* or activit* or regime*)):ti,ab,kw 
#42 (aerobic* near/2 (exercise* or training or program* or activit* or regime*)):ti,ab,kw 
#43 (strength* near (exercise* or training)):ti,ab,kw 
#44 (endurance near (exercise* or training)):ti,ab,kw 
#45 (fitness near/2 (training or program* or regime*)):ti,ab,kw 
#46 ((resistance or resistive) near (exercise* or training)):ti,ab,kw 
#47 (isometric near/2 (exercise* or training or program* or activit* or regime*)):ti,ab,kw
#48 ((high* frequency or low* frequency) near/2 (exercise* or training or program* or activit* or regime*)):ti,ab,kw
#49 ((high* intensi* or low* intensi*) near/2 (exercise* or training or program* or activit* or regime*)):ti,ab,kw 
#50 MeSH descriptor: [Managed Care Programs] explode all trees
#51 ((multifactor* or multifacet* or managed care) near program*):ti,ab,kw 
#52 {or #37-#51} 
#53 #36 and #52 Publication Year from 2009 to 2018
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Records identified through database searching
Cochrane (43), Embase (661), PubMed (161)
Total (n=865)
Records after duplicates removed
(n=811)
Records screened on basis of title and abstract
(n=811)
Full-text articles accessed for eligibility
(n=40)
KQ1 (n=32), KQ4 (n=26): Allow duplication between KQ
Studies included in qualitative synthesis
(n=11, KQ1: 9/KQ4: 2)
LOE evaluation (KQ-SR: 4, KQ4-SR:1)
Records excluded
(n=771)
Full-text articles excluded, with reasons (n=29)
1. The patient does not have acute coronary syndrome (n=2)
2. Literatures irrelevant to the key question (n=15)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=1)
5. Duplicate publication (n=0)
6. Full text unavailable (n=4)
7. Other (n=7; not SR or data for analysis are dated prior to 2009)
Finally Included Studies: KQ1
Reference  
number
Article
SR1 Goodwin L, Ostuzzi G, Khan N, Hotopf MH, Moss-Morris R. Can we identify the active ingredients 
of behaviour change interventions for coronary heart disease patients? A systematic review and 
meta-analysis. PLoS One 2016;11:1-23.
SR2 Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac 
rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll 
Cardiol 2016;67:1-12.
SR3 Powell R, McGregor G, Ennis S, Kimani PK, Underwood M. Is exercise-based cardiac rehabilita-
tion effective? A systematic review and meta-analysis to re-examine the evidence. BMJ Open 
2018;8:e019656.
SR4 Sumner J, Harrison A, Doherty P. The effectiveness of modern cardiac rehabilitation: A sys-
tematic review of recent observational studies in non-attenders versus attenders. PLoS One 
2017;12:e0177658.
SR, systematic reviews.
Flow Chart of Study Selection Process
Chul Kim, et al.
398 www.e-arm.org
Evidence Table for Assessment of Methodological Quality of Systematic Reviews using AMSTAR 2 and Level of Evi-
dence (LOE) using SIGN Methods: KQ1
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y P Y P Y Y Y Y Y N Y Y Y Y Y Y 1++
SR2 Y N Y N Y Y Y P Y N Y Y Y Y Y Y 1++
SR3 Y P Y N Y N Y Y Y N Y Y Y Y N Y 1++
SR4 Y N N P Y Y Y P Y N Y Y Y Y N Y 1++
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y, yes; N, no; P, partial yes.
Finally Included Studies: KQ4
Reference 
number
Article
SR1 Zhang YM, Lu Y, Tang Y, Yang D, Wu HF, Bian ZP, et al. The effects of different initiation time of exercise 
training on left ventricular remodeling and cardiopulmonary rehabilitation in patients with left ventric-
ular dysfunction after myocardial infarction. Disabil Rehabil 2016;38:268-76.
SR, systematic reviews.
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The following is the final Cochrane Library searching strategy used for KQ2 (“Does cardiac rehabilitation affect the 
outcomes of patients with cardiovascular disease?”) including the basic CR searching strategy:
Searching Strategies
#37 (“Cardiovascular mortality” or “all-cause mortality” or “hospital readmission rates” or morbidity  or “Quality 
of life” or QOL or “mental health” or “return to work”):ti,ab,kw 
#38 MeSH descriptor: [Morbidity] explode all trees
#39 MeSH descriptor: [Quality of Life] explode all trees
#40 MeSH descriptor: [Mental Health] explode all trees
#41 MeSH descriptor: [Return to Work] explode all trees
#42 self-efficacy or “patient satisfaction” or “CV recurrence rate” or “incidence of recurrent” or “fatal MI” or “non-
fatal MI” 
#43 incidence of recurrent MI or “progression of coronary atherosclerosis” or depression* 
#44 {or #37-#43} 
#45 #36 and #44 Publication Year from 2017 to 2018
Evidence Table for Assessment of Methodological Quality of Systematic Reviews using AMSTAR 2.0 and Level of Evi-
dence (LOE) using SIGN Methods: KQ4
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y P Y P Y Y Y P Y N Y Y Y Y Y Y 1++
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y, yes; N, no; P, partial yes.
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Finally Included Studies
Reference 
number
Article
SR1 Abell B, Glasziou P, Hoffmann T. The contribution of individual exercise training components to clini-
cal outcomes in randomised controlled trials of cardiac rehabilitation: a systematic review and meta-
regression. Sports Med Open 2017;3(1):19.
SR2 van Halewijn G, Deckers J, Tay HY, van Domburg R, Kotseva K, Wood D. Lessons from contemporary 
trials of cardiovascular prevention and rehabilitation: a systematic review and meta-analysis. Int J Car-
diol 201;232:294-303.
SR3 Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac re-
habilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Car-
diol 2016;67:1-12.
SR, systematic reviews.
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (4), Embase (84), PubMed (35)
Total (n=123)
Records after duplicates removed
(n=107)
Records screened on basis of title and abstract
(n=107)
Full-text articles accessed for eligibility
(n=8)
Studies included in qualitative synthesis
(n=3)
Records excluded
(n=99)
Full-text articles included, from KQ6
(n=2)
Full-text articles excluded, with reasons (n=7)
1. The patient does not have acute coronary syndrome (n=0)
2. Literatures irrelevant to the key question (n=5)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=1)
5. Duplicate publication (n=0)
6. Full text unavailable (n=1)
7. Other (n=0)
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The following is the final Cochrane Library searching strategy used for KQ3 (“Does cardiac rehabilitation improve 
the quality of life of patients with cardiovascular disease?”) including the basic CR searching strategy:
Searching Strategies
#37 (“quality of life” or qol):ti,ab,kw 
#38 (“quality of wellbeing” or “quality of well being” or qwb):ti,ab,kw 
#39 MeSH descriptor: [Quality of Life] explode all trees
#40 {or #37-#39} 
#41 #36 and #40 Publication Year from 2017 to 2018
Evidence Table for Assessment of Methodological Quality of Systematic Reviews using AMSTAR 2.0 and Level of Evi-
dence (LOE) using SIGN Methods: KQ 2
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y Y Y Y Y N N Y P N Y Y Y Y Y Y 1++
SR2 Y P Y P Y Y N N P N Y Y Y Y Y Y 1++
SR3 Y N Y N Y Y Y P Y N Y Y Y Y Y Y 1++
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y, yes; N, no; P, partial yes. 
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Finally Included Studies
Reference 
number
Article
SR1 Anderson L, Oldridge N, Thompson DR, et al. Exercise-Based Cardiac Rehabilitation for Coronary Heart 
Disease Cochrane Systematic Review and Meta-Analysis. J Am Coll Cardiol 2016;67(1):1-12.
SR, systematic reviews.
Records identified through database searching
Cochrane (90), Embase (39), PubMed (20)
Total (n=149)
Records after duplicates removed
(n=127)
Records screened on basis of title and abstract
(n=127)
Full-text articles accessed for eligibility
(n=7)
Studies included in qualitative synthesis
(n=1)
Records excluded
(n=120)
Full-text articles included, from KQ6
(n=1)
Full-text articles excluded, with reasons (n=7)
1. The patient does not have acute coronary syndrome (n=0)
2. Literatures irrelevant to the key question (n=0)
3. Non-human studies (animal study or preclinical studies) (n=4)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=0)
6. Full text unavailable (n=3)
7. Other (n=0)
Flow Chart of Study Selection Process
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Evidence Table for Assessment of Methodological Quality of Systematic Reviews using AMSTAR 2.0 and Level of Evi-
dence (LOE) using SIGN Methods:
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y N Y N Y Y Y P Y N Y Y Y Y Y Y 1++
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y, yes; N, no; P, partial yes.
The following is the final Cochrane Library searching strategy used for KQ5 (“How should cardiac rehabilitation be 
structured?”) including the basic CR searching strategy:
Searching Strategies
#37 (process* or facilit* or machine* or treadmill* or “cycle ergometer*” or “ECG  monitor*” or “blood pressure 
monitor*” or “automated external defibrillator*” or  AED or “emergency cart*” or “12-lead ECG” or “blood 
glucose monitor*” or  “percutaneous oxygen saturation monitor*” or “spirometry device*”):ti,ab,kw 
#38 (cardiology* or dietetic* or nursing* or “exercise physiolog*” or “occupational  therap*” or physiotherap* or 
psycholog* or “social work*”):ti,ab,kw 
#39 (“organizational structure” or policy or polices or process* or construction* or  concept* or content* or phase* 
or “flow chart” or “aerobic exercise machine*”  or treadmill or cycle* or ergometer* or “medical director*” or 
director* or  nurse* or “exercise physiologist*” or “occupational therapist*” or  physiotherapist* or psycholo-
gist* or “social work*” or dietician*):ti,ab,kw 
#40 (Facility or Equipment or Personnel* or medical staff* or staff* or Service* or  “service framework*” or 
Phase*):ti,ab,kw 
#41 MeSH descriptor: [Organizations] explode all trees
#42 MeSH descriptor: [Delivery of Health Care] explode all trees
#43 {or #37-#42} 
#44 #36 and #43 Publication Year from 2012 to 2018
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Finally Included Studies
Reference 
number
Article
SR1 Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac re-
habilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Car-
diol 2016;67:1-12.
SR2 Sumner J, Harrison A, Doherty P. The effectiveness of modern cardiac rehabilitation: A systematic re-
view of recent observational studies in non-attenders versus attenders. PLoS One 2017;12:e0177658.
SR3 Oldridge N. Exercise-based cardiac rehabilitation in patients with coronary heart disease: meta-analysis 
outcomes revisited. Future Cardiol 2012;8:729-51.
SR, systematic reviews.
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (30), Embase (683), PubMed (285)
Total (n=998)
Records after duplicates removed
(n=928)
Records screened on basis of title and abstract
(n=928)
Full-text articles accessed for eligibility
(n=19)
Studies included in qualitative synthesis
(n=3)
Records excluded
(n=909)
Full-text articles excluded, with reasons (n=16)
1. The patient does not have acute coronary syndrome (n=0)
2. Literatures irrelevant to the key question (n=8)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=3)
6. Full text unavailable (n=0)
7. Other (n=5, simple comment)
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Evidence Table for Assessment of Methodological Quality of Systematic Reviews using AMSTAR 2.0 and Level of Evi-
dence (LOE) using SIGN Methods: KQ 5
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y N Y N Y Y Y P Y N Y Y Y Y Y Y 1++
SR2 Y N N P Y Y Y P Y N Y Y Y Y N Y 1++
SR3 Y P Y P N N N P Y Y Y Y Y Y N Y 1++
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y=yes, N=no, P=partial yes.
The following is the final Cochrane Library searching strategy used for KQ6 (“Can cardiac rehabilitation programs 
lower the cost of health management for patients with acute coronary syndrome?”) including the basic CR searching 
strategy:
Searching Strategies
#37 MeSH descriptor: [Costs and Cost Analysis] explode all trees
#38 MeSH descriptor: [Economics] explode all trees
#39 MeSH descriptor: [Fees and Charges] explode all trees
#40 MeSH descriptor: [Budgets] explode all trees
#41 (cost* near/2 (effective* or utilit* or benefit* or minimi*)):ti,ab,kw 
#42 (price or pricing or financ* or fee or fees):ti,ab,kw 
#43 (value near/2 (money or monetary)):ti,ab,kw 
#44 {or #37-#43} 
#45 #36 and #44
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Finally Included Studies
Reference 
number
Article
SR1 Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, et al. Exercise-based cardiac reha-
bilitation for coronary heart disease: Cochrane systematic review and meta-analysis. J Am Coll Cardiol 
2016;67:1-12.
SR, systematic reviews.
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (19), Embase (456), PubMed (4)
Total (n=479)
Records after duplicates removed
(n=463)
Records screened on basis of title and abstract
(n=463)
Full-text articles accessed for eligibility
(n=11)
Studies included in qualitative synthesis
(n=1)
Records excluded
(n=452)
Full-text articles excluded, with reasons (n=10)
1. The patient does not have acute coronary syndrome (n=1)
2. Literatures irrelevant to the key question (n=4)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=1)
5. Duplicate publication (n=0)
6. Full text unavailable (n=2)
7. Other (n=2, simple comment)
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Evidence Table for Assessment of Methodological Quality of Systematic Reviews using AMSTAR 2.0 and Level of Evi-
dence (LOE) using SIGN Methods:
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y N Y N Y Y Y P Y N Y Y Y Y Y Y 1++
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y, yes; N, no; P, partial yes.
2. ASSESSMENT OF CARDIAC REHABILITATION
The following is the basic searching strategy used for cardiac rehabilitation assessment in the Cochrane Library, 
combined with the specific searching strategy for each question using AND.
#1 MeSH descriptor: [Cardiac Rehabilitation] explode all trees
#2 ((*cardia* or heart*) and *habilitation*):ti,ab,kw 
#3 #1 or #2 
#4 MeSH descriptor: [Myocardial Ischemia] explode all trees
#5 ((myocard* or heart* or coronary or cardia*) and (infarct* or isch* or attack*)):ti,ab,kw 
#6 (“acute coronary syndrome” or ACS):ti,ab,kw 
#7 (angina or stenocardia*):ti,ab,kw 
#8 MeSH descriptor: [Myocardial Revascularization] explode all trees
#9 ((Myocard* or cardi* or coronary) and (Revascular* or angioplast*)):ti,ab,kw 
#10 ((coronary or rotational) near atherectom*):ti,ab,kw 
#11 (“coronary artery bypass” or CABG or “aortocoronary bypass” or “coronary bypass”):ti,ab,kw 
#12 MeSH descriptor: [Percutaneous Coronary Intervention] explode all trees
#13 (“percutaneous coronary intervention*” or PCI):ti,ab,kw 
#14 (percutaneous next coronary near/2 (interven* or revascular*)):ti,ab,kw 
#15 (stent* and (heart or cardiac*)):ti,ab,kw 
#16 coronary near (disease* or bypass or thrombo* or angioplast*):ti,ab,kw 
#17 (PTCA or “percutaneous transluminal coronary angioplasty”):ti,ab,kw 
#18 MeSH descriptor: [Heart Bypass, Right] explode all trees
#19 (“heart manual”):ti,ab,kw 
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#20 {or #4-#19} 
#21 MeSH descriptor: [Rehabilitation] explode all trees
#22 (rehabilitat* or *habilitation):ti,ab,kw 
#23 MeSH descriptor: [Physical and Rehabilitation Medicine] explode all trees
#24 MeSH descriptor: [Health Facilities] explode all trees
#25 MeSH descriptor: [Rehabilitation Nursing] explode all trees
#26 {or #21-#25} 
#27 #20 and #26 
#28 #27 or #3 
The following is the final Cochrane Library searching strategy used for KQ7 (“Is individualized cardiac rehabilitation 
program more effective than the existing fixed cardiac rehabilitation program?”) including the basic CR assessment 
searching strategy:
Searching Strategies
#29 ((individual* or personal* or “patient centred” or “patient centered” or “person  centred” or “person cen-
tered”) near/5 need*):ti,ab,kw 
#30 (tailored near/6 need*):ti,ab,kw 
#31 (standard* near/6 program*):ti,ab,kw 
#32 {or #29-#31} 
#33 #28 and #32 Publication Year from 2016 to 2018
Flow Chart of the Study Selection Process
Records identified through database searching
Cochrane (41), Embase (1,120), PubMed (39)
Total (n=1,200)
Records after duplicates removed
(n=1,157)
Records screened on basis of title and abstract
(n= )1,157
Full-text articles accessed for eligibility
(n=7)
Studies included in qualitative synthesis
(n=3)
Records excluded
(n=1,150)
Full-text articles excluded, with reasons (n=4)
1. The patient does not have acute coronary syndrome (n=0)
2. Literatures irrelevant to the key question (n=1)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=0)
6. Full text unavailable (n=1)
7. Other (n=2, not RCT)
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Finally Included Studies
Reference 
number
Article
RCT1 Weibel L, Massarotto P, Hediger H, Mahrer-Imhof R. Early education and counselling of patients with 
acute coronary syndrome: a pilot study for a randomized controlled trial. Eur J Cardiovasc Nurs 
2016;15:213-22.
RCT2 Fors A, Swedberg K, Ulin K, Wolf A, Ekman I. Effects of person-centred care after an event of acute coro-
nary syndrome: two-year follow-up of a randomized controlled trial. Int J Cardiol 2017;249:42-7.
RCT3 Hill K, Walwyn R, Camidge MD. Murray J, Meads MD, Reynolds G, et al. A randomised feasibility trial of 
a new lifestyle referral assessment versus usual assessment in an acute cardiology setting. J Cardiovasc 
Nurs 2016;31:507-16.
RCT, randomized controlled trial.
Evidence Table for Assessment of Risk of Bias and Quality
Methodological Quality of Randomized Control Trials (RCT) using Cochrane Risk of Bias (RoB) tool and Level of Evi-
dence (LOE) using SIGN Methods
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7
RCT1 L L H H L L L 1+
RCT2 L L H U L L L 1+
RCT3 L U H U H U L 1+
1. Random sequence generation: selection bias (biased allocation to interventions) due to inadequate generation of a 
randomized. 2. Allocation concealment: selection bias (biased allocation to interventions) due to inadequate conceal-
ment of allocations prior to assignment. 3. Blinding of participants and personnel: performance bias due to knowledge 
of the allocated interventions by participants and personnel during the study. 4. Blinding of outcome assessment: 
detection bias due to knowledge of the allocated interventions by outcome assessors. 5. Incomplete outcome data: at-
trition bias due to amount, nature or handling of incomplete outcome data. 6. Selective reporting: reporting bias due 
to selective outcome reporting. 7. Other bias: bias due to problems not covered elsewhere in the table.
L, low risk of bias; H, high risk of bias; U, unclear risk of bias.
KQ8 (“Should psychological interventions concerning anxiety, depression, and stress be included in the cardiac re-
habilitation program?”) including the basic CR assessment searching strategy:
Searching Strategies
#1 ((matched or stepped) near/3 care):ti,ab,kw 
#2 (tier or tiers or tiered):ti,ab,kw 
#3 (level* near/2 intervention*):ti,ab,kw 
#4 (step* up or step* down):ti,ab,kw 
#5 (matrix and psych*):ti,ab,kw 
#6 psychologist*:ti,ab,kw 
#7 MeSH descriptor: [Psychology] explode all trees
#8 psycholog*:ti,ab,kw 
#9 (psychosocial or “psycho social”):ti,ab,kw 
#10 (stress near manage*):ti,ab,kw 
#11 (depress* or low next mood*):ti,ab,kw 
#12 {or #1-#11}
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Finally Included Studies
Reference 
number
Article
SR1 Klainin-Yobas P, Ng SH, Stephen PDM, Lau Y. Efficacy of psychosocial interventions on psychological 
outcomes among people with cardiovascular diseases: a systematic review and meta-analysis. Patient 
Educ Couns 2016;99:512-21.
SR2 Richards SH, Anderson L, Jenkinson CE, Whalley B, Rees K, Davies P, et al. Psychological interventions 
for coronary heart disease. Cochrane Database Syst Rev 2017;4:CD002902.
RCT1 von Kanel R, Barth J, Princip M, Meister-Langraf RE, Schmid JP, Znoj H, et al. Early psychological coun-
seling for the prevention of posttraumatic stress induced by acute coronary syndrome: the MI-SPRINT 
randomized controlled trial. Psychother Psychosom 2018;87:75-84.
SR, systematic reviews; RCT, randomized controlled trial.
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (77), Embase (548), PubMed (181)
Total (n=806)
Records after duplicates removed
(n=687)
Records screened on basis of title and abstract
(n=687)
Full-text articles accessed for eligibility
(n=11)
Studies included in qualitative synthesis
(n=3)
Records excluded
(n=675)
Full-text articles excluded, with reasons (n=8)
1. The patient does not have acute coronary syndrome (n=4)
2. Literatures irrelevant to the key question (n=2)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=0)
6. Full text unavailable (n=0)
7. Other (n=2, simple comment)
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Evidence Table for Assessment of Risk of Bias and Quality
Methodological Quality of Systematic Reviews using AMSTAR 2.0 and Level of Evidence (LOE) using SIGN Methods
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 N N Y N Y Y N Y P N Y N N N Y Y 1+
SR2 Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 1++
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y=yes, N=no, P=partial yes.
Methodological Quality of Randomized Control Trials (RCT) using RoB and Level of Evidence (LOE) using SIGN Methods
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7
RCT1 L H H H L L L 1–
1. Random sequence generation: selection bias (biased allocation to interventions) due to inadequate generation of a 
randomized. 2. Allocation concealment: selection bias (biased allocation to interventions) due to inadequate conceal-
ment of allocations prior to assignment. 3. Blinding of participants and personnel: performance bias due to knowledge 
of the allocated interventions by participants and personnel During the study. 4. Blinding of outcome assessment: 
detection bias due to knowledge of the allocated interventions by outcome assessors. 5. Incomplete outcome data: at-
trition bias due to amount, nature or handling of incomplete outcome data. 6. Selective reporting: reporting bias due 
to selective outcome reporting. 7. Other bias: bias due to problems not covered elsewhere in the table.
L, low risk of bias; H, high risk of bias; U, unclear risk of bias.
The following is the final Cochrane Library searching strategy used for KQ9 (“Is cardiopulmonary exercise test nec-
essary for cardiac rehabilitation?”) and KQ10 (“Is submaximal exercise test such as the 6-minute walk test useful for 
cardiac rehabilitation?”) including the basic CR assessment searching strategy:
Searching Strategies: KQ9 & KQ10
#1 (“cardiopulmonary exercise test” or “exercise stress test” or “submaximal  exercise test” or “submaximal exer-
cise stress test” or “six minute walk test”  or “six minute cycle test” or “walk test” or “cycle test”):ti,ab,kw 
#2 MeSH descriptor: [Exercise Test] explode all trees
#3 submaximal test:ti,ab,kw 
#4 {or #1-#3} 
#5 #4
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Finally Included Studies: KQ9
Reference 
number
Article
RCT1 Balady GJ, Leitschuh ML, Jacobs AK, Merrell D, Weiner DA, Ryan TJ. Safety and clinical use of exer-
cise testing one to three days after percutaneous transluminal coronary angioplasty. Am J Cardiol 
1992;69:1259-64.
OS1 Safstrom K, Swahn E. Early symptom-limited exercise test for risk stratification in post menopausal wom-
en with unstable coronary artery disease. Eur Heart J 2000;21:230-8.
OS2 Mark DB, Hlatky MA, Harrell FE Jr, Lee KL, Califf RM, Pryor DB. Exercise treadmill score for predicting 
prognosis in coronary artery disease. Ann Intern Med 1987;106:793-800.
OS3 Vanhees L, Fagard R, Thijs L, Staessen J, Amery A. Prognostic significance of peak exercise capacity in pa-
tients with coronary artery disease. J Am Coll Cardiol 1994;23:358-63.
OS3 Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, et al. Prediction of long-term prognosis 
in 12 169 men referred for cardiac rehabilitation. Circulation 2002;106:666-71.
OS4 Kavanagh T, Mertens DJ, Hamm LF, Beyene J, Kennedy J, Corey P, et al. Peak oxygen intake and cardiac 
mortality in women referred for cardiac rehabilitation. J Am Coll Cardiol 2003;42:2139-43.
RCT, randomized controlled trial; OS, observational study.
Flow Chart of Study Selection Process: KQ9 & KQ10
Records excluded
(n=1,387)
Records identified through database searching
Cochrane (450), Embase (740), PubMed (629)
Total (n=1,819)
Records after duplicates removed
(n=1,416)
Records screened on basis of title and abstract
(n=1,416)
Maximal cardiopulmonary
exercise test
Full-text articles accessed
for eligibility (add 4 article
in AHA 2001 guideline)
(n=13)
Studies included in
qualitative synthesis
(n=6)
Submaximal exercise test
Full-text articles
accessed for eligibility
(n=29)
Studies included in
qualitative synthesis
(n=7)
Records excluded
(n=1,407)
Full-text articles excluded,
with reasons (n=7)
1. The patient does not have acute
coronary syndrome (n=2)
2. Literatures irrelevant to the key
question (n=4)
3. Non-human studies (animal study or
preclinical studies) (n=0)
4. Literatures published in languages
other than English or Korean (n=0)
5. Duplicate publication (n=0)
6. Full text unavailable (n=1)
7. Other (n=0)
Full-text articles excluded,
with reasons (n=22)
1. The patient does not have acute
coronary syndrome (n=7)
2. Literatures irrelevant to the key
question (n=6)
3. Non-human studies (animal study or
preclinical studies) (n=0)
4. Literatures published in languages
other than English or Korean (n=2)
5. Duplicate publication (n=0)
6. Full text unavailable (n=1)
7. Other (n=5, no 6MWT; n=1, narrative
review)
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Evidence Table for Assessment of Risk of Bias and Quality:KQ9
Methodological Quality of Randomized Control Trials (RCT) using RoB and Level of Evidence (LOE) using SIGN Meth-
ods
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7
RCT1 H H H H L L L 1–
1. Random sequence generation: selection bias (biased allocation to interventions) due to inadequate generation of a 
randomized. 2. Allocation concealment: selection bias (biased allocation to interventions) due to inadequate conceal-
ment of allocations prior to assignment. 3. Blinding of participants and personnel: performance bias due to knowledge 
of the allocated interventions by participants and personnel During the study. 4. Blinding of outcome assessment: 
detection bias due to knowledge of the allocated interventions by outcome assessors. 5. Incomplete outcome data: at-
trition bias due to amount, nature or handling of incomplete outcome data. 6. Selective reporting: reporting bias due 
to selective outcome reporting. 7. Other bias: bias due to problems not covered elsewhere in the table.
L, low risk of bias; H, high risk of bias; U, unclear risk of bias.
Methodological Quality of Observation Study (OS) using The Risk of Bias Assessment Tool for Non-randomized Stud-
ies (RoBANS) and Level of Evidence (LOE) using SIGN Methods
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8
OS1 L L L L L L U L 2++
OS2 U L H L L L L L 2++
OS3 U L L L L L L L 2++
OS4 U L L L L L L L 2++
OS5 U L L L L L L L 2++
1. Comparability = selection bias caused by inappropriate participant selection. 2. Selection of participants = selec-
tion bias caused by inadequate selection of participants for intervention, exposure, or patient group. 3. Confounding 
variables = Selection bias caused by inadequate confirmation and consideration of confounding variables. 4. Expo-
sure measurement = performance bias caused by inadequate measurement of intervention or exposure. 5. Blinding of 
outcome assessment = detection bias caused by inadequate blinding of outcome assessment. 6. Outcome assessment 
= detection bias caused by inappropriate outcome assessment method. 7. Incomplete outcome data = attrition bias 
caused by inappropriate handling of inappropriate data. 8. Selective outcome reporting = reporting bias caused by se-
lective outcome reporting.
L, low risk of bias; H, high risk of bias; U, unclear risk of bias.
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Finally Included Studies: KQ10
Reference 
number
Article
SR1 Bellet RN, Adams L, Morris NR. The 6-minute walk test in outpatient cardiac rehabilitation: validity, reli-
ability and responsiveness. A systematic review. Physiotherapy 2012;98:277-86.
OS1 Wright DJ, Khan KM, Gossage EM, Saltissi S. Assessment of a low-intensity cardiac rehabilitation pro-
gramme using the six-minute walk test. Clin Rehabil 2001;15:119-24.
OS2 Nogueira PA, Leal AC, Pulz C, Nogueira ID, Filho JA. Clinical reliability of the 6 minute corridor walk test 
performed within a week of a myocardial infarction. Int Heart J 2006;47:533-40.
OS3 Gremeaux M, Hannequin A, Laurent Y, Laroche D, Casillas JM, Gremeaux V. Usefulness of the 6-minute 
walk test and the 200-metre fast walk test to individualize high intensity interval and continuous exercise 
training in coronary artery disease patients after acute coronary syndrome: a pilot
controlled clinical study. Clin Rehabil 2011;25:844-55.
OS4 Hanson LC, McBurney H, Taylor NF. The retest reliability of the six-minute walk test in patients referred to 
a cardiac rehabilitation programme. Physiother Res Int 2012;17:55-61.
OS5 Diniz LS, Neves VR, Starke AC, Barbosa MP, Britto RR, Ribeiro AL. Safety of early performance of the 
six-minute walk test following acute myocardial infarction: a cross-sectional study. Braz J Phys Ther 
2017;21:167-74.
OS6 Harris KM, Anderson DR, Landers JD, Emery CF. Utility of walk tests in evaluating functional status among 
participants in an outpatient cardiac rehabilitation program. J Cardiopulm Rehabil Prev 2017;37:329-33.
 SR, systematic reviews; OS, observational study.
Evidence Table for Assessment of Risk of Bias and Quality: KQ10
Evidence Table for Assessment of Risk of Bias and Quality
Methodological Quality of Systematic Reviews using AMSTAR 2.0 and Level of Evidence (LOE) using SIGN Methods
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y Y Y Y Y Y P Y Y N Y Y N Y N Y 2+
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y, yes; N, no; P, partial yes.
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Methodological Quality of Observation Study (OS) using The Risk of Bias Assessment Tool for Non-randomized Stud-
ies (RoBANS) and Level of Evidence (LOE) using SIGN Methods
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8
OS1 H L L L H L L L 2+
OS2 U H L U H L L L 2+
OS3 H H H L H L L L 2-
OS4 U L L L H L L L 2+
OS5 H L H L H L L L 2+
OS6 U H L L H L L L 2++
1. Comparability = selection bias caused by inappropriate participant selection. 2. Selection of participants = selec-
tion bias caused by inadequate selection of participants for intervention, exposure, or patient group. 3. Confounding 
variables = Selection bias caused by inadequate confirmation and consideration of confounding variables. 4. Expo-
sure measurement = performance bias caused by inadequate measurement of intervention or exposure. 5. Blinding of 
outcome assessment = detection bias caused by inadequate blinding of outcome assessment. 6. Outcome assessment 
= detection bias caused by inappropriate outcome assessment method. 7. Incomplete outcome data = attrition bias 
caused by inappropriate handling of inappropriate data. 8. Selective outcome reporting = reporting bias caused by se-
lective outcome reporting
L, low risk of bias; H, high risk of bias; U, unclear risk of bias. 
The following is the final Cochrane Library searching strategy used for KQ11 (“What measures effectively promote 
participation in cardiac rehabilitation?”) and KQ12 (“What measures effectively increase physical activity compli-
ance?”) including the basic CR assessment searching strategy:
Searching Strategies
#1 (increase* near/10 participat*):ti,ab,kw 
#2 (comply or complian*):ti,ab,kw 
#3 (remain* or adhere* or uptake or “take up” or “sign up” or “ sign on” or  “follow up” or engage* or attend* or 
maintenance*):ti,ab,kw 
#4 (enrollment or enrolment or enroling or enrolling):ti,ab,kw 
#5 (participat* or motivation* or uptake or referral or adherence or attend* or  non-attend* or barrier* or engag-
ing or engagement):ti,ab,kw 
#6 MeSH descriptor: [Health Services Accessibility] explode all trees
#7 MeSH descriptor: [Patient Compliance] explode all trees
#8 MeSH descriptor: [Referral and Consultation] explode all trees
#9 MeSH descriptor: [Patient Satisfaction] explode all trees
#10 MeSH descriptor: [Patient Participation] explode all trees
#11 MeSH descriptor: [Self Efficacy] explode all trees
#12 MeSH descriptor: [Motivation] explode all trees
#13 {or #1-#12}
Chul Kim, et al.
416 www.e-arm.org
Finally Included Studies: KQ11
Reference 
number
Article
SR1 Grace SL, Chessex C, Arthur H, Chan S, Cyr C, Dafoe W, et al. Systematizing inpatient referral to cardiac 
rehabilitation 2010: Canadian Association of Cardiac Rehabilitation and Canadian Cardiovascular Soci-
ety joint position paper endorsed by the Cardiac Care Network of Ontario. Can J Cardiol 2011;27:192-9.
RCT1 Grace SL, Midence L, Oh P, Brister S, Chessex C, Stewart DE, et al. Cardiac rehabilitation program 
adherence and functional capacity among women: a randomized controlled trial. Mayo Clin Proc 
2016;91:140-8.
RCT2 Lynggaard V, Nielsen CV, Zwisler AD, Taylor RS, May O. The patient education: learning and coping strat-
egies. Improves adherence in cardiac rehabilitation (LC-REHAB): a randomised controlled trial. Int J 
Cardiol 2017;236:65-70.
SR, systematic reviews; RCT, randomized controlled trial.
Flow Chart of Study Selection Process: KQ11 & KQ12
Records excluded
(n=1,387)
Records identified through database searching
Cochrane (546)
Total (n=4,498): Search SR and clinical trials
PubMed (232), Embase (3,720),
Records after duplicates removed
(n=3,991)
Records screened on basis of title and abstract
(n= )3,991
Participation in CR
Full-text articles
accessed for eligibility
(n=16)
Studies included in
qualitative synthesis
(n=2) + An article
before following
search stratage
for participation in
CR (n=1)
Maintain physical activity
Full-text articles
accessed for eligibility
(n=9)
Studies included in
qualitative synthesis
(n=2)
Records excluded
(n=1,407)
Full-text articles excluded,
with reasons (n=12)
1. The patient does not have acute
coronary syndrome (n=0)
2. Literatures irrelevant to the key
question (n=9)
3. Non-human studies (animal study or
preclinical studies) (n=0)
4. Literatures published in languages
other than English or Korean (n=0)
5. Duplicate publication (n=1)
6. Full text unavailable (n=0)
7. Other (n=1, simple comment; n=1,
substandard article)
Full-text articles excluded,
with reasons (n=7)
1. The patient does not have acute
coronary syndrome (n=1)
2. Literatures irrelevant to the key
question (n=5)
3. Non-human studies (animal study or
preclinical studies) (n=0)
4. Literatures published in languages
other than English or Korean (n=0)
5. Duplicate publication (n=0)
6. Full text unavailable (n=0)
7. Other (n=1, no comparison group)
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Evidence Table for Assessment of Risk of Bias and Quality: KQ11
Systematic Reviews (SR)
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y Y Y Y Y Y N N N N N N N P N N 2–
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y, yes; N, no; P, partial yes.
Randomized Control Trials (RCTs)
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7
RCT1 L L L L H L L 1++
RCT2 L U U U L L L 1+
1. Random sequence generation: selection bias (biased allocation to interventions) due to inadequate generation of a 
randomized. 2. Allocation concealment: selection bias (biased allocation to interventions) due to inadequate conceal-
ment of allocations prior to assignment. 3. Blinding of participants and personnel: performance bias due to knowledge 
of the allocated interventions by participants and personnel during the study. 4. Blinding of outcome assessment: 
detection bias due to knowledge of the allocated interventions by outcome assessors. 5. Incomplete outcome data: at-
trition bias due to amount, nature or handling of incomplete outcome data. 6. Selective reporting: reporting bias due 
to selective outcome reporting. 7. Other bias: bias due to problems not covered elsewhere in the table.
L, low risk of bias; H, high risk of bias; U, unclear risk of bias.
Finally Included Studies: KQ12
Reference 
number
Article
RCT1 Fournier M, Radel R, Bailly L, Pradier C, Fabre R, Fuch A, et al. "As du Coeur" study: a randomized 
controlled trial on physical activity maintenance in cardiovascular patients. BMC Cardiovasc Disord 
2018;18:77.
RCT2 Ter Hoeve N, Sunamura M, Stam HJ, Boersma E, Geleijnse ML, van Domburg RT, et al. Effects of two 
behavioral cardiac rehabilitation interventions on physical activity: a randomized controlled trial. 
Int J Cardiol 2018;255:221-8.
 RCT, randomized controlled trial.
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Evidence Table for Assessment of Risk of Bias and Quality: KQ12
Randomized Control Trials (RCTs)
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7
RCT1 L L L L L L H 1+
RCT2 L L H H L L L 1+
1. Random sequence generation: selection bias (biased allocation to interventions) due to inadequate generation of a 
randomized. 2. Allocation concealment: selection bias (biased allocation to interventions) due to inadequate conceal-
ment of allocations prior to assignment. 3. Blinding of participants and personnel: performance bias due to knowledge 
of the allocated interventions by participants and personnel during the study. 4. Blinding of outcome assessment: 
detection bias due to knowledge of the allocated interventions by outcome assessors. 5. Incomplete outcome data: at-
trition bias due to amount, nature or handling of incomplete outcome data. 6. Selective reporting: reporting bias due 
to selective outcome reporting. 7. Other bias: bias due to problems not covered elsewhere in the table.
L, low risk of bias; H, high risk of bias; U, unclear risk of bias.
3. EXERCISE THERAPY FOR CARDIAC REHABILITATION
The following is the common searching strategy for KQ13 (“When should patients begin cardiac rehabilitation after 
CABG?”) combined with the specific searching strategies for each question shown below:
#1 MeSH descriptor: [Myocardial Ischemia] explode all trees
#2 ((myocard* or heart* or coronary or cardia*) and (infarct* or isch* or attack*)):ti,ab,kw
#3 (“acute coronary syndrome” or ACS):ti,ab,kw
#4 (angina or stenocardia*):ti,ab,kw
#5 {or #1-#4}
#6 MeSH descriptor: [Cardiac Surgical Procedures] explode all trees
#7 (“coronary artery bypass” or “CABG” or “aortocoronary bypass” or “coronary bypass”):ti,ab,kw
#8 (“coronary” near “arter*” near “bypass”):ti,ab,kw
#9 {or #6-#8}
#10 #5 and #9
The following is the specific searching strategy for KQ13-1, “CABG ambulation”:
#11 MeSH descriptor: [Ambulatory Care] explode all trees
#12 MeSH descriptor: [Early Ambulation] explode all trees
#13 (ambulat* or mobili* or gait):ti,ab,kw
#14 {or #11-#13}
#15 #10 and #14
The following is the specific searching strategy for KQ13-2, “CABG aerobic and strengthening”:
#11 MeSH descriptor: [Exercise] explode all trees
#12 MeSH descriptor: [Exercise Therapy] explode all trees
#13 ((“exercise*” or “train*” or fitness) and (“strength*” or “aerobic”)):ti,ab,kw
#14 (physical near (train* or activ*)):ti,ab,kw
#15 ((physio or physic* or kinesio*) near therap*):ti,ab,kw
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#16 ((interval or aerobic) near (train* or exercise* or run* or fitness)):ti,ab,kw
#17 ((muscle* or resistan*) near (train* or activ* or strength* or exercise*)):ti,ab,kw
#18 {or #11-#17}
#19 #10 and #18
The following is the specific searching strategy for KQ13-3, “CABG + Stretching”:
#11 MeSH descriptor: [Range of Motion, Articular] explode all trees
#12 (stretch* or flexibilit*):ti,ab,kw
#13 #11 or #12
#14 #10 and #13
The following is the specific searching strategy for KQ13-4, “CABG + Respiration training”:
#11 (respirat* or inspirat*) near (train* or educat* or exercise* or physiotherap*):ti,ab,kw
#12 spiromet*:ti,ab,kw
#13 #11 or #12
#14 #10 and #13
The following is the specific searching strategy for KQ13-5. “CABG + Dysphagia”:
#11 MeSH descriptor: [Deglutition Disorders] explode all trees
#12 (dysphagia or (swallow* near (difficult* or disorder))):ti,ab,kw
#13 #11 or #12
#14 #10 and #13
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (6), Embase (67), PubMed (48)
Total (n=103)
Records after duplicates removed
(n=92)
Records screened on basis of title and abstract
(n=92)
Full-text articles accessed for eligibility
(n=16)
Studies included in qualitative synthesis
(n=1)
Records excluded
(n=77)
1 paper added among other key question
database searching
Full-text articles excluded, with reasons (n=15)
1. The patient does not have acute coronary syndrome (n=1)
2. Literatures irrelevant to the key question (n=8)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=2)
6. Full text unavailable (n=1)
7. Other (n=3)
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Finally Included Studies
Reference 
number
Article
SR1 Aldahash R, Al Dera HS. Physical therapy program improves the physiological impact towards better 
quality of life and low cardiac risk factors in patients following coronary artery bypass grafting: system-
atic review. Acta Medica Int 2016;3:185-95.
SR, systematic reviews.
Evidence Table for Assessment of Risk of Bias and Quality
Methodological Quality of Systematic Reviews using AMSTAR 2.0 and Level of Evidence (LOE) using SIGN Methods
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y N Y P N N N P N N N M M N M Y 1–
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y, yes; N, no; P, partial yes; M, no meta-analysis conducted.
Methodological Quality of Systematic Reviews using GRADE and Level of Evidence (LOE) using SIGN Methods
Reference 
number
1 2 3 4 5 6 7 8 GRADE LOE
SR1 –1 –1 –1 Very low (1) 1–
1. Limitation, 2. Inconsistency, 3. Indirectness, 4. Imprecision, 5. Publication bias, 6. Large magnitude effect, 7. All 
plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect, 8. 
Dose response gradient.
The following is the basic searching strategy used for cardiac rehabilitation treatment (KQ 14-18) in the Cochrane Li-
brary, combined with the specific searching strategy for each question using AND.
#1 MeSH descriptor: [Myocardial Ischemia] explode all trees
#2 ((myocard* or heart* or coronary or cardia*) and (infarct* or isch* or  attack*)):ti,ab,kw
#3 (“acute coronary syndrome” or ACS):ti,ab,kw
#4 (angina or stenocardia*):ti,ab,kw
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#5 {or #1-#4}
#6 MeSH descriptor: [Myocardial Revascularization] explode all trees
#7 ((Myocard* or cardi* or coronary) and (Revascular* or angioplast*)):ti,ab,kw
#8 ((coronary or rotational) near atherectom*):ti,ab,kw
#9 MeSH descriptor: [Percutaneous Coronary Intervention] explode all trees
#10 (“percutaneous coronary intervention*” or PCI):ti,ab,kw
#11 (percutaneous next coronary near/2 (interven* or revascular*)):ti,ab,kw
#12 (stent* and (heart or cardiac*)):ti,ab,kw
#13 coronary near (disease* or bypass or thrombo* or angioplast*):ti,ab,kw
#14 (PTCA or “percutaneous transluminal coronary angioplasty”):ti,ab,kw
#15 MeSH descriptor: [Cardiac Surgical Procedures] explode all trees
#16 (“coronary artery bypass” or “CABG” or “aortocoronary bypass” or “coronary bypass”):ti,ab,kw
#17 (“coronary” near “arter*” near “bypass”):ti,ab,kw
#18 {or #6-#17}
#19 #5 and #18
The same Cochrane Library searching strategy was used for KQ14 (“Should aerobic exercise be included in the car-
diac rehabilitation program?”) and KQ15 (“Should resistance (muscle training) exercise be included in the cardiac re-
habilitation program?”) The following is the final searching strategy, including the basic searching strategy for exercise 
therapy for CR:
Searching Strategies
#20 MeSH descriptor: [Exercise] explode all trees
#21 MeSH descriptor: [Exercise Therapy] explode all trees
#22 ((“exercise*” or “train*” or fitness) and (“strength*” or “aerobic”)):ti,ab,kw
#23 (physical near (train* or activ*)):ti,ab,kw
#24 ((physio or physic* or kinesio*) near therap*):ti,ab,kw
#25 ((interval or aerobic) near (train* or exercise* or run* or fitness)):ti,ab,kw
#26 ((muscle* or resistan*) near (train* or activ* or strength* or exercise*)):ti,ab,kw
#27 {or #20-#26}
#28 #19 and #27
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Finally Included Studies: KQ14
Reference 
number
Article
SR1 Chen YC, Tsai JC, Liou YM, Chan P. Effectiveness of endurance exercise training in patients with coronary 
artery disease: a meta-analysis of randomised controlled trials. Eur J Cardiovasc Nurs 2017;16:397-408.
SR2 Liou K, Ho S, Fildes J, Ooi SY. High intensity interval versus moderate intensity continuous training in 
patients with coronary artery disease: a meta-analysis of physiological and clinical parameters. Heart 
Lung Circ 2016;25:166-74.
SR, systematic reviews.
Flow Chart of Study Selection Process: KQ14
Records identified through database searching
Cochrane (37), Embase (70), PubMed (156)
Total (n=263)
Records after duplicates removed
(n=249)
Records screened on basis of title and abstract
(n=249)
Full-text articles accessed for eligibility
(n=72)
Studies included in qualitative synthesis
(n=2)
Records excluded
(n=177)
Full-text articles excluded, with reasons (n=70)
1. The patient does not have acute coronary syndrome (n=5)
2. Literatures irrelevant to the key question (n=37)
3. Non-human studies (animal study or preclinical studies) (n=1)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=6)
6. Full text unavailable (n=9)
7. Other (n=12, not SR, etc.)
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Evidence Table for Assessment of Risk of Bias and Quality: KQ14
Systematic Reviews (SR)
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y Y Y Y Y Y N P Y N Y Y Y Y Y Y 1–
SR2 Y Y Y Y N N N Y Y N Y Y Y N Y N 1+
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y, yes; N, no; P, partial yes.
Methodological Quality of Systematic Reviews using GRADE and Level of Evidence (LOE) using SIGN Methods
Reference 
number
1 2 3 4 5 6 7 8 GRADE LOE
SR1 –1 –1   Very low (1) 1–
SR2 –1 Moderate (3) 1+
1. Limitation, 2. Inconsistency, 3. Indirectness, 4. Imprecision, 5. Publication Bias, 6. Large magnitude effect, 7. All 
plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect, 8. 
Dose response gradient.
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Finally Included Studies: KQ15
Reference 
number
Article
SR1 Hollings M, Mavros Y, Freeston J, Fiatarone Singh M. The effect of progressive resistance training on aero-
bic fitness and strength in adults with coronary heart disease: a systematic review and meta-analysis of 
randomized controlled trials. Eur J Prev Cardiol 2017;24:1242-59.
SR2 Karagiannis C, Savva C, Mamais I, Efstathiou M, Monticone M, Xanthos T. Eccentric exercise in ischemic 
cardiac patients and functional capacity: a systematic review and meta-analysis of randomized con-
trolled trials. Ann Phys Rehabil Med 2017;60:58-64.
SR3 Xanthos PD, Gordon BA, Kingsley MI. Implementing resistance training in the rehabilitation of coronary 
heart disease: a systematic review and meta-analysis. Int J Cardiol 2017;230:493-508.
SR, systematic reviews.
Flow Chart of Study Selection Process: KQ15
Records identified through database searching
Cochrane (37), Embase (70), PubMed (156)
Total (n=263)
Records after duplicates removed
(n=249)
Records screened on basis of title and abstract
(n=249)
Full-text articles accessed for eligibility
(n=72)
Studies included in qualitative synthesis
(n=3)
Records excluded
(n=177)
Full-text articles excluded, with reasons (n=69)
1. The patient does not have acute coronary syndrome (n=5)
2. Literatures irrelevant to the key question (n=36)
3. Non-human studies (animal study or preclinical studies) (n=1)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=6)
6. Full text unavailable (n=9)
7. Other (n=12, same clinical trials cited in other SR, etc.)
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Evidence Table for Assessment of Risk of Bias and Quality: KQ15
Systematic Reviews (SR)
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y Y Y Y Y Y Y Y Y N Y Y Y Y Y Y 1–
SR2 Y Y Y Y Y Y Y Y Y N Y Y Y Y Y Y 1–
SR3 Y Y N N Y Y Y P Y Y Y Y Y Y Y Y 1+
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y, yes; N, no; P, partial yes.
Methodological Quality of Systematic Reviews using GRADE and Level of Evidence (LOE) using SIGN Methods
Reference 
number 
1 2 3 4 5 6 7 8 GRADE LOE
SR1 –2 –1 –1 +1   Very low (1) 1–
SR2 –1 –1 –1 Very low (1) 1–
SR3 –1 Moderate (3) 1+
1. Limitation, 2. Inconsistency, 3. Indirectness, 4. Imprecision, 5. Publication Bias, 6. Large magnitude effect, 7. All 
plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect, 8. 
Dose response gradient.
The following is the final Cochrane Library searching strategy used for KQ16 (“How can the safety of cardiac rehabili-
tation exercise be enhanced?”) including the basic searching strategy for exercise therapy for CR:
Searching Strategies
#20 MeSH descriptor: [Cardiac Rehabilitation] explode all trees
#21 ((*cardia* or heart*) and *habilitation*):ti,ab,kw
#22 {or #20-#21}
#23 MeSH descriptor: [Wireless Technology] explode all trees
#24 MeSH descriptor: [Electrocardiography] explode all trees
#25 ((electrocardiography or ecg or ekg) near monitor*):ti,ab,kw
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#26 MeSH descriptor: [Safety] explode all trees
#27 (safe* or risk):ti,ab,kw
#28 {or #23-#27}
#29 #19 and #22 and #28
Finally Included Studies
Reference number Article
- -
The following is the final Cochrane Library searching strategy used for KQ17 (“Can a home-based cardiac rehabili-
tation program replace a hospital-based cardiac rehabilitation program?”) including the basic searching strategy for 
exercise therapy for CR:
Searching Strategies
#20 MeSH descriptor: [Cardiac Rehabilitation] explode all trees
#21 ((*cardia* or heart*) and *habilitation*):ti,ab,kw
#22 MeSH descriptor: [Rehabilitation] explode all trees
#23 (rehabilitat* or *habilitation):ti,ab,kw
#24 MeSH descriptor: [Physical and Rehabilitation Medicine] explode all trees
#25 MeSH descriptor: [Health Facilities] explode all trees
#26 MeSH descriptor: [Rehabilitation Nursing] explode all trees
#27 {or #20-#26}
#28 (home or center or centre):ti,ab,kw
#29 #19 and #27 and #28
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (37), Embase (70), PubMed (156)
Total (n=263)
Records after duplicates removed
(n=85)
Records screened on basis of title and abstract
(n=85)
Full-text articles accessed for eligibility
(n=52)
Studies included in qualitative synthesis
(n=0)
Records excluded
(n=33)
Full-text articles excluded, with reasons (n=52)
1. The patient does not have acute coronary syndrome (n=1)
2. Literatures irrelevant to the key question (n=33)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=7)
6. Full text unavailable (n=6)
7. Other (n=5)
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Finally Included Studies
Reference 
number
Article
SR1 Claes J, Buys R, Budts W, Smart N, Cornelissen VA. Longer-term effects of home-based exercise interven-
tions on exercise capacity and physical activity in coronary artery disease patients: a systematic review 
and meta-analysis. Eur J Prev Cardiol 2017;24:244-56.
SR2 Anderson L, Sharp GA, Norton RJ, Dalal H, Dean SG, Jolly K, et al. Home-based versus centre-based car-
diac rehabilitation. Cochrane Database Syst Rev 2017;6:CD007130.
SR3 Huang K, Liu W, He D, Huang B, Xiao D, Peng Y, et al. Telehealth interventions versus center-based car-
diac rehabilitation of coronary artery disease: a systematic review and meta-analysis. Eur J Prev Cardiol 
2015;22:959-71.
SR4 McClure T, Haykowsky MJ, Schopflocher D, Hsu ZY, Clark AM. Home-based secondary prevention pro-
grams for patients with coronary artery disease: a meta-analysis of effects on anxiety. J Cardiopulm Re-
habil Prev 2013;33:59-67.
SR, systematic reviews.
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (12), Embase (41), PubMed (28)
Total (n=81)
Records after duplicates removed
(n=68)
Records screened on basis of title and abstract
(n=68)
Full-text articles accessed for eligibility
(n=25)
Studies included in qualitative synthesis
(n=4)
Records excluded
(n=43)
Full-text articles excluded, with reasons (n=21)
1. The patient does not have acute coronary syndrome (n=1)
2. Literatures irrelevant to the key question (n=10)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=6)
6. Full text unavailable (n=0)
7. Other (n=4, not meta-analysis)
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Evidence Table for Assessment of Risk of Bias and Quality: KQ17
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 1–
SR2 Y Y Y Y Y Y Y Y Y N N N N N N N 1+
SR3 Y Y Y Y Y Y Y Y Y N Y Y Y Y Y Y 1–
SR4 Y Y Y P Y P P Y Y N Y Y Y Y Y N 1–
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y, yes; N, no; P, partial yes.
Methodological Quality of Systematic Reviews using GRADE and Level of Evidence (LOE) using SIGN Methods
Reference 
number 
1 2 3 4 5 6 7 8 GRADE LOE
SR1 –1 –1   Low (2) 1–
SR2 –1 –1 +1 Moderate (3) 1+
SR3 –1 –1 Low (2) 1–
SR4 –1 –1 –1 Very low (1) 1–
1. Limitation, 2. Inconsistency, 3. Indirectness, 4. Imprecision, 5. Publication Bias, 6. Large magnitude effect, 7. All 
plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect, 8. 
Dose response gradient.
The following is the final Cochrane Library searching strategy used for KQ18 (“Should cardiac rehabilitation pro-
grams be recommended to elderly patients?”) including the basic searching strategy for exercise therapy for CR:
Searching Strategies
MeSH descriptor: [Cardiac Rehabilitation] explode all trees
#21 ((*cardia* or heart*) and *habilitation*):ti,ab,kw
#22 MeSH descriptor: [Rehabilitation] explode all trees
#23 (rehabilitat* or *habilitation):ti,ab,kw
#24 MeSH descriptor: [Physical and Rehabilitation Medicine] explode all trees
#25 MeSH descriptor: [Health Facilities] explode all trees
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#26 MeSH descriptor: [Rehabilitation Nursing] explode all trees
#27 {or #20-#26}
#28 MeSH descriptor: [Women] explode all trees
#29 MeSH descriptor: [Aged] explode all trees
#30 (women or woman or female or gender):ti,ab,kw
#31 (old* or elder* or aged):ti,ab,kw
#32 {or #28-#31}
#33 #19 and #27 and #32
Finally Included Studies
Reference 
number
Article
SR1 Yamamoto S, Hotta K, Ota E, Mori R, Matsunaga A. Effects of resistance training on muscle strength, ex-
ercise capacity, and mobility in middle-aged and elderly patients with coronary artery disease: a meta-
analysis. J Cardiol 2016;68:125-34.
SR, systematic reviews.
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (21), Embase (76), PubMed (22)
Total (n=119)
Records after duplicates removed
(n=113)
Records screened on basis of title and abstract
(n=113)
Full-text articles accessed for eligibility
(n=29)
Studies included in qualitative synthesis
(n=1)
Records excluded
(n=84)
Full-text articles excluded, with reasons (n=28)
1. The patient does not have acute coronary syndrome (n=0)
2. Literatures irrelevant to the key question (n=17)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=4)
6. Full text unavailable (n=4)
7. Other (n=3, same clinical trials cited in other SR)
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Evidence Table for Assessment of Risk of Bias and Quality
Methodological Quality of Systematic Reviews using AMSTAR 2.0 and Level of Evidence (LOE) using SIGN Methods
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
SR1 Y Y Y Y Y Y P Y Y N Y Y Y Y Y Y 1++
1. Did the research questions and inclusion criteria for the review include the components of PICO? 2. Did the report 
of the review contain an explicit statement that the review methods were established prior to the conduct of the review 
and did the report justify any significant deviations from the protocol? 3. Did the review authors explain their selec-
tion of the study designs for inclusion in the review? 4. Did the review authors use a comprehensive literature search 
strategy? 5. Did the review authors perform study selection in duplicate? 6. Did the review authors perform data ex-
traction in duplicate? 7. Did the review authors provide a list of excluded studies and justify the exclusions? 8. Did the 
review authors describe the included studies in adequate detail? 9. Did the review authors use a satisfactory technique 
for assessing the risk of bias (RoB) in individual studies that were included in the review? 10. Did the review authors 
report on the sources of funding for the studies included in the review? 11. If meta-analysis was performed did the re-
view authors use appropriate methods for statistical combination of results? 12. If meta-analysis was performed, did 
the review authors assess the potential impact of RoB in individual studies on the results of the meta-analysis or other 
evidence synthesis? 13. Did the review authors account for RoB in individual studies when interpreting/ discussing 
the results of the review? 14. Did the review authors provide a satisfactory explanation for, and discussion of, any het-
erogeneity observed in the results of the review? 15. If they performed quantitative synthesis did the review authors 
carry out an adequate investigation of publication bias (small study bias) and discuss its likely impact on the results of 
the review? 16. Did the review authors report any potential sources of conflict of interest, including any funding they 
received for conducting the review?
Y, yes; N, no; P, partial yes.
Methodological Quality of Systematic Reviews using GRADE and Level of Evidence (LOE) using SIGN Methods
Reference 
number 
1 2 3 4 5 6 7 8 GRADE LOE
SR1   High (4) 1++
1. Limitation, 2. Inconsistency, 3. Indirectness, 4. Imprecision, 5. Publication Bias, 6. Large magnitude effect, 7. All 
plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect, 8. 
Dose response gradient.
4. EDUCATION FOR CARDIAC REHABILITATION
The following is the basic searching strategy commonly used in education for cardiac rehabilitation in the Cochrane 
Library. This basic searching strategy was combined with the specific searching strategy for each question using AND.
MeSH descriptor: [Myocardial Ischemia] explode all trees
#17 ((myocard* or heart* or coronary or cardia*) and (infarct* or isch* or attack*)):ti,ab,kw 
#18 (“acute coronary syndrome” or ACS):ti,ab,kw 
#19 (angina or stenocardia*):ti,ab,kw 
#20 MeSH descriptor: [Myocardial Revascularization] explode all trees
#21 ((Myocard* or cardi* or coronary) and (Revascular* or angioplast*)):ti,ab,kw 
#22 ((coronary or rotational) near atherectom*):ti,ab,kw 
#23 (“coronary artery bypass” or CABG or “aortocoronary bypass” or “coronary bypass”):ti,ab,kw 
#24 MeSH descriptor: [Percutaneous Coronary Intervention] explode all trees
#25 (“percutaneous coronary intervention*” or PCI):ti,ab,kw 
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#26 (percutaneous next coronary near/2 (interven* or revascular*)):ti,ab,kw 
#27 (stent* and (heart or cardiac*)):ti,ab,kw 
#28 coronary near (disease* or bypass or thrombo* or angioplast*):ti,ab,kw 
#29 (PTCA or “percutaneous transluminal coronary angioplasty”):ti,ab,kw 
#30 MeSH descriptor: [Heart Bypass, Right] explode all trees
#31 (“heart manual”):ti,ab,kw 
#32 {or #16-#31} 
#33 MeSH descriptor: [Rehabilitation] explode all trees
#34 (rehabilitat* or *habilitation):ti,ab,kw 
#35 MeSH descriptor: [Physical and Rehabilitation Medicine] explode all trees
#36 MeSH descriptor: [Health Facilities] explode all trees
#37 MeSH descriptor: [Rehabilitation Nursing] explode all trees
#38 {or #33-#37} 
#39 MeSH descriptor: [Cardiac Rehabilitation] explode all trees
#40 ((*cardia* or heart*) and *habilitation*):ti,ab,kw 
#41 #39 or #40 
#42 (#32 and #38) or #41 
The following is the final Cochrane Library searching strategy used for KQ19 (“Is patient education necessary as part 
of cardiac rehabilitation?”) including the basic searching strategy for education for secondary prevention:
Searching Strategies
#1 MeSH descriptor: [Health Behavior] explode all trees
#2 (health next behaviour* or health next behavior*):ti,ab,kw 
#3 MeSH descriptor: [Patient Discharge] explode all trees
#4 (“patient discharge” or discharging next patient*):ti,ab,kw 
#5 MeSH descriptor: [Patient Transfer] explode all trees
#6 MeSH descriptor: [Patient Handoff ] explode all trees
#7 (handoff or handover or “hand off” or “hand over”):ti,ab,kw 
#8 shared care:ti,ab,kw 
#9 (“behaviour change” or “behavior change”):ti,ab,kw 
#10 (maintenance*):ti,ab,kw 
#11 (transition* near/3 care):ti,ab,kw 
#12 (“peer support” or “peer mentoring” or peer next counsel*):ti,ab,kw 
#13 MeSH descriptor: [Health Education] explode all trees
#14 (“health education”):ti,ab,kw 
#15 {or #1-#14}
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Finally Included Studies
Reference 
Number
Article
SR1 Anderson L, Brown JP, Clark AM, Dalal H, Rossau HK, Bridges C, et al. Patient education in the manage-
ment of coronary heart disease. Cochrane Database Syst Rev 2017;6:CD008895.
SR, systematic reviews.
Evidence Table for Assessment of Risk of Bias and Quality
Methodological Quality of Systematic Reviews using GRADE and Level of Evidence (LOE) using SIGN Methods
Reference 
number 
1 2 3 4 5 6 7 8 GRADE LOE
SR1     1  1         Low (2) 1–
1. Limitation, 2. Inconsistency, 3. Indirectness, 4. Imprecision, 5. Publication Bias, 6. Large magnitude effect, 7. All 
plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect, 8. 
Dose response gradient.
The following is the final Cochrane Library searching strategy used for KQ20 (“What contents should be included in 
patient education?”) and KQ21 (“What interventions are needed to boost patients’ drug compliance?”) including the 
basic searching strategy in education for cardiac rehabilitation:
Searching Strategies
#1 Medication Adherence*:ti,ab,kw 
#2 medication adj3 (adherence* or “non-adherence” or nonadherence* or “non adherence” or  compliance* or 
non-compliance* or “non compliance” or persistence*):ti,ab,kw 
#3 *Patient Compliance:ti,ab,kw 
#4 MeSH descriptor: [Medication Adherence] explode all trees
#5 #1 or #2 or #3 or #4
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (31), Embase (217), PubMed (132)
Total (n=380)
Records after duplicates removed
(n=359)
Records screened on basis of title and abstract
(n=359)
Full-text articles accessed for eligibility
(n=9)
Studies included in qualitative synthesis
(n=1)
Records excluded
(n=350)
Full-text articles excluded, with reasons (n=8)
1. The patient does not have acute coronary syndrome (n=3)
2. Literatures irrelevant to the key question (n=2)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=0)
6. Full text unavailable (n=1)
7. Other (n=3, not SR)
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Finally Included Studies
Reference 
number
Article
SR1 Adler AJ, Martin N, Mariani J, Tajer CD, Owolabi OO, Free C, et al. Mobile phone text messaging to im-
prove medication adherence in secondary prevention of cardiovascular disease. Cochrane Database 
Syst Rev 2017;4:CD011851.
SR2 Chase JA, Bogener JL, Ruppar TM, Conn VS. The effectiveness of medication adherence interventions 
among patients with coronary artery disease: a meta-analysis. J Cardiovasc Nurs 2016;31:357-66.
SR3 Gandapur Y, Kianoush S, Kelli HM, Misra S, Urrea B, Blaha MJ, et al. The role of mHealth for improving 
medication adherence in patients with cardiovascular disease: a systematic review. Eur Heart J Qual 
Care Clin Outcomes 2016;2:237-44.
SR4 Johnston N, Weinman J, Ashworth L, Smethurst P, El Khoury J, Moloney C. Systematic reviews: causes of 
non-adherence to P2Y12 inhibitors in acute coronary syndromes and response to intervention. Open 
Heart 2016;3:e000479.
SR5 Gandhi S, Chen S, Hong L, Sun K, Gong E, Li C, et al. Effect of mobile health interventions on the sec-
ondary prevention of cardiovascular disease: systematic review and meta-analysis. Can J Cardiol 
2017;33:219-31.
SR6 Zullig LL, Ramos K, Bosworth HB. Improving medication adherence in coronary heart disease. Curr Car-
diol Rep 2017;19:113.
SR, systematic reviews.
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (37), Embase (255), PubMed (73)
Total (n=365)
Records after duplicates removed
(n=337)
Records screened on basis of title and abstract
(n=337)
Full-text articles accessed for eligibility
(n=14)
Studies included in qualitative synthesis
(n=6)
Records excluded
(n=323)
Full-text articles excluded, with reasons (n=8)
1. The patient does not have acute coronary syndrome (n=3)
2. Literatures irrelevant to the key question (n=2)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=0)
6. Full text unavailable (n=3)
7. Other (n=0)
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Evidence Table for Assessment of Risk of Bias and Quality
Methodological Quality of Systematic Reviews using GRADE and Level of Evidence (LOE) using SIGN Methods
Reference 
number 
1 2 3 4 5 6 7 8 GRADE LOE
SR1     1 1         Low (2) 1–
SR2 1 1 1 Very low (1) 1–
SR3 1 1 1 Very low (1) 1–
SR4 1 1 1 Very low (1) 1–
SR5 1 1 Low (2) 1–
SR6 1 1 Low (2) 1–
1. Limitation, 2. Inconsistency, 3. Indirectness, 4. Imprecision, 5. Publication Bias, 6. Large magnitude effect, 7. All 
plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect, 8. 
Dose response gradient.
The following is the final Cochrane Library searching strategy used for KQ22 (“What is a good brief intervention for 
patients who need to quit smoking?”) including the basic searching strategy for education for cardiac rehabilitation:
Searching Strategies
#1 brief smoking cessation:ti,ab,kw 
#2 (brief intervention* near/4 smoking):ti,ab,kw 
#3 (brief near/3 smoking cessation):ti,ab,kw 
#4 #1 or #2 or #3 
#5 MeSH descriptor: [Tobacco Use Cessation] explode all trees
#6 MeSH descriptor: [Tobacco Use] explode all trees
#7 ((smok* or tobacco or cigar* or nicotine) near/3 (quit* or stop* or ceas* or cessation)):ti,ab,kw 
#8 MeSH descriptor: [Tobacco Use Disorder] explode all trees
#9 MeSH descriptor: [Tobacco Products] explode all trees
#10 #6 or #8 or #9 
#11 (quit* or stop* or ceas* or cessation):ti,ab,kw 
#12 #10 and #11 
#13 #5 or #7 or #12
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Finally Included Studies
Reference 
number
Article
SR1 Franck C, Filion KB, Eisenberg MJ. Smoking cessation in patients with acute coronary syndrome. Am J 
Cardiol 2018;121:1105-11.
SR, systematic reviews.
Evidence Table for Assessment of Risk of Bias and Quality
Methodological Quality of Systematic Reviews using GRADE and Level of Evidence (LOE) using SIGN Methods
Reference 
Number 
1 2 3 4 5 6 7 8 GRADE LOE
SR1 1   1  1         Very low (1) 1–
1. Limitation, 2. Inconsistency, 3. Indirectness, 4. Imprecision, 5. Publication Bias, 6. Large magnitude effect, 7. All 
plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect, 8. 
Dose response gradient.
KQ23. Should a specific food supplement be recommended for patients undergoing cardiac rehabilitation? For 
KQ24-1, omega-3: The following searching strategy was used without combining the common searching strategy:
Searching Strategies
#1 (omega-3 or “omega 3”) .ti,ab. 
#2 MeSH descriptor: [Fatty Acids, Omega-3] explode all trees
#3 #1 or #2 
#4 MeSH descriptor: [Myocardial Ischemia] explode all trees
#5 ((myocard* or heart* or coronary or cardia*) and (infarct* or isch* or attack*)):ti,ab,kw 
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (8), Embase (425), PubMed (22)
Total (n=72)
Records after duplicates removed
(n=67)
Records screened on basis of title and abstract
(n=67)
Full-text articles accessed for eligibility
(n=4)
Studies included in qualitative synthesis
(n=1)
Records excluded
(n=63)
Full-text articles excluded, with reasons (n=3)
1. The patient does not have acute coronary syndrome (n=1)
2. Literatures irrelevant to the key question (n=0)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=0)
6. Full text unavailable (n=0)
7. Other (n=2, not SR)
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#6 (“acute coronary syndrome” or ACS):ti,ab,kw 
#7 (angina or stenocardia*):ti,ab,kw 
#8 MeSH descriptor: [Myocardial Revascularization] explode all trees
#9 ((Myocard* or cardi* or coronary) and (Revascular* or angioplast*)):ti,ab,kw 
#10 ((coronary or rotational) near atherectom*):ti,ab,kw 
#11 (“coronary artery bypass” or CABG or “aortocoronary bypass” or “coronary bypass”):ti,ab,kw 
#12 MeSH descriptor: [Percutaneous Coronary Intervention] explode all trees
#13 (“percutaneous coronary intervention*” or PCI):ti,ab,kw 
#14 (percutaneous next coronary near/2 (interven* or revascular*)):ti,ab,kw 
#15 (stent* and (heart or cardiac*)):ti,ab,kw 
#16 coronary near (disease* or bypass or thrombo* or angioplast*):ti,ab,kw 
#17 (PTCA or “percutaneous transluminal coronary angioplasty”):ti,ab,kw 
#18 MeSH descriptor: [Heart Bypass, Right] explode all trees
#19 (“heart manual”):ti,ab,kw 
#20 {or #4-#19} 
#21 #3 and #20
Finally Included Studies
Reference 
number
Article
SR1 Abdelhamid A, Martin N, Bridges C, Song F, Deane KH, Hooper L. Polyunsaturated fat intake for 
prevention of cardiovascular disease. Cochrane Database Syst Rev 2016 Sep 7 [Epub]. https://doi.
org//10.1002/14651858.CD012345.
SR, systematic reviews.
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (34), Embase (175), PubMed (37)
Total (n=246)
Records after duplicates removed
(n=235)
Records screened on basis of title and abstract
(n=235)
Full-text articles accessed for eligibility
(n=18)
Studies included in qualitative synthesis
(n=1)
Records excluded
(n=217)
Full-text articles excluded, with reasons (n=17)
1. The patient does not have acute coronary syndrome (n=14)
2. Literatures irrelevant to the key question (n=0)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=0)
6. Full text unavailable (n=3)
7. Other (n=0)
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Evidence Table for Assessment of Risk of Bias and Quality: KQ24-1
Methodological Quality of Systematic Reviews using GRADE and Level of Evidence (LOE) using SIGN Methods
Reference 
number 
1 2 3 4 5 6 7 8 GRADE LOE
SR1   High (4) 1++
1. Limitation, 2. Inconsistency, 3. Indirectness, 4. Imprecision, 5. Publication Bias, 6. Large magnitude effect, 7. All 
plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect, 8. 
Dose response gradient.
For KQ24-2, policosanol: Only policosanol was used for the search due to a lack of relevant literature.
Searching Strategies
#1 (policosanol or polycosanol).ti,ab
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (14), Embase (379), PubMed (51)
Total (n=444)
Records after duplicates removed
(n=427)
Records screened on basis of title and abstract
(n=427)
Full-text articles accessed for eligibility
(n=131)
Studies included in qualitative synthesis
(n=3)
Records excluded
(n=296)
Full-text articles excluded, with reasons (n=128)
1. The patient does not have acute coronary syndrome (n=126)
2. Literatures irrelevant to the key question (n=0)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=0)
6. Full text unavailable (n=2)
7. Other (n=0)
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Finally Included Studies
Reference 
number
Article
RCT1 Marazzi G, Campolongo G, Pelliccia F, Quattrino S, Vitale C, Cacciotti L, et al. Comparison of low-dose 
statin versus low-dose statin + Armolipid plus in high-intensity statin-intolerant patients with a pre-
vious coronary event and percutaneous coronary intervention (ADHERENCE Trial). Am J Cardiol 
2017;120:893-7.
RCT2 Marazzi G, Pelliccia F, Campolongo G, Quattrino S, Cacciotti L, Volterrani M, et al. Usefulness of nutra-
ceuticals (Armolipid Plus) versus ezetimibe and combination in statin-intolerant patients with dyslipid-
emia with coronary heart disease. Am J Cardiol 2015;116:1798-801.
RCT3 Xu K, Liu X, Li Y, Wang Y, Zang H, Guo L, et al. Safety and efficacy of policosanol in patients with high on-
treatment platelet reactivity after drug-eluting stent implantation: two-year follow-up results. Cardio-
vasc Ther 2016;34:337-42.
RCT, randomized controlled trial.
Evidence Table for Assessment of Risk of Bias and Quality
Randomized Control Trials (RCTs)
Reference 
number
Quality items
LOE
1 2 3 4 5 6 7
RCT1 L U H L L L L 1+
RCT2 L U H L L L L 1+
RCT3 U U U U L U L 1–
1. Random sequence generation: selection bias (biased allocation to interventions) due to inadequate generation of a 
randomized. 2. Allocation concealment: selection bias (biased allocation to interventions) due to inadequate conceal-
ment of allocations prior to assignment. 3. Blinding of participants and personnel: performance bias due to knowledge 
of the allocated interventions by participants and personnel During the study. 4. Blinding of outcome assessment: 
detection bias due to knowledge of the allocated interventions by outcome assessors. 5. Incomplete outcome data: at-
trition bias due to amount, nature or handling of incomplete outcome data. 6. Selective reporting: reporting bias due 
to selective outcome reporting. 7. Other bias: bias due to problems not covered elsewhere in the table.
L, low risk of bias; H, high risk of bias; U, unclear risk of bias.
For KQ24-3, antioxidants: The following searching strategy was used without combining the common searching 
strategy:
Searching Strategies
#1 antioxidant 
#2 MeSH descriptor: [Antioxidants] explode all trees
#3 {or #1-#2} 
#4 MeSH descriptor: [Myocardial Ischemia] explode all trees
#5 ((myocard* or heart* or coronary or cardia*) and (infarct* or isch* or attack*)):ti,ab,kw 
#6 (“acute coronary syndrome” or ACS):ti,ab,kw 
#7 (angina or stenocardia*):ti,ab,kw 
#8 MeSH descriptor: [Myocardial Revascularization] explode all trees
#9 ((Myocard* or cardi* or coronary) and (Revascular* or angioplast*)):ti,ab,kw 
#10 ((coronary or rotational) near atherectom*):ti,ab,kw 
#11 (“coronary artery bypass” or CABG or “aortocoronary bypass” or “coronary bypass”):ti,ab,kw 
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#12 MeSH descriptor: [Percutaneous Coronary Intervention] explode all trees
#13 (“percutaneous coronary intervention*” or PCI):ti,ab,kw 
#14 (percutaneous next coronary near/2 (interven* or revascular*)):ti,ab,kw 
#15 (stent* and (heart or cardiac*)):ti,ab,kw 
#16 coronary near (disease* or bypass or thrombo* or angioplast*):ti,ab,kw 
#17 (PTCA or “percutaneous transluminal coronary angioplasty”):ti,ab,kw 
#18 MeSH descriptor: [Heart Bypass, Right] explode all trees
#19 (“heart manual”):ti,ab,kw 
#20 {or #4-#19} 
#21 #3 and #20
Finally Included Studies
Reference 
number
Article
SR1 Loffredo L, Perri L, Di Castelnuovo A, Iacoviello L, De Gaetano G, Violi F. Supplementation with vitamin 
E alone is associated with reduced myocardial infarction: a meta-analysis. Nutr Metab Cardiovasc Dis 
2015;25:354-63.
SR2 Myung SK, Ju W, Cho B, Oh SW, Park SM, Koo BK, et al. Efficacy of vitamin and antioxidant supplements 
in prevention of cardiovascular disease: systematic review and meta-analysis of randomized controlled 
trials. BMJ 2013;346:f10.
SR3 Ye Y, Li J, Yuan Z. Effect of antioxidant vitamin supplementation on cardiovascular outcomes: a meta-
analysis of randomized controlled trials. PLoS One 2013;8:e56803.
SR, systematic reviews.
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (58), Embase (253), PubMed (34)
Total (n=345)
Records after duplicates removed
(n=326)
Records screened on basis of title and abstract
(n=326)
Full-text articles accessed for eligibility
(n=13)
Studies included in qualitative synthesis
(n=3)
Records excluded
(n=313)
Full-text articles excluded, with reasons (n=10)
1. The patient does not have acute coronary syndrome (n=1)
2. Literatures irrelevant to the key question (n=6)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=0)
6. Full text unavailable (n=3)
7. Other (n=0)
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Evidence Table for Assessment of Risk of Bias and Quality
Methodological Quality of Systematic Reviews using GRADE and Level of Evidence (LOE) using SIGN Methods
Reference 
Number 
1 2 3 4 5 6 7 8 GRADE LOE
SR1 1 1   Low (2) 1-
SR2 1 Moderate (3) 1+
SR3 High (4) 1++
1. Limitation, 2. Inconsistency, 3. Indirectness, 4. Imprecision, 5. Publication Bias, 6. Large magnitude effect, 7. All 
plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect, 8. 
Dose response gradient.
The following is the final Cochrane Library searching strategy used for KQ25 (“Would ICT-based modality be help-
ful in maintaining the effects of education in the long-term?”) including the basic searching strategy for education for 
cardiac rehabilitation:
Searching Strategies
#1 MeSH descriptor: [Social Media] explode all trees
#2 (social next medi*):ti,ab,kw 
#3 (twitter or facebook):ti,ab,kw 
#4 (web next 2* or web2*):ti,ab,kw 
#5 {or #1-#4} 
#6 pedometer*:ti,ab,kw 
#7 (activity monitor* or activity track* or acceleromet* or fitness monitor* or fitness track*):ti,ab,kw 
#8 (fitbit or fitband or “fit band” or fitness next watch*):ti,ab,kw 
#9 {or #6-#8} 
#10 MeSH descriptor: [Mobile Applications] explode all trees
#11 (mobile app* or portable electronic app* or portable software app*):ti,ab,kw 
#12 (virtual realit* or exergam* or exer gam* or wifit or wi fit):ti,ab,kw 
#13 {or #10-#12} 
#14 (interactive near/2 (technol* or software)):ti,ab,kw 
#15 {or #14} 
#16 MeSH descriptor: [Telemedicine] explode all trees
#17 (telehealth* or tele-health* or telemedicine* or tele-medicine*):ti,ab,kw 
#18 (mhealth or m-health or mobile next health*):ti,ab,kw 
#19 {or #16-#18} 
#20 #5 or #9 or #13 or #15 or #19
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Finally Included Studies
Reference 
number
Article
SR1 Coorey GM, Neubeck L, Mulley J, Redfern J. Effectiveness, acceptability and usefulness of mobile applica-
tions for cardiovascular disease self-management: systematic review with meta-synthesis of quantita-
tive and qualitative data. Eur J Prev Cardiol 2018;25:505-21.
SR2 Gandapur Y, Kianoush S, Kelli HM, Misra S, Urrea B, Blaha MJ, et al. The role of mHealth for improving 
medication adherence in patients with cardiovascular disease: a systematic review. Eur Heart J Qual 
Care Clin Outcomes 2016;2:237-44.
SR3 Hamilton SJ, Mills B, Birch EM, Thompson SC. Smartphones in the secondary prevention of cardiovascu-
lar disease: a systematic review. BMC Cardiovasc Disord 2018;18:25.
SR4 Rawstorn JC, Gant N, Direito A, Beckmann C, Maddison R. Telehealth exercise-based cardiac rehabilita-
tion: a systematic review and meta-analysis. Heart 2016;102:1183-92.
SR, systematic reviews.
Evidence Table for Assessment of Risk of Bias and Quality
Methodological Quality of Systematic Reviews using GRADE and Level of Evidence (LOE) using SIGN Methods
Reference 
number 
1 2 3 4 5 6 7 8 GRADE LOE
SR1 1 1 1   Very low (1) 1-
SR2 1 1 1 Very low (1) 1-
SR3 1 1 1 Very low (1) 1-
SR4 1 Moderate (3) 1+
1. Limitation, 2. Inconsistency, 3. Indirectness, 4. Imprecision, 5. Publication Bias, 6. Large magnitude effect, 7. All 
plausible confounding would reduce a demonstrated effect or suggest a spurious effect when results show no effect, 8. 
Dose response gradient.
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (16), Embase (91), PubMed (26)
Total (n=133)
Records after duplicates removed
(n=125)
Records screened on basis of title and abstract
(n=125)
Full-text articles accessed for eligibility
(n=7)
Studies included in qualitative synthesis
(n=4)
Records excluded
(n=118)
Full-text articles excluded, with reasons (n=3)
1. The patient does not have acute coronary syndrome (n=1)
2. Literatures irrelevant to the key question (n=1)
3. Non-human studies (animal study or preclinical studies) (n=0)
4. Literatures published in languages other than English or Korean (n=0)
5. Duplicate publication (n=0)
6. Full text unavailable (n=0)
7. Other (n=1, not SR)
Chul Kim, et al.
442 www.e-arm.org
Korean Literature Search and Selection
Korean literatures were searched on RISS, KMbase, and KoreaMed, using terms “심장재활” and “cardiac rehabilita-
tion.”
Previous Published Clinical Guideline Search
1. PubMed Search
1.1 Guidelines in PubMed were searched using the term “cardiac rehabilitation.”
Search “cardiac rehabilitation”[TIAB] OR “cardiac rehabilitation”[MeSH] Filters: Consensus Development Confer-
ence; Guideline; NIH; Practice Guideline
PubMed date: February 2, 2018
Search results: 86 
1.2 Guidelines in PubMed were searched using specific key terms such as “myocardial infarction.”
Search “cardiac rehabilitation”[TIAB] OR “cardiac rehabilitation”[MeSH] Filters: Consensus Development Confer-
ence; Guideline; NIH; Practice Guideline
PubMed date: February 2, 2018
Search results: 68 → 22 were selected after reviewing the title and abstract
2. Review the Reference Lists of Two Recent Systemic Reviews of Cardiac Rehabilitation Guidelines
Flow Chart of Study Selection Process
Records identified through database searching
Cochrane (139), Embase (119), PubMed (93)
Total (n=351)
Records after duplicates removed
(n=162)
Records screened on basis of abstract
(n=74)
Full-text articles accessed for eligibility
(n=49)
Studies included in qualitative synthesis
(n=17)
Records excluded
(n=25)
Full-text articles excluded, with reasons (n=32)
n=25 (old article before 2010)
n=7 (non-RCT subjects <30)
n=2 (not releated with PICO)
Records screeded on basis of title
(n=162)
Records excluded
(n=88)
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2.1 Abel et al. article: 59 articles 
Abell B, Glasziou P, Hoffmann T. Exploration of the methodological quality and clinical usefulness of a cross-sectional 
sample of published guidance about exercise training and physical activity for the secondary prevention of coronary 
heart disease. BMC Cardiovasc Disord 2017;17:153.
2.2 Seron article: 9 articles 
Seron P, Lanas F, Ríos E, Bonfill X, Alonso-Coello P. Evaluation of the quality of clinical guidelines for cardiac rehabili-
tation: a critical review. J Cardiopulm Rehabil Prev 2015;35:1-12.
3. Search of the Database Recorded in the Guideline
 
Search term: “cardiac rehabilitation”
Search date: January 15, 2018
No. Guideline Homepage URL
Search 
results
1 National Electronic Library for Health (NeLH) 
Guidelines Finder 
https://www.evidence.nhs.uk/ 89
2 National Guidelines Clearinghouse https://www.guideline.gov 10
3 Scottish Intercollegiate Guidelines Network (SIGN) https://www.sign.ac.uk/ 2
4 Guidelines International Network (GIN) http://www.g-i-n.net/ 5
5 Canadian Medical Association (CMA) Infobase 
(Canadian guidelines)
https://www.cma.ca/en/Pages/cpg-by-special-
ty.aspx?categoryCode=CARDIO 
1
6 National Health and Medical Research Council 
(NHMRC) 
https://www.nhmrc.gov.au/guidelines/search 1
7 Clinical Practice Guidelines (Australian Guide-
lines) 
https://www.clinicalguidelines.gov.au/ 0
8 New Zealand Guidelines Group https://www.health.govt.nz/about-ministry/minis-
try-health-websites/new-zealand-guidelines-group 
0
9 BMJ Clinical Evidence http://clinicalevidence.bmj.com/ 17
10 Cochrane Database of Systematic Reviews (CDSR) http://onlinelibrary.wiley.com/cochraneli-
brary/search/ 
16
11 Database of Abstracts of Reviews of Effects (DARE) http://onlinelibrary.wiley.com/cochraneli-
brary/search/ 
25
12 Heath Technology Assessment Database (HTA) http://onlinelibrary.wiley.com/cochraneli-
brary/search/ 
19
